Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40058,-0.224331177159325,0.00516408769228661,-0.234452789036207,-0.214209565282443,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39477,-0.544740868584773,0.0117499005099243,-0.567770673584224,-0.521711063585321,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.349160550010198,0.00789886122074813,-0.364642318002864,-0.333678782017532,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.26524427509229,0.00492666178099612,-0.274900532183042,-0.255588018001538,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,39858,-0.232368883783245,0.00406797494710135,-0.240342114679564,-0.224395652886927,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.284809378080323,0.00637536317000628,-0.297305089893535,-0.27231366626711,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.108678915576356,0.00274013753782572,0.103308246002218,0.114049585150495,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.171713994476843,0.00385102819847486,-0.179262009745854,-0.164165979207833,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.119454731833637,0.00311935118775955,0.113340803505628,0.125568660161646,4.07379531224175e-307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,39805,-0.146809014254566,0.00391517419782088,-0.154482755682295,-0.139135272826837,5.54294854380293e-295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.104264814253987,0.00285071067632579,-0.109852207179585,-0.0986774213283882,2.84203744281681e-281
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.277823104282422,0.00781429178297923,-0.293139116177062,-0.262507092387783,1.56046747097576e-266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,39868,0.163374874727384,0.00464749793973298,0.154265778765508,0.172483970689261,7.66628524858397e-261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,39758,-0.26235583046146,0.00750974114074904,-0.277074923097328,-0.247636737825592,1.0727522295542e-257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37445,0.174396124189642,0.00522662497910076,0.164151939230604,0.184640309148679,1.07515760030055e-234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37021,-0.298211478800826,0.00909760068397671,-0.316042776141421,-0.280380181460232,1.31817336798262e-226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.15186997963735,0.00466546008933882,-0.161014281412454,-0.142725677862246,3.68783739936494e-225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.286344773019891,0.00880431439860068,-0.303601229241148,-0.269088316798634,1.04353957351798e-224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.20578544569616,0.0063406678690587,-0.218213154719515,-0.193357736672805,1.0327071100093e-223
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.389192040182704,0.0121579027614873,0.365362550770189,0.413021529595219,4.60537992558091e-218
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.175149281020874,0.00550624718777582,-0.185941525508914,-0.164357036532833,3.46315545175182e-214
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,37453,0.207085603132772,0.00653320840184334,0.194280514665159,0.219890691600385,8.50154134930449e-213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.164273873620293,0.00524108265097905,-0.174546395616212,-0.154001351624375,2.40038189160537e-209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.126875952813785,0.00410741842125038,-0.134926492919435,-0.118825412708134,1.49560006116991e-203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FURIN,Furin,39913,-0.103583979474865,0.00335500119973606,-0.110159781826347,-0.0970081771233819,2.21225479943711e-203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.42058636932723,0.013749055013461,-0.447534517153614,-0.393638221500847,7.93472303402954e-200
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.187956443251962,0.00620173081093393,-0.200111835641392,-0.175801050862531,3.09234110268592e-196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37039,-0.238919488234712,0.00792438511344739,-0.254451283057069,-0.223387693412355,3.59676046526524e-193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,39899,-0.0891963601515582,0.00297119706558084,-0.0950199064000966,-0.0833728139030197,1.09307015527241e-192
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.106438524510618,0.00356580264903417,0.0994495513185106,0.113427497702725,1.30860765354087e-190
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,39955,-0.100880871519715,0.00342250447733627,-0.107588980295294,-0.0941727627441362,4.98337817838533e-186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37445,0.0760007514189588,0.00257254535308545,0.0709585625269114,0.0810429403110063,5.75326906454994e-186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37124,-0.0831336097574094,0.002862827547601,-0.0887447517507074,-0.0775224677641114,8.41096534409745e-180
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0867742726917829,0.00299181081549833,0.0809103234934061,0.0926382218901596,2.19177326612213e-179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,39868,-0.175159696979843,0.00614336704692728,-0.18720069639182,-0.163118697567865,1.84828183838743e-174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.336216375386527,0.0118665069438141,-0.359474728996402,-0.312958021776651,2.15684825952739e-172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0814176419365286,0.0028792919122047,-0.0870610540844498,-0.0757742297886074,1.08881411265731e-171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.0835846092046906,0.00303630967516934,0.0776334422413587,0.0895357761680225,4.94073369762104e-163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,39949,0.0759109264339713,0.00276264579637166,0.0704961406730828,0.0813257121948597,1.78885725805797e-162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0894376236389332,0.00325911019256695,-0.0958254796163644,-0.0830497676615019,4.33367054440316e-162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0696723297639532,0.00255102774048707,-0.0746723441353078,-0.0646723153925985,7.11977443976179e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,39858,0.0723000291698622,0.00266110394355221,0.0670842654404999,0.0775157928992246,5.95207508227657e-159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.227847371479225,0.00841459045517171,-0.244339968771362,-0.211354774187089,7.35638627425641e-158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.14083472130959,0.00520288721908006,-0.151032380258987,-0.130637062360193,7.37707485607643e-158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.206172359020654,0.00765519638846462,-0.221176543942044,-0.191168174099263,1.12716063916061e-155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0885522304706727,0.00333094979157072,-0.0950808920621513,-0.0820235688791941,2.00610983500441e-152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.383138888768772,0.0144539185977275,-0.411468569220317,-0.354809208317226,1.6550288977668e-151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,39908,-0.0479668227668656,0.00181694909634659,-0.051528042995705,-0.0444056025380263,2.20835600253846e-150
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.154263574067945,0.00586866601003861,-0.16576615944762,-0.142760988688269,3.89438931956964e-149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.174449362097587,0.0066450222312996,-0.187473605670934,-0.161425118524239,9.5631764872708e-149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0883844521045218,0.00339545182713783,0.0817293665233317,0.095039537685712,2.27326101744533e-146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.132070711859693,0.00510572713310832,-0.142077937040586,-0.122063486678801,1.68397186584341e-144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.219456706666336,0.00848872148988317,-0.236094600786507,-0.202818812546165,2.07544666184116e-144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.116562290910852,0.00452169811757933,0.107699762600396,0.125424819221307,1.312899703814e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.236960999921446,0.0092125476878769,-0.255017593389684,-0.218904406453207,1.68938397443163e-142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.084402961069121,0.00331425293962175,-0.0908988968307796,-0.0779070253074623,2.65292314235442e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.135998841546575,0.0053426811407158,-0.146470496582378,-0.125527186510772,3.81433767555928e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0928748280644688,0.00366393329102496,0.0856935188140599,0.100056137314878,5.11615268699691e-139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40003,-0.0489033567888646,0.00193363046783227,-0.0526932725058158,-0.0451134410719133,1.96538660509315e-138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,39587,-0.199662354550993,0.00791606845614331,-0.215177848725034,-0.184146860376952,1.21994897702229e-137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.103521722624084,0.00411450365378424,-0.111586149785501,-0.0954572954626664,4.84461897824268e-137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.156122373620106,0.00621514169963698,0.143940695888818,0.168304051351395,1.2551676030904e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.135317508339838,0.00539435100777302,0.124744580364603,0.145890436315073,3.3255984262853e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0779387439706625,0.00311313088713607,-0.0840404805094492,-0.0718370074318758,9.83379012234049e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.198413937682982,0.00795113353436825,-0.213998159410344,-0.18282971595562,7.39324978101048e-135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0800359823441272,0.00320179640562681,-0.0863115032991557,-0.0737604613890986,9.81982605620546e-135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0869263711407964,0.0035149225748372,0.0800371228941155,0.0938156193874773,1.4374685891094e-132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.146196736133127,0.00593185735115837,-0.157823176541397,-0.134570295724856,1.30988104719444e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.153312550339648,0.00625747093635229,-0.165577193374899,-0.141047907304398,4.09937375612709e-130
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,38721,-0.0954534054394346,0.00393042774157486,-0.103157043812921,-0.0877497670659478,8.46187827078402e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,39826,-0.243450787731881,0.0100318839723762,-0.263113280317738,-0.223788295146023,8.77946970230705e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.200799383259733,0.00828537929415752,-0.217038726676282,-0.184560039843185,2.10083982635528e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.135831803031896,0.00560863502791331,-0.146824727686606,-0.124838878377186,2.82476569969973e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.20511049837897,0.00846523115557329,-0.221702351443894,-0.188518645314047,5.44014290295081e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0730299674763297,0.00302626106428651,-0.0789614391623313,-0.0670984957903282,2.06536210549804e-126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.081695553689197,0.00339659032276856,-0.0883528707218234,-0.0750382366565707,1.26149791019491e-125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.20918197661075,0.00870289915003906,-0.226239658944826,-0.192124294276673,1.98786751587445e-125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.110440821937714,0.00466135453600275,-0.119577076828279,-0.101304567047149,5.63104663897863e-122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.180010658982343,0.00767542576003077,-0.195054493472003,-0.164966824492682,1.42819361444679e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFM,Afamin,37453,-0.0445950177201866,0.00190579675163747,-0.048330379353396,-0.0408596560869771,9.43979031785576e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.12101852914547,0.0051819100921146,0.110861985364925,0.131175072926014,2.64535409767183e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.247421028491994,0.0106922947836586,-0.268377926267965,-0.226464130716023,1.51651323844675e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.115472364659571,0.00499679433526314,-0.125266081556686,-0.105678647762455,3.19977520644671e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.126899278421819,0.00549314182285426,-0.137665836394613,-0.116132720449025,3.81561727362002e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.085277356232075,0.0037445590613865,-0.0926166919923925,-0.0779380204717575,1.19340098165599e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37309,-0.0572313070959764,0.00253198469954219,-0.0621939971070791,-0.0522686170848737,4.65065744559016e-111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0781835242525335,0.00349704416954235,-0.0850377308248365,-0.0713293176802305,4.73812991014344e-109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MME,Neprilysin,39788,-0.176276437600103,0.00790577488204418,-0.19177175636891,-0.160781118831297,1.78772415579854e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0633255357822527,0.00284301887214616,-0.0688978527716591,-0.0577532187928462,5.60850827875728e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0843645238456805,0.00380694199905361,-0.0918261301638255,-0.0769029175275354,7.16007201173332e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37437,0.12915979241484,0.00584915185901085,0.117695454771179,0.140624130058501,3.46271438262021e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.114767960772628,0.0052516500772119,-0.125061194923964,-0.104474726621293,4.98315917039802e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0715549020068259,0.00328878501850441,0.0651088833705573,0.0780009206430946,1.82754478425551e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40058,-0.0563009683902098,0.00258801971689505,-0.0613734870353241,-0.0512284497450955,1.88813138010981e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.0518705274047432,0.00238485862671509,-0.0565448503131048,-0.0471962044963816,2.16637072422956e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0782902887209666,0.00360975110509017,-0.0853654008869433,-0.0712151765549899,8.1148109191402e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0929662642853702,0.0042926800505291,-0.101379917184407,-0.0845526113863331,1.49785430842001e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0490450594148148,0.00226855622050391,-0.0534914296070024,-0.0445986892226271,3.3762144950381e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37411,-0.0963741486442,0.00447548280096199,-0.105146094934085,-0.0876022023543145,3.69413823481396e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.127133076952209,0.00591823939603509,-0.138732826168438,-0.115533327735981,5.9664129814145e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.111918652296591,0.00526291209502461,-0.122233960002839,-0.101603344590343,5.37165179588561e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0936688873756254,0.00439904900506583,-0.102291023425554,-0.0850467513256963,6.06154985817071e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.236521217474766,0.0111276543739188,-0.258331420047647,-0.214711014901885,1.20169672991993e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.0722910788572081,0.00342063594292162,-0.0789955253053344,-0.0655866324090817,8.10453744108866e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0639974010418058,0.0030301119464595,-0.0699364204568664,-0.0580583816267452,1.12199968235269e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0453032116439223,0.00214589844024545,0.0410972507010412,0.0495091725868034,1.2940859636681e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.172658473814273,0.00818532350933163,-0.188701707892563,-0.156615239735983,1.94800152153154e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.104319057498624,0.00495124539181419,-0.11402349846658,-0.0946146165306684,3.10222635039922e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0669335642099511,0.00319080324562933,-0.0731875385713846,-0.0606795898485176,2.14691668924649e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.136311615235312,0.00651031289216029,-0.149071828503946,-0.123551401966678,7.87104099094184e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.11865642883247,0.00569392620706433,-0.129816524198316,-0.107496333466624,3.50550085350833e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0592561483073001,0.00284048767768152,-0.0648235041555559,-0.0536887924590443,3.7326909036978e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39489,-0.106119502504415,0.00510292391059521,-0.116121233369181,-0.096117771639648,9.03264614278616e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.1896396712941,0.00915769657755096,-0.2075887565861,-0.1716905860021,5.22768313553079e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0798136346599669,0.00387277219068351,0.0722230011662273,0.0874042681537066,3.64588310901421e-93
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,36780,0.0899923358268875,0.00437809082886122,0.0814112778023195,0.0985733938514555,2.06728866853314e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.158616642058392,0.00773557903061554,-0.173778376958399,-0.143454907158386,2.88659122938322e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37124,-0.0852932102833584,0.00417274948507417,-0.0934717992741038,-0.077114621292613,1.85929557933105e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0577855199622062,0.00283150078782991,-0.0633352615063528,-0.0522357784180596,2.00468527110487e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.11195949160084,0.00548608369968951,-0.122712215652231,-0.101206767549448,2.16576571420506e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,39862,-0.108241286129582,0.00531025914950744,-0.118649394062617,-0.0978331781965478,3.36771311106325e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0811215899331448,0.00399746625386442,-0.088956623790719,-0.0732865560755705,2.11508122646969e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.147243790454866,0.00725632765206581,-0.161466192652915,-0.133021388256817,2.13225045632456e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.101057963132644,0.00499393450408432,-0.11084607476065,-0.091269851504639,6.12759083034148e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40058,-0.0606774345888041,0.00301818898283713,-0.0665930849951649,-0.0547617841824433,8.2431557246748e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0925944007656493,0.00461073280723886,-0.101631437067837,-0.0835573644634612,1.29667633696254e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40052,-0.100678281161582,0.00501833633600609,-0.110514220380154,-0.0908423419430098,1.87676203427599e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,39858,-0.0657838512179493,0.00328978836338393,-0.0722318364101818,-0.0593358660257168,7.00104520122592e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0746863718160752,0.00375457768817856,-0.0820453440849052,-0.0673273995472452,5.22178431582743e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.143958991070772,0.00722965242687767,-0.158129109827452,-0.129788872314092,5.58954753789472e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,39908,-0.0674701429280378,0.00339434250010538,-0.0741230542282443,-0.0608172316278313,7.09667969894183e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.108176967901951,0.00544707983412051,-0.118853244376827,-0.0975006914270751,1.02322208142146e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37043,-0.130020322596247,0.00654629179695601,-0.14285105451828,-0.117189590674213,1.60066449536643e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0637459416061943,0.0032118941367431,-0.0700412541142108,-0.0574506290981778,2.02652369712013e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0553321608904695,0.00278998664600152,-0.0608005347166325,-0.0498637870643066,2.67086205189093e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0429423014445187,0.00217254703660809,-0.0472004936362706,-0.0386841092527669,6.14892927324686e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.117516269393579,0.00594988037909385,-0.129178034936603,-0.105854503850555,8.75631752229835e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.11433232144558,0.00580197899084233,-0.125704200267631,-0.102960442623529,3.22641436106566e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0972930337195291,0.00495206438451723,-0.106999079913183,-0.0875869875258753,9.78805324851023e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.116904847260137,0.00597205079868965,-0.128610066825568,-0.105199627694705,2.39035897825178e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0416554450920664,0.0021348528241201,-0.0458397566273418,-0.037471133556791,7.99408812415901e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0640549200238619,0.00328369518171197,-0.0704909625800173,-0.0576188774677064,8.75099088917196e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.124505906000154,0.00638261754658729,0.111995975608843,0.137015836391465,9.07108637515189e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.134025456199331,0.00690316145175483,-0.14755565264477,-0.120495259753891,8.24850243409574e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40058,-0.0885514228174794,0.00458839640946617,-0.0975446797800331,-0.0795581658549257,4.56318809886183e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0492662001526421,0.0025753126876934,-0.0543138130205212,-0.044218587284763,1.1237305152323e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.101175962237092,0.00528968582010127,-0.11154374644449,-0.0908081780296932,1.73707571797575e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELN,Elastin,37437,-0.0645165032474578,0.00339743886918263,-0.0711754834310557,-0.0578575230638598,2.20901244685959e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.143817192076158,0.00759110126216739,-0.158695750550006,-0.12893863360231,3.67694321904203e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.139366025415748,0.00736150522288669,-0.153794575652606,-0.12493747517889,4.6053833023285e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.2103922466559,0.01112238507118,-0.232192121395413,-0.188592371916387,6.39930455918864e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0796332237295433,0.00422138257949958,-0.0879071335853625,-0.0713593138737242,1.64895446088866e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40012,0.0998259500279885,0.00531798415151756,0.0894027010910141,0.110249198964963,8.69897100889385e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0515480167380796,0.00274359586421857,-0.056925464631948,-0.0461705688442112,9.55573090630752e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,39949,-0.0588483201011102,0.00314044660671435,-0.0650035954502703,-0.0526930447519501,1.59536183598551e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.107334276093358,0.00573855623317352,-0.118581846310378,-0.0960867058763382,4.25955945307321e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,37453,-0.037740835954186,0.00201939908477524,-0.0416988581603455,-0.0337828137480265,5.5801151156183e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.127362796849825,0.00682923460325187,-0.140748096672199,-0.113977497027451,8.66428751128923e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.242219526387225,0.0130139161904337,-0.267726802120475,-0.216712250653975,1.6066327968675e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0540031766316515,0.00290427003534543,0.0483108073623744,0.0596955459009285,2.26050141198195e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,39865,-0.0581644649355107,0.00313131243411132,-0.0643018373063689,-0.0520270925646525,3.23029523705117e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0891022635705262,0.00480196779795109,-0.0985141204545103,-0.079690406686542,6.73333430526873e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0925697586595186,0.00501511418659626,-0.102399382465247,-0.0827401348537899,2.71991443636162e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.132454003641482,0.00719338828987254,-0.146553044689632,-0.118354962593332,8.34574896754019e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.119631158599269,0.00651012126440921,-0.132390996277511,-0.106871320921027,1.18421118211247e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.137355276185501,0.00748075161794969,-0.152017549356682,-0.122693003014319,1.58427165932159e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,39846,0.334720286664477,0.0182323848441635,0.298984812369917,0.370455760959038,1.64285965100673e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37241,-0.0434134248020961,0.0023681984546347,-0.0480550937731801,-0.0387717558310121,3.71912303824795e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37445,-0.0492061716643078,0.00268470189186761,-0.0544681873723683,-0.0439441559562473,3.83846698341917e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0479008536303689,0.00262661219539301,-0.0530490135333392,-0.0427526937273986,1.48125196487316e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,39868,-0.115973457418381,0.00639944549318461,-0.128516370585023,-0.103430544251739,1.12861854913033e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37437,-0.203398828551763,0.0112679407709369,-0.225483992462799,-0.181313664640726,5.35990992902076e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0711876213530043,0.00395420188823675,-0.0789378570539483,-0.0634373856520602,9.47788807420451e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,39846,-0.0512235700874911,0.00285044771103895,-0.0568104476011274,-0.0456366925738547,1.67915595421779e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,39908,0.0482262712316987,0.00269139721406018,0.0429511326921408,0.0535014097712567,4.15427744351839e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0769504020844901,0.00429783503034221,-0.0853741587439609,-0.0685266454250194,5.32460461048795e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0875872708781192,0.00489548311136591,0.077992123979842,0.0971824177763964,8.94715720602151e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.123551301206897,0.00692208122179909,-0.137118580401624,-0.109984022012171,1.41073158520293e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,39897,-0.0479134802842535,0.00268481819334909,-0.0531757239432177,-0.0426512366252893,1.49089212896161e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.125162325734372,0.00701914040771781,-0.138919840933499,-0.111404810535245,2.56627246381233e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0358555403684884,0.00201318725829936,-0.0398013873947552,-0.0319096933422217,2.81232388065207e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0691636800020267,0.00389094106952269,-0.0767899244982912,-0.0615374355057622,5.05963408663426e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0392870235173535,0.00221609298240715,-0.0436305657628715,-0.0349434812718355,1.54316828030133e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.154547861537685,0.0087190793167473,-0.17163725699851,-0.13745846607686,1.70724259364063e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.0498041856932519,0.00281416687283847,-0.0553199527640152,-0.0442884186224885,2.00267075119476e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0974310767833377,0.00552133180673056,-0.10825288712453,-0.0866092664421458,5.10565970229291e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0498736130136778,0.00283109518957435,-0.0554225595852435,-0.044324666442112,8.17487825901931e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40058,-0.073198909035634,0.00416375649847363,-0.0813598717726423,-0.0650379462986257,1.5169063558426e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37437,0.0659045564892015,0.00376176069259949,0.0585315055317065,0.0732776074466965,5.6710364741152e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0458929477332123,0.00262702789553797,-0.0510419224084667,-0.0407439730579579,1.34858419305957e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0597267939835904,0.00342286996514546,-0.0664356191152755,-0.0530179688519053,1.45061244521853e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0637848281205532,0.00367012851132556,-0.0709782800027513,-0.0565913762383551,4.78822503075331e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.16023170903481,0.00922227868081897,-0.178307375249215,-0.142156042820405,5.28487443690091e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLN,Promotilin,39866,-0.156392138403099,0.00901505503751582,-0.17406164627663,-0.138722630529568,8.35224452832082e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0997598674489791,0.00576297465214734,-0.111055297767188,-0.0884644371307703,1.56429916162418e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0646659034369089,0.00373594122185142,-0.0719883482317377,-0.0573434586420801,1.63619621932406e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37056,-0.148376974774908,0.00857284291145629,-0.165179746881362,-0.131574202668454,2.21777999658096e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0573827418709455,0.00332348841661276,-0.0638967791675065,-0.0508687045743845,3.34427405641429e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.100241425865774,0.00580687246338233,-0.111622895894003,-0.0888599558375446,3.52091624163152e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.159728969333192,0.00925188536309241,-0.177862664644853,-0.141595274021531,4.41456640990584e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40058,-0.0483234440674406,0.00280158478485259,-0.0538145502457517,-0.0428323378891295,4.46025319827811e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0704854920778762,0.00409245744492992,-0.0785067086699389,-0.0624642754858136,6.96971675398429e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37043,-0.105607252386957,0.0061264914662216,-0.117615175660752,-0.0935993291131629,7.27336869513259e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0641157445380531,0.00372333817548275,-0.0714134873619992,-0.0568180017141069,7.37172423171571e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,39931,0.0754885075526535,0.00439426143684243,0.0668757551364423,0.0841012599688646,1.47064105879359e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0735411785945132,0.00428813072065888,-0.0819459148070046,-0.0651364423820218,2.37582877535229e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.215247732423584,0.0125889544364823,-0.23992208311909,-0.190573381728079,5.81815177848087e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,39868,-0.0606573315075154,0.00354890104194655,-0.0676131775497306,-0.0537014854653001,6.42479488524145e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0332840721520653,0.00194725470611189,-0.0371006913760446,-0.029467452928086,6.58629284756401e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEP,Leptin,39868,-0.116888018744149,0.00685307153389398,-0.130320038950581,-0.103455998537717,1.16885396304653e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0645718061041633,0.00378968048152874,-0.0719995798479597,-0.057144032360367,1.55101657903109e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0460141947097599,0.00270093029055313,0.0407203713402757,0.051308018079244,1.6334163500391e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0745937470723563,0.00438444531739667,-0.0831872598944538,-0.0660002342502589,2.3721110468593e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,39788,-0.117762609355784,0.00696231248568264,-0.131408741827722,-0.104116476883846,1.26761534581246e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.056226569027549,0.00332629131334432,-0.0627461000017039,-0.0497070380533942,1.50343870437557e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.113865520299006,0.00675503448749779,-0.127105387894501,-0.10062565270351,3.26715520361574e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0332175269834194,0.00197545076632165,0.029345643481429,0.0370894104854098,6.54280271424813e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.107448094589883,0.00640121143996375,-0.119994469012212,-0.0949017201675545,1.06904716291031e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.116868971531542,0.00696432270274705,-0.130519044028926,-0.103218899034158,1.43145696443373e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0432015424201226,0.00257956346383261,-0.0482574868092345,-0.0381455980310107,1.98677011386068e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0454300422796568,0.00271454151853385,0.0401095409033305,0.0507505436559832,2.43387231814135e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0985054531774497,0.00588657907861044,-0.110043148171526,-0.0869677581833733,3.12345474175267e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.155018785383447,0.00927664508785677,-0.173201009755646,-0.136836561011248,3.69434012347105e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRN,Agrin,39931,-0.0550552583273354,0.00329788347600355,-0.0615191099403024,-0.0485914067143685,4.81674051107187e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0797371030714215,0.00477300907464859,-0.0890922008577328,-0.0703820052851103,4.96691484742913e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0471836540570719,0.00283517174548921,-0.0527405906782307,-0.041626717435913,1.1358503845227e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0607299682837276,0.00365376991093548,-0.0678913573091611,-0.053568579258294,1.58246152004107e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.114926253437499,0.00691713481954479,-0.128483837683807,-0.101368669191191,1.79419984724131e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.142901509908539,0.00862656268803689,-0.159809572777091,-0.125993447039987,4.08959480181369e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.142781628919638,0.00862072789437472,-0.159678255592612,-0.125885002246663,5.36122207518401e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.19080057755871,0.0115345077775894,-0.213408212802786,-0.168192942314635,5.92129958273456e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.113219384569723,0.00684703644289019,-0.126639575997788,-0.0997991931416585,6.4280799354152e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,39931,-0.0859158525519255,0.00519684804660958,-0.0961016747232803,-0.0757300303805707,6.83428911617954e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.048760901264356,0.00296748801448914,-0.0545771777727548,-0.0429446247559573,3.52157903297279e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,39839,-0.0799015205925354,0.00490617974670241,-0.0895176328960721,-0.0702854082889986,3.72228067645629e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0982174122607807,0.00603820660618628,-0.110052297208906,-0.0863825273126556,5.14302297093782e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.106806737468399,0.00657915915967808,-0.119701889421368,-0.09391158551543,8.44200893484908e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.124953447987603,0.00769676237368323,-0.140039102240022,-0.109867793735184,1.05652146817153e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,36763,-0.0387645885193568,0.00239138823964723,-0.0434517094690654,-0.0340774675696482,1.61834287242976e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39489,-0.0847340114732822,0.00523648960894001,-0.0949975311068046,-0.0744704918397598,2.03328701784351e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0641033905727856,0.00396957114071877,0.0563230311369768,0.0718837500085944,3.34590128694255e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37043,-0.0993892778963866,0.00615039979522058,-0.111444061495019,-0.0873344942977543,3.50540654382084e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.179636186300452,0.0111203352640369,-0.201432043417964,-0.157840329182939,3.73068166517949e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.135362764797445,0.00841018118823907,-0.151846719926393,-0.118878809668496,8.05529824958096e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.09718816457605,0.00604428200593494,-0.109034957307683,-0.0853413718444175,9.99183249172979e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0869074678051451,0.00540666006103371,-0.0975045215247712,-0.076310414085519,1.09525059485723e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.169682874912251,0.0105729237283729,-0.190405805419862,-0.14895994440464,1.64814260628312e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.144718808428066,0.00902876540087029,-0.162415188613772,-0.12702242824236,2.27098791989224e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0713007003942416,0.00445873488406819,-0.0800398207670153,-0.062561580021468,4.09282426705965e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37411,-0.0697235652262825,0.00436203566164715,-0.0782731551231109,-0.0611739753294541,5.46166068987387e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37124,0.0360562603058457,0.00225778610371677,0.0316309995425608,0.0404815210691306,7.03275090394706e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.114740054587538,0.00719040954249449,-0.128833257290827,-0.100646851884249,7.12605567947428e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0992731485501517,0.00622388171709766,-0.111471956715663,-0.0870743403846402,9.6278055995783e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37124,-0.0744025359490204,0.00466984040979542,-0.0835554231522194,-0.0652496487458214,1.26125481480715e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0702325250173811,0.00441770616335679,-0.0788912290975604,-0.0615738209372018,1.77940553335486e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.116534246385643,0.0073329929820843,-0.130906912630528,-0.102161580140758,1.93772493231472e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,39660,-0.0603687116113611,0.00380323791495962,-0.0678230579246819,-0.0529143652980402,2.6550846930414e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0559451251400512,0.00352506429816209,-0.0628542511644489,-0.0490359991156535,2.71782563493043e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.128554462922106,0.00811255784801999,-0.144455076304225,-0.112653849539986,4.76139237965441e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.131748921006347,0.00832481210950831,-0.148065552740984,-0.115432289271711,6.53767281438103e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0811891819654947,0.00513784641504378,-0.0912593609389805,-0.0711190029920089,7.94090044398462e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.194180647006351,0.0122896934061537,-0.218268446082412,-0.17009284793029,1.00483202840211e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37333,-0.0557569267689923,0.00353415789485176,-0.0626838762429018,-0.0488299772950829,1.41673559016743e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.0415730652948146,0.00263969973146631,-0.0467468767684886,-0.0363992538211406,2.22194877611366e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0730520540411116,0.00464500208482963,-0.0821562581273777,-0.0639478499548455,2.53769706932653e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.091106504723968,0.00578928675137285,-0.102453506756659,-0.0797595026912772,2.60893201780402e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.155155613686381,0.0098865965665998,-0.174533342956916,-0.135777884415845,4.33042336466921e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.152909100002029,0.00975332815024223,-0.172025623176504,-0.133792576827555,5.47075771872344e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0818500834448509,0.00522623944382461,-0.0920935127547471,-0.0716066541349547,7.25736427854359e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0832946006353969,0.00532076729455565,-0.093723304532726,-0.0728658967380678,7.88230944097827e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.141904764832791,0.0090663216551765,-0.159674755276936,-0.124134774388645,8.2936640111357e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0557793455849222,0.00358832524320322,-0.0628124630616005,-0.0487462281082439,4.31603741088407e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0501154030222621,0.00322231489896119,-0.056431140224226,-0.0437996658202982,4.46906175240061e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.116076897604638,0.00748920018497395,-0.130755729967187,-0.101398065242089,8.82654833998022e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.221600132148549,0.0143139467374676,-0.249655467753986,-0.193544796543113,1.33480592888539e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.167233693848831,0.0108042719556268,-0.188410066881859,-0.146057320815802,1.39600353971264e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0757263397359476,0.00491654124101639,-0.0853627605683397,-0.0660899189035555,3.75832870686073e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.135450301894421,0.00880619842808143,-0.152710450813461,-0.118190152975382,5.36455083374566e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0931312179809866,0.00606140747170414,-0.105011576625527,-0.0812508593364465,7.89594113972089e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37437,-0.0436137821797926,0.00284452937989612,-0.049189059764389,-0.0380385045951962,1.27899864661344e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0650370470984449,0.00424662541081227,-0.073360432903637,-0.0567136612932529,1.42153063187952e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0988463459572196,0.00645590435844724,-0.111499918499776,-0.086192773414663,1.81302951489337e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0940793409175081,0.0061561924024521,0.0820132038087019,0.106145478026314,2.82346375149113e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0760700756213687,0.00500059167175079,-0.0858712352980003,-0.0662689159447372,6.90841028958908e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0418607725998384,0.00275910158169027,-0.0472686116999513,-0.0364529334997255,1.26601260766694e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.122695258192718,0.00808302743114199,-0.138537991957756,-0.10685252442768,1.32058349413826e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,39885,0.0594424208263723,0.00393463345390663,0.0517305392567153,0.0671543023960293,3.25612504293951e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,37453,-0.0314818251044404,0.00208539483608202,-0.0355691989831611,-0.0273944512257196,4.43946818784284e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.10060837967597,0.0066736843281289,-0.113688800959103,-0.0875279583928378,5.24857222565567e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,39585,-0.0802786608327187,0.00532520132495263,-0.0907160554296258,-0.0698412662358115,5.35344046428187e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0588760589700077,0.00390389083294256,-0.0665276850025751,-0.0512244329374403,5.57336876706586e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,39846,-0.0442081270982608,0.00293431899841779,-0.0499593923351597,-0.0384568618613619,6.07350640696781e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0401089176723732,0.00266636548449896,-0.0453349940219912,-0.0348828413227552,8.52484729089539e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40009,-0.0566821682511492,0.00376968581765528,-0.0640707524537536,-0.0492935840485449,9.36371626672088e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,39866,0.0518650279857629,0.00344995676153661,0.0451031127331511,0.0586269432383746,9.8281981515006e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.115528768105489,0.00768992657323725,-0.130601024189034,-0.100456512021944,1.13230123533792e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0671591360644194,0.00447165685931228,-0.0759235835086715,-0.0583946886201673,1.40736460997855e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,39866,-0.0607103998848946,0.00404490733075718,-0.0686384182531787,-0.0527823815166105,1.41368007354329e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0326548682293216,0.00217668005400815,-0.0369211611351776,-0.0283885753234657,1.55349374657221e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.067956925887366,0.00452675790964293,-0.0768293713902661,-0.0590844803844659,1.59345812755772e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0898469755581679,0.0059932519026189,-0.101593749287301,-0.0781002018290349,1.82353293650615e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40052,0.0404234495163816,0.00269977726488075,0.0351318860772153,0.0457150129555478,2.39879396702406e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0848149273952139,0.00566632329412232,-0.0959209210516937,-0.0737089337387341,2.59256086655269e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.1282000988243,0.00856556528809163,-0.144988606788959,-0.11141159085964,2.65429328536089e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0459922779736854,0.00308431710798215,-0.0520375395053304,-0.0399470164420404,6.01010729280951e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0450250906376353,0.00302254967520936,-0.0509492880010457,-0.039100893274225,8.69646925413376e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,39843,-0.0508967355556839,0.00342188660195697,-0.0576036332955196,-0.0441898378158482,1.04712985878762e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0706817578928291,0.00478025498516341,-0.0800510576637494,-0.0613124581219088,3.79304566498783e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.028785216995177,0.00195200210420855,-0.0326111411194257,-0.0249592928709282,6.79979535544675e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0953065528013444,0.00648038774657014,-0.108008112784622,-0.082604992818067,1.2306766378393e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0809557378907649,0.00551192689464787,-0.0917591146042747,-0.0701523611772551,1.61252577255801e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0517686836592322,0.00352666112323965,0.0448564278576824,0.0586809394607819,1.80898454015775e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0534109891375118,0.00363920114982391,-0.0605438233911666,-0.0462781548838569,1.88711346878092e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40009,-0.0357247256245575,0.00243540610659343,-0.0404981215934806,-0.0309513296556344,2.08913545187618e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.085456572439971,0.00582989562345964,-0.0968831678619518,-0.0740299770179901,2.43907293164685e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,39859,-0.0467226555291531,0.00318840087302564,-0.0529719212402833,-0.0404733898180228,2.61359666902562e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37388,-0.17305394457838,0.0118028529785434,-0.196187536416325,-0.149920352740435,2.64758407356073e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.111423648618071,0.00760606052290433,-0.126331527242964,-0.0965157699931789,3.25905665760513e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37124,-0.172856695647239,0.0118092340189873,-0.196002794324454,-0.149710596970024,3.84623780938474e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.148196772932015,0.0101323060645071,-0.168056092818449,-0.128337453045581,4.45708868529316e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.162185597146689,0.0110951013607716,-0.183931995813801,-0.140439198479576,5.03572947893096e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0857895685174159,0.00587731311280176,-0.0973091022185073,-0.0742700348163244,5.95211715664392e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37169,-0.191055046982636,0.0130800467544181,-0.216691938621296,-0.165418155343977,5.98776384039623e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0757760406253725,0.00519147499355887,0.0656007496379971,0.0859513316127479,6.03119564787869e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.103788068972818,0.00712551430758211,-0.117754077015679,-0.0898220609299576,1.08888094935253e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0573283700251937,0.00393959128578833,0.0496067711050486,0.0650499689453388,1.14552386861479e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0677190620517738,0.00465750985070296,-0.0768477813591516,-0.058590342744396,1.36395044144908e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0291591803702943,0.00200718752911139,0.025225092813236,0.0330932679273526,1.63575841680923e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,39720,-0.0757717799452026,0.0052172425195085,-0.0859975752834392,-0.0655459846069659,1.73900745800864e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.166799972573842,0.0114979278596692,-0.189335911178794,-0.14426403396889,2.18931685788897e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0377518843779483,0.00260192947760714,0.0326521026018384,0.0428516661540583,2.39373943636016e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELP,P-selectin,39931,-0.0843252632913801,0.00581825013054754,-0.0957290335472533,-0.0729214930355069,2.6573342786176e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.107134238786445,0.00740215577452555,-0.121642464104515,-0.092626013468375,4.09831399446553e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,39788,-0.0748468726073847,0.00518134570543531,-0.0850023101900379,-0.0646914350247315,5.30738428036719e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.143611321361893,0.00995007189360404,-0.163113462273357,-0.124109180450429,7.12056943931961e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.12031563810618,0.00834384308280183,-0.136669570548472,-0.103961705663889,7.60347448806423e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,39749,-0.0615255134672755,0.00427436003832585,-0.0699032591423942,-0.0531477677921569,1.10819437354527e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0402167068196676,0.00279547642333768,-0.0456958406094094,-0.0347375730299257,1.2402382471704e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0341998823314351,0.00237985607783987,-0.0388644002440013,-0.029535364418869,1.54299034760147e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.120696196883509,0.00841314490045524,-0.137185960888402,-0.104206432878617,2.50125522657607e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.146793856908697,0.0102403356654273,-0.166864914812934,-0.126722799004459,2.55756003563861e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0782275604248563,0.0054587333290862,-0.0889266777498653,-0.0675284430998474,2.71505682799059e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0820312051189224,0.00574285333363985,-0.0932871976528565,-0.0707752125849883,5.27596033581258e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0384470822351125,0.00269572646325246,-0.0437307061030873,-0.0331634583671376,7.18822868234321e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0568398586368309,0.00398578222291579,-0.0646519917937459,-0.049027725479916,7.47374452453724e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0730617404224093,0.00512540209668532,-0.0831075285319125,-0.063015952312906,8.10363146910015e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0498015251403416,0.0035025016388579,-0.0566664283525031,-0.0429366219281802,1.32422639257367e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0733199662839297,0.00515935632399783,-0.0834323046789654,-0.0632076278888939,1.50400092709311e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0312760671733656,0.00220017413146295,-0.035588408471033,-0.0269637258756982,1.59017744122431e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0934088392094585,0.00658036580927155,-0.106306356195631,-0.0805113222232863,1.88396124126769e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.163948443575281,0.0115444552981526,-0.18657557595966,-0.141321311190902,1.92532731646946e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,39880,-0.0841243935249629,0.00592888503422259,-0.0957450081920392,-0.0725037788578866,2.02210524316191e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0723909408637446,0.0051035462244845,-0.0823938914637343,-0.062387990263755,2.1551423490111e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37208,-0.0397916787378194,0.00280880651524062,-0.0452969395076911,-0.0342864179679478,3.128619029223e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.106531105445306,0.0075270068576142,-0.12128403888623,-0.0917781720043821,3.3438270559111e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.118845665927585,0.00841561349113851,-0.135340268370216,-0.102351063484953,5.16683943419474e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0520409283377384,0.00368534658410098,-0.0592642076425763,-0.0448176490329005,5.28836774932778e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,39868,0.0530061966591816,0.00375889647079689,0.0456387595764197,0.0603736337419435,6.89866725984679e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0420181828178083,0.00297843247865397,-0.0478559104759701,-0.0361804551596465,7.08443158975298e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0244509796464493,0.00173732246543385,-0.0278561316786996,-0.0210458276141989,1.13038034722058e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0589394365425893,0.00419097269048673,-0.0671537430159433,-0.0507251300692353,1.31331752097136e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.113334977373175,0.00808084500727735,-0.129173433587439,-0.0974965211589116,2.03364881157243e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,39913,-0.0806048995314507,0.0057618501087989,-0.0918981257446965,-0.0693116733182048,3.28863126891309e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39504,-0.0703002992438653,0.00503374514806253,-0.0801664397340678,-0.0604341587536627,4.63456028955193e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0735842215590096,0.00527721978578436,-0.0839275723391469,-0.0632408707788722,6.19646334212884e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.0364506629775642,0.00261454268745654,-0.041575166644979,-0.0313261593101494,6.39179844228751e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0867843213581408,0.00622663849257045,-0.0989885328035788,-0.0745801099127027,6.85776942644368e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.122938235955265,0.00882352321644999,-0.140232341459507,-0.105644130451023,7.19991576953379e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0753919475548099,0.00541965355929067,-0.0860144685310196,-0.0647694265786002,9.82470714104827e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0372917711680657,0.00268153366677825,-0.042547577154951,-0.0320359651811803,1.03153313153387e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.141380762281684,0.0101691210395591,-0.16131223951922,-0.121449285044148,1.11165269494952e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0865042267381705,0.00622906337363962,-0.0987131909505041,-0.0742952625258368,1.35708573726298e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,39720,-0.038974489678002,0.00280704341836292,-0.0444762947779933,-0.0334726845780107,1.41406339593294e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0603585803570483,0.00435475450778883,-0.0688938991923144,-0.0518232615217822,1.94851320541526e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.137961653320992,0.00996348947570641,-0.157490092693377,-0.118433213948608,2.36767075600794e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,39788,-0.144167793895732,0.010422570462053,-0.164596032001356,-0.123739555790108,2.89606830515998e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,39713,-0.11198067532847,0.00809878219583685,-0.127854288432311,-0.09610706222463,3.1281288923526e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.099303968901545,0.00718510291033856,-0.113386770605809,-0.0852211671972814,3.41420748921851e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0714473163664986,0.00518704715819575,-0.0816139287965622,-0.0612807039364349,7.23636946896024e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0879582414575738,0.00639190122182314,-0.100486367852347,-0.0754301150628004,8.49650301928576e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0859107839034336,0.00624756036540943,-0.0981560022196361,-0.0736655655872312,8.90065210231242e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,39846,-0.0519402230430051,0.00378433960924532,-0.059357528677126,-0.0445229174088843,1.25406893950723e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0940291251803543,0.00684773906715993,-0.107450693751988,-0.0806075566087209,1.29441959891998e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0473665946665301,0.00345510074758609,0.0405945972012614,0.0541385921317988,1.55589118630396e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0381415929800469,0.00278501609208805,-0.0436002245205395,-0.0326829614395543,1.88010807451376e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0703704544402052,0.00514169105856126,-0.0804481689149853,-0.0602927399654251,2.34917158380622e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0537594682263663,0.00393312333226513,-0.061468389957606,-0.0460505464951267,3.03619371922103e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.105680673479756,0.00777026164733933,-0.120910386308541,-0.0904509606509706,7.45967265824264e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39315,-0.0555278225384163,0.00408689658688793,-0.0635381398487166,-0.0475175052281159,8.33663709800499e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0370427365401008,0.00272760616429989,-0.0423888446221285,-0.031696628458073,8.8429534204183e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0599153916749741,0.0044120862544417,-0.0685630807336798,-0.0512677026162683,8.98684429172647e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,39866,-0.131592690428541,0.00969382545969634,-0.150592588329546,-0.112592792527536,9.60565430925444e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,39866,0.0590456259827522,0.00434967870508999,0.0505202557207758,0.0675709962447286,9.63006240662582e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,39795,-0.0626298812277126,0.00461403926978515,-0.0716733981964915,-0.0535863642589337,9.77666502059841e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.146215870470776,0.0107988194777789,-0.167381556647223,-0.12505018429433,1.537595539711e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,39906,0.0529704602769044,0.00391338580795387,0.0453002240933148,0.060640696460494,1.62653268499233e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.149127388187047,0.0110434110727494,-0.170772473889636,-0.127482302484458,2.75107092100877e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,39858,0.0389854718383076,0.00289258580085888,0.0333160036686242,0.044654940007991,3.54878166688722e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37056,-0.127017395547388,0.00941916094198618,-0.145478950993681,-0.108555840101095,3.59005368872452e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.132730876359101,0.00986234614041863,-0.152061074794321,-0.11340067792388,5.05016689575894e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0747978984552818,0.00556157411148227,-0.0856985837137871,-0.0638972131967766,5.20764039795422e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.116493484344139,0.00866130712731115,-0.133469646313669,-0.0995173223746095,5.21437356160911e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.129064623957612,0.00961358565185638,-0.14790725183525,-0.110221996079973,7.11610560722678e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0782816278151752,0.00583180084775999,-0.0897119574767848,-0.0668512981535656,7.37980875975811e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,39866,-0.110666022959513,0.00824940118219686,-0.126834849276619,-0.0944971966424075,8.20216584679771e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.102523645156912,0.00764270460816092,-0.117503346188908,-0.0875439441249168,9.03010192380147e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37437,0.0540660344677,0.00403222191717909,0.046162879510029,0.061969189425371,9.79114111656169e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0712183407059847,0.00531490730250669,-0.0816355590188979,-0.0608011223930716,1.00957319808498e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0948806989697338,0.00708737493118255,-0.108771953834852,-0.0809894441046161,1.2021596109833e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.13526841481698,0.0101128897454094,-0.155089678717983,-0.115447150915978,1.37435670120992e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,39847,0.0695875343947486,0.0052024669590256,0.0593906991550584,0.0797843696344388,1.38275387535485e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.094519032187116,0.00706386900063585,-0.108364215428362,-0.0806738489458697,1.42107713457121e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.101604905797875,0.00759822604657878,-0.11649742884917,-0.0867123827465808,1.61425399713017e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.090774470528104,0.00683026041035771,-0.104161780932405,-0.0773871601238029,4.36507152865986e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0805265597362722,0.00605744118086197,-0.0923991444507617,-0.0686539750217828,4.4868539091558e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.032927223876843,0.00247872438216712,0.0280689240877954,0.0377855236658905,4.64907774381137e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0447369204997108,0.00337419717781059,0.038123494031202,0.0513503469682195,6.53373620566105e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0419404276080584,0.00316456137368523,0.0357378873156354,0.0481429679004815,7.01102630501124e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.034269460612496,0.00258899874316811,-0.0393438981491055,-0.0291950230758865,8.72023806127174e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,39587,-0.0638368631597054,0.00483735000466679,-0.0733180691688523,-0.0543556571505585,1.48818943242724e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.118488978286825,0.00897841342270974,-0.136086668595336,-0.100891287978314,1.59979581032405e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,39785,-0.0957331008626948,0.00725833139559821,-0.109959430398067,-0.0815067713273223,1.627022271567e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37383,0.0250513684707704,0.00190075163319159,0.0213258952697149,0.0287768416718259,2.00902987807648e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.18343225071988,0.0139707576374796,-0.210814935689341,-0.15604956575042,3.55382013765932e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40030,0.0220207031963704,0.00167793547071678,0.0187319496737655,0.0253094567189753,3.81885634463522e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.122866918029666,0.00936297912273381,-0.141218357110224,-0.104515478949108,3.89017922951758e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.128840440611867,0.00982510002699153,-0.148097636664771,-0.109583244558964,4.42473278669364e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.106201942432219,0.00810977888576533,-0.122097109048319,-0.0903067758161191,6.01159087643881e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0775612768129654,0.00592717853238072,-0.0891785467364316,-0.0659440068894992,6.27147699618739e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0770066050656485,0.00589109330512398,-0.0885531479436915,-0.0654600621876055,7.58052360694383e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.114426045733748,0.00875662948358409,-0.131589039521573,-0.0972630519459232,8.68851686052338e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.11156039106636,0.00854559079447314,-0.128309749023528,-0.0948110331091931,9.41998273580982e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.12530807204969,0.00960069506628341,-0.144125434379606,-0.106490709719775,9.74993699007776e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.140275324814537,0.0107433341756286,-0.161332259798769,-0.119218389830305,9.93202052252992e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.113362452806352,0.00869119632640696,-0.13039719760611,-0.0963277080065943,1.08983145619432e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0407958615330027,0.00312912930728108,0.0346627680907318,0.0469289549752737,1.17289445328249e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.080101119994109,0.00615752058916929,-0.0921698603488808,-0.0680323796393372,1.71211529976267e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.0566801362737536,0.00435579424503282,-0.0652174929940179,-0.0481427795534892,1.79215957882614e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0593379316269402,0.00456357277576624,-0.068282534267442,-0.0503933289864384,1.8543500961003e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,39913,-0.0533355352619673,0.00410205020276183,-0.0613755536593805,-0.0452955168645541,1.85995979453275e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0530812185502469,0.00408368477786295,-0.0610852407148583,-0.0450771963856356,1.94632990808506e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0379111670236209,0.00292107325991798,-0.0436364706130602,-0.0321858634341817,2.55621713137352e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0731439987225303,0.00563655303409351,-0.0841916426693536,-0.062096354775707,2.58439140697756e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0579782706952173,0.00446640046062668,-0.0667324155980456,-0.049224125792389,2.65780508429562e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.124557475850538,0.0096023713954976,-0.143378123785713,-0.105736827915362,2.77621214094866e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37437,-0.0603392870477394,0.00465708431613863,-0.0694671723073711,-0.0512114017881077,3.63622049158251e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0390753356242413,0.00301603759513062,-0.0449867693106973,-0.0331639019377853,3.67211385572375e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0998298220350319,0.00770771566865196,-0.11493694474559,-0.084722699324474,3.85393844643566e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.100754807041321,0.00779189864691978,-0.116026928389284,-0.0854826856933586,4.69375096441107e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.08049115549222,0.00622683779516855,-0.0926957575707503,-0.0682865534136896,4.95594172395926e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.114610636783882,0.00886256623494643,-0.131981266604377,-0.097240006963387,4.98979279224556e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.113189335428751,0.00877264596410976,-0.130383721518406,-0.095994949339096,6.72947856700532e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.106960494877126,0.00829709245005086,-0.123222796079225,-0.0906981936750258,7.77111847375919e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37124,-0.038298020472855,0.00296941498093195,-0.0441180738354816,-0.0324779671102284,7.84758148104831e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37382,-0.136776409636864,0.0106080521011117,-0.157568191755043,-0.115984627518685,8.16386618651308e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNST,Consortin,39868,-0.141239469040591,0.0109677510857949,-0.162736261168749,-0.119742676912433,9.25386550282747e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.120310294399203,0.00934267337278622,-0.138621934209864,-0.101998654588542,9.27855332953136e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37437,-0.0386892444000748,0.0030040166132331,-0.0445771169620117,-0.032801371838138,9.80562178890131e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0587290693564855,0.00456137001137724,-0.0676693545787849,-0.0497887841341862,1.04528055119096e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.113389918711209,0.00882217059959186,-0.130681373086409,-0.0960984643360085,1.27119273597599e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0915172395721299,0.00714763166393978,-0.105526597633452,-0.0775078815108079,2.39695453159962e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.149017164047367,0.0116528015898508,-0.171856655163474,-0.126177672931259,3.14118883152388e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37445,-0.0943341440331742,0.00738370168228787,-0.108806199330458,-0.07986208873589,3.65309375371872e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39489,-0.0841539816227028,0.00659737403530684,-0.0970848347319042,-0.0712231285135014,4.4365519662628e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0360515721442808,0.00282715831550867,-0.0415928024426778,-0.0305103418458838,5.01970094672074e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.163286283317583,0.012815849365129,-0.188405348073236,-0.13816721856193,5.28606637485366e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39489,-0.0447991752833977,0.00351763385843436,-0.051693737645929,-0.0379046129208664,5.72422065333442e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40058,-0.0437012323506527,0.00343409654545223,-0.0504320615797391,-0.0369704031215664,6.39594628929988e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0530158735953361,0.00416944981471103,-0.0611879952321697,-0.0448437519585024,7.31729959733123e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.134014660118537,0.0105612429573697,-0.154714696314981,-0.113314623922092,1.01879742827938e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0878230319498694,0.00692305336664692,-0.101392216548497,-0.0742538473512414,1.06468632649867e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0306274107454814,0.00241509916285828,0.0258938163862792,0.0353610051046836,1.12089813067507e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.100222382623409,0.00790827124212413,-0.115722594257972,-0.0847221709888453,1.24976793544608e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0662921568766491,0.00523786870999921,-0.0765583795482475,-0.0560259342050506,1.54494338683021e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,39749,0.0427183424023143,0.00338001504717663,0.0360935129098481,0.0493431718947805,1.93904495679095e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40030,-0.0703289957370183,0.00556681921626722,-0.081239961400902,-0.0594180300731345,2.04814324427025e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.0497509919580009,0.0039398567613432,-0.0574731112102336,-0.0420288727057683,2.22392111884881e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.099519332741734,0.00787983900999443,-0.114963817201323,-0.0840748482821449,2.32525372143717e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.0418813490891261,0.00331903394588655,-0.0483866556230637,-0.0353760425551885,2.49044050574152e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0393905906065694,0.0031204110994399,-0.0455065963614716,-0.0332745848516672,2.51001160880175e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0637162630021614,0.00505206921361921,-0.0736183186608551,-0.0538142073434678,2.70134146911716e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0358161382380335,0.00284433567609952,-0.0413910361631886,-0.0302412403128785,3.47135527514419e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0932062634560168,0.00740887346970821,-0.107727655456645,-0.0786848714553887,4.31471821621098e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0819626832332544,0.0065188764302096,-0.0947396810364652,-0.0691856854300436,4.71179157555363e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40009,-0.0780378395827783,0.00621112381330389,-0.0902116422568539,-0.0658640369087027,4.89725181734455e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0801359008545765,0.00638294195586675,-0.0926464670880753,-0.0676253346210777,5.53518900272697e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0565923116893519,0.00451139807362156,-0.0654346519136501,-0.0477499714650536,6.32202003411247e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.0500643062615142,0.00399378453702065,-0.0578921239540747,-0.0422364885689537,7.02973751373473e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0749826673938925,0.00598881549232775,-0.0867207457588549,-0.0632445890289302,8.5740935027994e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,39749,-0.08251240175097,0.00659708241073162,-0.095442683276004,-0.0695821202259361,1.00186693055531e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40030,0.0572769500541381,0.00458171495799647,0.0482967887364651,0.0662571113718112,1.07519752833014e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0375594613247413,0.00300433065325445,-0.0434479494051201,-0.0316709732443626,1.16281017565903e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0803453471415841,0.00642739251388628,-0.0929430364688012,-0.067747657814367,1.16815376850785e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0824042253451954,0.00659890129468417,-0.0953380718827764,-0.0694703788076144,1.27481645179598e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,39931,-0.0614894925956369,0.00492585814542702,-0.0711441745606739,-0.0518348106306,1.3518202644834e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0542676954954451,0.00434780781494615,0.0457459921781507,0.0627893988127396,1.37987496827964e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0494873477496892,0.0039658844990427,-0.0572604813678129,-0.0417142141315655,1.55285557098494e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0974023215481586,0.00781934471891839,-0.112728237197239,-0.0820764058990786,2.01436648293327e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0529102040839786,0.00425190605988783,-0.0612439399613587,-0.0445764682065985,2.20101594939637e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.0350283933652826,0.00281657548600854,-0.0405488813178594,-0.0295079054127059,2.58224713903159e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0813742952903227,0.00654332745121494,-0.094199217094704,-0.0685493734859414,2.58952298221847e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37388,-0.0478624791984001,0.00385455268235625,-0.0554174024558183,-0.0403075559409818,3.28164603611268e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37437,-0.0332950271076575,0.00268288520065336,-0.0385534821009381,-0.0280365721143769,3.57115680683408e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0246753950317911,0.00198932245021213,-0.0285744670342068,-0.0207763230293753,3.61343006125121e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.108432019262321,0.00874213645565052,-0.125566606715396,-0.0912974318092456,3.63468106897198e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,39713,-0.0766642021476996,0.00619049122726413,-0.0887975649531373,-0.0645308393422619,4.62354866165966e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,39846,-0.0481146340120802,0.00388644487449624,-0.0557320659660928,-0.0404972020580675,4.84691520131728e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0974570691331844,0.00790273560981279,-0.112946430928417,-0.0819677073379513,9.34793157929006e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0730117086416353,0.00592646907630352,-0.0846275880311902,-0.0613958292520804,1.02063675168486e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0623800535037526,0.00506650043732429,-0.0723103943609082,-0.052449712646597,1.11986107805674e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0452564324531485,0.0036758912614123,-0.0524611793255166,-0.0380516855807804,1.12982530877686e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,39810,-0.0505445765059829,0.00411848480136945,-0.0586168067166671,-0.0424723462952988,1.81793057611848e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0579298472101835,0.00472712284221282,-0.0671950079809206,-0.0486646864394463,2.25859324258743e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.141789899890748,0.0115710831727472,-0.164469222909332,-0.119110576872163,2.28807663297394e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0782117927060649,0.006382908503648,-0.090722293373215,-0.0657012920389148,2.4520534949113e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0998272315359154,0.00814696007375806,-0.115795273280481,-0.0838591897913496,2.48040968652965e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0909621895331248,0.00743001753845908,-0.105525023908505,-0.076399355157745,2.63926446838156e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0775939289572373,0.0063412826587868,-0.0900228429684595,-0.0651650149460152,2.85417053021843e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.10482684501301,0.00857574149212399,-0.121635298337574,-0.0880183916884475,3.30726109557244e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0424604356452901,0.0034764784344602,-0.0492743333768321,-0.0356465379137481,3.76306467210533e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0834138349577115,0.00684366819310939,-0.0968274246162059,-0.0700002452992171,5.10961996739268e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0819288391301208,0.00672542846225632,-0.0951106789161432,-0.0687469993440984,5.48499149804401e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0350593428242967,0.00287979325678669,-0.0407037376075986,-0.0294149480409948,6.03585698008819e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0481089749361255,0.00395197280492363,-0.0558548416337758,-0.0403631082384752,6.09658008010854e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0641400965046755,0.00526777898641699,-0.0744649433180528,-0.0538152496912982,6.34881388494016e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.138337983636813,0.0113774348959324,-0.160637756032841,-0.116038211240785,7.27310488511867e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.112374809325097,0.00924377379779229,-0.13049260596877,-0.0942570126814245,7.92215124869255e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0494781883091025,0.00407388354914813,-0.0574630000654328,-0.0414933765527721,8.56681227746999e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.0296181405336035,0.00243941284276987,0.0248368913617746,0.0343993897054325,8.9740106624673e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40030,-0.137423856417789,0.011325483443726,-0.159621803967492,-0.115225908868085,9.77290162550274e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,39868,0.038097987165905,0.00313971313212228,0.0319441494269454,0.0442518249048647,9.78402346107824e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37415,-0.0550843859792498,0.00455303331985109,-0.064008331286158,-0.0461604406723417,1.60294239187184e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0368316418361523,0.00304593653462157,-0.0428016774440106,-0.030861606228294,1.63080194001774e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.13037645356091,0.0107829351191156,-0.151511006394376,-0.109241900727443,1.64736985612375e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.103966372468666,0.0085995862531825,-0.120821561524904,-0.0871111834124288,1.67849208309322e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.102118555620377,0.00844850192001863,-0.118677619383614,-0.0855594918571408,1.83725731915556e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0959909069826612,0.00795013515654924,-0.111573171889498,-0.0804086420758247,2.16539500139843e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.053200102499513,0.00441498193474781,-0.0618534670916187,-0.0445467379074072,2.71015734313813e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0675078122007504,0.00561421876285616,-0.0785116809759484,-0.0565039434255523,3.6799671606107e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0635522338334066,0.00528825959006982,-0.0739172226299434,-0.0531872450368697,3.99720099820979e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.0743837192139776,0.00619569781026708,-0.0865272869221011,-0.0622401515058542,4.63532797074197e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0875863333666377,0.00729691115258769,-0.10188827922571,-0.0732843875075658,4.72118008053023e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0341809566282109,0.00285277234684095,-0.0397723904280191,-0.0285895228284026,6.13229348064599e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0839064986444171,0.00700405276009546,-0.0976344420542042,-0.07017855523463,6.72644794024015e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37430,-0.0687275157489315,0.00573784006177887,-0.0799736822700181,-0.057481349227845,6.7927561656712e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0920962256543931,0.00769418580110614,-0.107176829824561,-0.0770156214842251,7.51587087914481e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0379715572214151,0.00317580674904319,-0.0441961384495397,-0.0317469759932905,8.25158782488042e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0700794715152935,0.00586398462449756,-0.0815728813793087,-0.0585860616512782,8.83718764686112e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40030,-0.048584975830512,0.00406852477337108,-0.0565592843863193,-0.0406106672747047,9.8532923196974e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37124,-0.0840659604232858,0.00703806537202578,-0.0978605685524564,-0.0702713522941153,1.02106076312914e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.063014770965661,0.00528646220146878,0.0526533050507822,0.0733762368805399,1.27930044651808e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0905507213029186,0.00760389570428724,-0.105454356883322,-0.0756470857225157,1.47077368310726e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39314,-0.111079395330477,0.00933729788895716,-0.129380499192833,-0.0927782914681208,1.71469668000692e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.065168260025434,0.00547648057097908,-0.0759021619445529,-0.054434358106315,1.73635521813748e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.0468357200421403,0.00394066106641651,-0.0545594157323166,-0.0391120243519639,1.93352000139451e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.125045796775279,0.0105173341725453,-0.145659771753468,-0.10443182179709,1.96569845668996e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0675894040159397,0.00569468930227889,-0.0787509950484063,-0.0564278129834731,2.33984102663045e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40058,-0.046011159311433,0.00387940163175849,-0.0536147865096797,-0.0384075321131864,2.58686065971135e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.101264176944255,0.00853927344169913,-0.118001152889985,-0.0845272009985245,2.80519245664087e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0631515990306166,0.00533329705347321,0.0526983368058091,0.0736048612554241,3.26502060810689e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,39868,-0.147543229128019,0.0124666033102806,-0.171977771616169,-0.123108686639869,3.50177619177987e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0870571947947252,0.00736799928701984,-0.101498473397284,-0.0726159161921663,4.65543252837013e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0529115608838431,0.00447836387214912,-0.0616891540732553,-0.0441339676944308,4.70234357581865e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0761839035230329,0.00645797841079528,-0.0888415412081916,-0.0635262658378741,5.49616281095955e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,36543,-0.0294245488493981,0.00249441099153592,-0.0343135943928085,-0.0245355033059877,5.99764153648302e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.098535605297765,0.0083630305403647,-0.11492714515688,-0.0821440654386502,6.88722566814947e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0313298113541456,0.00266012517023994,-0.0365436566878159,-0.0261159660204753,6.88916256485187e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.033091516149295,0.00281333182793649,-0.0386056465320505,-0.0275773857665395,8.23434724720861e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0873632295457115,0.00742412674858246,-0.101914517972933,-0.0728119411184899,8.28276497609506e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0870867798828763,0.0074023425340393,-0.101595371249593,-0.0725781885161593,8.46588053351682e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.132177819356524,0.0112391469309163,-0.154206547341121,-0.110149091371928,8.93917158350758e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0738770872227729,0.00630113160126276,-0.0862273051612479,-0.0615268692842979,1.28976527604813e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0478128119153055,0.00408878688220806,-0.0558268342044333,-0.0397987896261777,1.94347518932586e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37371,-0.101243036101424,0.00865923548222289,-0.118215137646581,-0.0842709345562676,1.98638106411415e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0918579426153226,0.00786541987052871,-0.107274165561559,-0.0764417196690863,2.33674919112273e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0767429715230013,0.00657512566825118,-0.0896302178327736,-0.063855725213229,2.3838626524123e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0528441932674969,0.00452942833185976,0.0439665137370518,0.0617218727979421,2.51431673728057e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0377754724881651,0.00323976906312329,-0.0441254198518867,-0.0314255251244434,2.72605075051662e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0900849164852534,0.00772788776884559,-0.105231576512191,-0.0749382564583161,2.97706090958222e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0872041463319458,0.00748442261338322,-0.101873614654177,-0.0725346780097147,3.02150896535946e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0372583403492783,0.00319716234564695,-0.0435247785467464,-0.0309919021518103,3.13047451161535e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0814692772260668,0.00699469179326239,-0.0951788731408611,-0.0677596813112725,3.15644562609184e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0666018419318377,0.00572063488169908,-0.0778142862999679,-0.0553893975637075,3.56651621048601e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37437,-0.0893341228697186,0.00767483551456583,-0.104376800478268,-0.0742914452611696,3.63295243704716e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37306,-0.111579497555175,0.00958814680200542,-0.130372265287105,-0.092786729823244,3.75843742428059e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.026668032194111,0.00229312938717843,-0.0311625657929808,-0.0221734985952413,4.12870104598439e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0546126606185931,0.00469926636092453,-0.0638232226860051,-0.045402098551181,4.28583133293437e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0316993441817184,0.00272909363431987,-0.0370483677049853,-0.0263503206584514,4.5834469369342e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.061857509242949,0.00532942026953394,-0.0723031729712355,-0.0514118455146625,5.05097465828088e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,39788,-0.0551558383185758,0.0047521618839188,-0.0644700756110567,-0.045841601026095,5.09272252952158e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0633607984513703,0.00545854169011843,-0.0740595401640024,-0.0526620567387382,5.33200141181237e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0784034816850505,0.006762671198972,-0.0916583172350356,-0.0651486461350654,5.90987209050446e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37445,-0.0264920726414907,0.00228738457055961,-0.0309753463997876,-0.0220087988831939,7.11484909835506e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37388,-0.0723135093179495,0.00625059693061057,-0.0845646793019462,-0.0600623393339528,8.25593438603163e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.120761724621652,0.0104433460267913,-0.141230682834163,-0.100292766409141,8.80292942778768e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0251724069889395,0.00217807298784223,-0.0294414300451103,-0.0209033839327687,9.47138184791791e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0486800609222415,0.00421631329622178,-0.0569440349828362,-0.0404160868616468,1.02647700405378e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0393554515536217,0.00340947914077393,-0.0460380306695386,-0.0326728724377048,1.06225025936729e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.080349153225381,0.00696435129982864,-0.0939992817730452,-0.0666990246777169,1.12989431040452e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0303883349135096,0.00263337506462012,0.0252269197868542,0.0355497500401651,1.15676265020097e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.037521169198269,0.00325302063594752,-0.0438970896447262,-0.0311452487518119,1.16813042194393e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.091463020846059,0.00792935253028514,-0.107004551805418,-0.0759214898867001,1.22536281552475e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.058912082399124,0.00511313123411653,-0.0689338196179924,-0.0488903451802556,1.3580831004989e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37437,0.0317041173739213,0.00275089218541773,0.0263123686905025,0.03709586605734,1.36929115061522e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0900071628796342,0.00782177540123913,-0.105337842666063,-0.0746764830932056,1.68060046886136e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0548524922064874,0.00477399387023336,-0.0642095201921448,-0.04549546422083,1.95225798223723e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0942170451454986,0.00820391314848407,-0.110296714916527,-0.0781373753744698,2.18420945718643e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_E,,39866,-0.0319668617743505,0.00278609926577259,-0.0374276163352648,-0.0265061072134363,2.35059446939051e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0511824045317098,0.00446186637128622,-0.0599276626194308,-0.0424371464439889,2.55948597100815e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0682809006869367,0.00595451428602229,-0.0799517486875403,-0.056610052686333,2.6818517309844e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0649386574891883,0.00566663045918767,-0.0760452531891961,-0.0538320617891804,2.74668952649382e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0346590228629706,0.00302564938696794,-0.0405892956614277,-0.0287287500645134,2.90750526996965e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.114831603662605,0.0100252412138956,-0.134481076441841,-0.0951821308833698,2.95708678917715e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0769143371090554,0.00671376525137861,-0.0900733170017575,-0.0637553572163533,3.01581526052584e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0830172848964577,0.00726049273671419,-0.0972478506604175,-0.0687867191324978,3.88446222609774e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0563108271184957,0.00493132226553255,-0.0659762187589394,-0.0466454354780519,4.61582347587594e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37385,-0.112195641312996,0.00983840932431006,-0.131478923588644,-0.0929123590373485,5.48423130233466e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.081993651297729,0.00719655389266229,-0.0960988969273471,-0.0678884056681109,6.21976938141668e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.120312391129482,0.0105715720665433,-0.141032672379907,-0.0995921098790571,6.78778508810875e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0550297876081359,0.00483627885671209,-0.0645088941672916,-0.0455506810489802,7.31244233205752e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.0519373062305545,0.00456651889671471,-0.0608876832681153,-0.0429869291929937,7.38818079390867e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.0316773096016824,0.00278443373529967,0.0262198194804951,0.0371347997228698,7.46553201208056e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0552909881757404,0.00487057666610016,-0.0648373184412967,-0.045744657910184,9.86996131446278e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.107885019920138,0.00951167947682632,-0.126527911694717,-0.0892421281455583,1.05071405225014e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40009,-0.0255021668750309,0.00224990840019528,-0.0299119873394137,-0.0210923464106482,1.14273942226746e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0522643171016051,0.00461102260215798,-0.0613019214018347,-0.0432267128013754,1.15421539344735e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37420,0.0392140490224088,0.00345980207242423,0.0324328369604573,0.0459952610843603,1.20785551496925e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0741289490195897,0.00654564869217366,-0.0869584204562501,-0.0612994775829293,1.28355599603214e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0584484394287509,0.00516540815860265,-0.0685726394196121,-0.0483242394378897,1.50454868120993e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.088512529703444,0.00783922856847259,0.0731476417092377,0.10387741769765,1.8780278147493e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39448,0.137038009340985,0.0121382671628584,0.113247005701783,0.160829012980187,1.91849598472612e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0638852854103859,0.00566110680715632,-0.0749810547524123,-0.0527895160683595,2.1064409246987e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,39585,0.0267804278727643,0.00237538578075629,0.022124671742482,0.0314361840030467,2.28264637167131e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0760557203234189,0.00674836766989256,-0.0892825209564083,-0.0628289196904295,2.4870373193048e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.0547372956990776,0.00485904247143381,0.0452135724550673,0.0642610189430878,2.63362123274434e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0895304187790545,0.00796132693583079,-0.105134619573283,-0.0739262179848261,3.1506567012389e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37124,-0.0606275112626591,0.00539182557452416,-0.0711954893887264,-0.0500595331365917,3.34713994702403e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0460237847000637,0.004094651219551,-0.0540493010903837,-0.0379982683097438,3.49487392022802e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40058,-0.0566686389723458,0.00504590410205848,-0.0665586110123804,-0.0467786669323112,3.69672074760544e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0387886449759594,0.00345425137191016,-0.0455589776649033,-0.0320183122870155,3.762561880541e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0658727557467503,0.00587237841494684,-0.0773826174400462,-0.0543628940534545,4.52788629746451e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0641920821480651,0.00573693397919277,-0.0754364727472829,-0.0529476915488473,5.92941644526072e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.096537144921046,0.00863148874814505,-0.11345486286741,-0.0796194269746817,6.51459309444148e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0536709500060712,0.0048136417854188,-0.063105687905492,-0.0442362121066503,9.65257005642406e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.060481886101632,0.00543045749253441,-0.0711255827869994,-0.0498381894162645,1.05036390499247e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0282894515374572,0.00254689768733702,-0.0332813710046378,-0.0232975320702766,1.46717970589406e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0622650981276279,0.00560549923866215,-0.0732518766354057,-0.0512783196198501,1.46971478865176e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.055706966710466,0.00501493519038449,-0.0655362396836196,-0.0458776937373124,1.53179764863416e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.051785773075233,0.00466273455603357,-0.0609247328050588,-0.0426468133454072,1.56389432878796e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0367671809529696,0.003312683562637,-0.0432600407357382,-0.0302743211702011,1.61552954034253e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.066724716646006,0.00601051989855507,-0.0785053356471739,-0.0549440976448381,1.63948005656337e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.122324953212372,0.0110436085695183,-0.143970426008628,-0.100679480416116,2.15987217761514e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0328454693970077,0.0029676483187721,-0.038662060101801,-0.0270288786922144,2.29059261669753e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.114359522737694,0.0103345026684099,-0.134615147967777,-0.0941038975076106,2.4295422737775e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0615079288673289,0.00556191646937679,-0.0724092851473074,-0.0506065725873504,2.52078801089907e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.100865816954727,0.00912286927535154,-0.118746640734416,-0.0829849931750379,2.58847537339935e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0888474295394565,0.00803517940520504,-0.104596381173658,-0.0730984779052547,2.69000224172409e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0345743415781797,0.00313478636900437,0.0284301602949312,0.0407185228614283,3.5959104803359e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.115168046606231,0.0104525385587445,-0.135655022181371,-0.094681071031092,4.11253221925436e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0263995667480785,0.00239720251479847,-0.0310980836770835,-0.0217010498190735,4.18210813138532e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0585869782604368,0.0053225978380339,-0.0690192700229832,-0.0481546864978904,4.43581417405398e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37043,-0.0838682654825694,0.00761974410835748,-0.0988029639349501,-0.0689335670301888,4.69934196824531e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0537351903317555,0.00489209365656839,-0.0633236938986296,-0.0441466867648815,5.76019208194701e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.0434110379945679,0.00395282346629353,-0.0511585719885032,-0.0356635040006325,5.85339408306356e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.0182418676813724,0.00166111972106401,-0.0214976623346579,-0.014986073028087,6.13504163347557e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0663608624904224,0.00605647859555082,-0.078231560537702,-0.0544901644431428,7.75412062460196e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0708753276180026,0.006489573936607,-0.0835948925337524,-0.0581557627022529,1.14660244866701e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40009,0.0407505252627558,0.00373170386105606,0.0334363856950859,0.0480646648304256,1.15462745421985e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,39866,-0.0360614254415277,0.00330393121866786,-0.0425371306301167,-0.0295857202529387,1.22700508345876e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0367036761820819,0.00336488985403645,-0.0432988602959933,-0.0301084920681704,1.39269078663742e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDK,Midkine,39843,-0.0560639801708143,0.005142716290258,-0.06614370409972,-0.0459842562419086,1.41570726470566e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.0272362437614631,0.00249833371089366,-0.0321329778348146,-0.0223395096881115,1.46994697083002e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0839075121533012,0.00770246004993933,-0.0990043338511823,-0.0688106904554201,1.55090378472402e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0725220691929172,0.00665890014302419,-0.0855735134732446,-0.0594706249125898,1.66314255971781e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0688660421950635,0.0063280992314921,-0.081269116688788,-0.0564629677013389,1.74150658777237e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.114026813969582,0.0104786394254591,-0.134564947243482,-0.0934886806956822,1.75342590201567e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39489,-0.0789177645541234,0.0072713586969985,-0.0931696276002405,-0.0646659015080064,2.40956760007682e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARC,SPARC,39913,-0.0777422800676278,0.00716486628473274,-0.0917854179857039,-0.0636991421495516,2.46799962154898e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0604029983878187,0.0055671820207188,-0.0713146751484275,-0.0494913216272098,2.50067142462483e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0649435814947818,0.00599069880266071,-0.0766853511479968,-0.0532018118415668,2.76022228066872e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0884757023704017,0.00816244357752846,-0.104474091782358,-0.0724773129584459,2.91919445574801e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0309661996064788,0.00286345187869993,0.025353833924227,0.0365785652887307,3.65701732780479e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0349269526321575,0.00323170695027194,-0.0412610982546905,-0.0285928070096245,3.93078213389766e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0848935585791435,0.00785915620972458,-0.100297504750204,-0.0694896124080833,4.37883950172922e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0987613330402139,0.00916055242984746,-0.116716015802715,-0.0808066502777129,5.23379149055362e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0412301342465447,0.00382644758122272,-0.0487299715057412,-0.0337302969873482,5.61653757552971e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.10019550410343,0.00929602195477689,-0.118415707134793,-0.0819753010720674,5.64347469884475e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0408269050677681,0.00378999298500878,-0.0482552913183853,-0.0333985188171509,5.77862634550166e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39477,-0.0446486509856534,0.00414662916592488,-0.0527760441508662,-0.0365212578204406,6.09682004262401e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0780730700190593,0.00725735256712524,-0.0922974810506248,-0.0638486589874939,6.72732971404901e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0653783144878936,0.00607605046960018,-0.07728737340831,-0.0534692555674773,6.83159943782213e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0327714822222472,0.00304752183945503,0.0267983394169153,0.0387446250275791,7.04398589974697e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,39897,0.0393344947932143,0.00365809896672474,0.0321646208184338,0.0465043687679948,7.10584731112459e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0508191740765058,0.00473102423179911,-0.0600919815708321,-0.0415463665821795,8.01500788683108e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.066208747459805,0.00616587472311198,-0.0782938619171045,-0.0541236330025055,8.65591676746976e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0679535142628311,0.00633445340077945,-0.0803690429283588,-0.0555379855973033,9.7371704850271e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.123529061794319,0.011526025380681,-0.146120071540453,-0.100938052048184,1.03905563068944e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0652751890892986,0.00609867906494124,-0.0772286000565835,-0.0533217781220138,1.20831975521997e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0596915709291836,0.00558978591153733,-0.0706475513157968,-0.0487355905425704,1.64320434169218e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.105467733241052,0.00988138796623794,-0.124835253654879,-0.0861002128272258,1.66765902677616e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.106065898832601,0.00993489061188764,-0.125538284431901,-0.086593513233301,1.68960368878962e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0613370544042609,0.00575011956445255,-0.0726072887505879,-0.0500668200579339,1.78980632630382e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0395810142978012,0.00371289602232222,-0.0468582905015528,-0.0323037380940497,1.91522147388298e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.029498708828606,0.00276960124853972,0.0240702903814681,0.0349271272757439,2.11693015559788e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0851568391934243,0.00799579987553308,-0.100828606949469,-0.0694850714373794,2.13589168793058e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0558799313955085,0.00525303213031628,-0.0661758743709284,-0.0455839884200886,2.4423848802391e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37388,-0.0600188887150546,0.0056499936734264,-0.0710928763149703,-0.0489449011151389,2.96153278187749e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.116571509338717,0.0109896315998342,-0.138111187274392,-0.0950318314030415,3.48532382838276e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,39619,-0.0456952192424836,0.00431357120879667,-0.0541498188117251,-0.0372406196732422,3.91645056101391e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0837780227002523,0.00791386200520092,-0.0992891922304461,-0.0682668531700585,4.20342327008366e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0732265706666445,0.00691604513950422,-0.0867820191400728,-0.0596711221932162,4.28910748315127e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.105351526835437,0.00996465310120873,-0.124882246913806,-0.0858208067570674,5.07772359511448e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0637503435797602,0.0060351015258785,-0.0755791425704821,-0.0519215445890384,5.36360776091238e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.100905871996427,0.00955522743243818,-0.119634117764006,-0.0821776262288481,5.5628173526307e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37124,-0.0580999347433196,0.00550445252310883,-0.0688886616886129,-0.0473112077980263,6.09814422016955e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0671993969077917,0.00637505739061708,-0.0796945093934012,-0.0547042844221822,7.08892037987898e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0367846550681435,0.00349194869664416,-0.043628874513566,-0.0299404356227209,7.33273989629188e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0884905647209824,0.00840331841227245,-0.104961068809036,-0.0720200606329284,7.87279970554852e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.115291426069113,0.0110187533438008,-0.136888182622963,-0.0936946695152638,1.5953204831577e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0533023506606951,0.00509412826961682,-0.063286842069144,-0.0433178592522461,1.59947665888713e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0689413055229591,0.00659124711951119,-0.0818601498772011,-0.0560224611687172,1.65660293994053e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0779622874765533,0.00745623884293445,-0.0925765156087048,-0.0633480593444018,1.66226824416309e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0571164297214993,0.00547299795622586,-0.067843505715702,-0.0463893537272966,2.13798815620164e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0395654954460419,0.00381074184000009,-0.0470345494524421,-0.0320964414396417,3.56933380021043e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0721842709393925,0.00695292236605616,-0.0858119987768626,-0.0585565431019225,3.74342016504859e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.107214377443193,0.0103319043347594,-0.127464909939321,-0.0869638449470642,3.7906308972909e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0454411194756103,0.00438051733682974,0.036855305495424,0.0540269334557966,3.93071707731056e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,36879,-0.0738580941102628,0.00712570368570217,-0.087824473334239,-0.0598917148862865,4.47697490159447e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37437,-0.0241717298753559,0.0023361381369336,-0.0287505606237457,-0.019592899126966,5.35460395835184e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0628401283160979,0.00607706996902383,-0.0747511854553845,-0.0509290711768112,5.55464454274298e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0411065341012754,0.00397799114744649,-0.0489033967502706,-0.0333096714522803,5.95162166488038e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0473275122475579,0.00458232849731683,-0.0563088761022989,-0.0383461483928169,6.31699547196315e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,37453,-0.0436930703335908,0.00423039065029838,-0.0519846360081756,-0.035401504659006,6.4830044050024e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0955165675258146,0.00925085717582739,-0.113648247590436,-0.077384887461193,6.70407158869004e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0345170288702417,0.00334902085211418,0.0279529480000979,0.0410811097403855,8.12052327500804e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0315932677075856,0.00306795501346627,-0.0376064595339795,-0.0255800758811917,8.60018512917318e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,39881,-0.111963519618677,0.0108816148955837,-0.133291484814022,-0.0906355544233334,9.40941404501412e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0729241379944244,0.00708860235803618,-0.0868177986161753,-0.0590304773726735,9.93521538711775e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.0210495661020429,0.00204836958439976,0.0170347617166194,0.0250643704874664,1.07512912738556e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0385216570314649,0.00374927757886683,-0.0458702410860439,-0.031173072976886,1.13883018025276e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0868228278315819,0.00845538349829285,-0.103395379488236,-0.070250276174928,1.16745580731958e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBN,Nibrin,39587,-0.053751934770198,0.00524007932270227,-0.0640224902426945,-0.0434813792977016,1.30439974732259e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0434383857953666,0.00424136516824931,-0.0517514615251353,-0.035125310065598,1.59271778483769e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,39973,-0.0557953336508661,0.00545301855815014,-0.0664832500248404,-0.0451074172768918,1.69375408721683e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37056,-0.0437951643277965,0.0042786960589852,-0.0521814086034074,-0.0354089200521855,1.69510404511671e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.030692960632703,0.003000746130255,-0.0365744230480027,-0.0248114982174032,1.75884308288107e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0660463773986579,0.00646558623296568,0.0533738283820452,0.0787189264152706,2.018492703141e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0977674501406312,0.00957228361762657,-0.116529126031179,-0.0790057742500831,2.11263338874783e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0752952048833296,0.00737218955704928,-0.0897446964151462,-0.060845713351513,2.12594929576541e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,39866,-0.0802051757498694,0.00786026924762658,-0.0956113034752175,-0.0647990480245213,2.26239759184574e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0333339133652646,0.00326730558878873,-0.0397378323192905,-0.0269299944112387,2.38512064169279e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0419140022430684,0.0041155714506499,-0.0499805222863422,-0.0338474821997946,2.77342218011332e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0694420435842274,0.0068196044981845,-0.082808468400669,-0.0560756187677858,2.8964809638488e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.153308134191129,0.0150591134688999,-0.182823996590173,-0.123792271792085,2.96608537388252e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,37453,-0.0226798137808382,0.00222814641955084,-0.0270469807631579,-0.0183126467985186,3.01300406097321e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0429603407908804,0.00422284429701635,-0.0512371156130324,-0.0346835659687283,3.0916848574808e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0701373193727428,0.00689774376977635,-0.0836568971615044,-0.0566177415839811,3.25216295134603e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0410965256180703,0.0040422695350255,-0.0490193739067203,-0.0331736773294203,3.41216740947223e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0305394896217166,0.00300604962263478,-0.0364313468820808,-0.0246476323613525,3.56249246867475e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0515511139294869,0.00507362607518758,-0.0614954210368545,-0.0416068068221192,3.66444105316634e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0647249210605592,0.00637369299891608,-0.0772173593384347,-0.0522324827826836,3.8407553883814e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0341392268610117,0.00337698634601104,-0.0407581200991933,-0.0275203336228301,5.92128585578725e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0672432524350645,0.00665896196322634,-0.0802948178829881,-0.0541916869871408,6.63962487993519e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.058162973096832,0.00576161631000764,-0.069455741064447,-0.046870205129217,6.86146009756989e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.0257592973440918,0.00255226367920478,-0.0307617341553332,-0.0207568605328504,7.24810589318898e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.132846806532439,0.013173261409343,-0.158666398894752,-0.107027214170127,7.61119094666578e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0320398247510416,0.00317903874715755,-0.0382707406954704,-0.0258089088066128,8.34758025959731e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.11795913660004,0.0117101699920258,-0.140911069784411,-0.0950072034156698,8.79841956589879e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0831868519549498,0.00826982901500835,-0.0993957168243662,-0.0669779870855335,9.86680269708054e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0778445759092002,0.00774197539428699,-0.0930188476820027,-0.0626703041363977,1.05871659323035e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.135413679580986,0.0134737178536069,-0.161822166574055,-0.109005192587916,1.1156163617421e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.016387341933084,0.00163120818357843,0.0131901738932703,0.0195845099728977,1.12083186754662e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37039,-0.0431058904428189,0.00429017381075531,-0.0515146311118993,-0.0346971497737385,1.14547345814518e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0509201983806038,0.00507247119592726,-0.0608622419246212,-0.0409781548365863,1.2099619831323e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.109457067773432,0.0109027197500682,-0.130826398483566,-0.0880877370632987,1.23686824682353e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0414326300387569,0.00412932655015879,-0.0495261100770681,-0.0333391500004457,1.30999102002748e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0435761032848223,0.00435770728023345,0.0350349970155647,0.0521172095540799,1.79010523063429e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37411,-0.0560826993613477,0.00561031637428085,-0.0670789194549382,-0.0450864792677572,1.90621906403904e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0587927728067821,0.0058838840844702,-0.0703251856123437,-0.0472603600012206,1.99860500139825e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.0947613441269279,0.00948477549491691,-0.113351504096965,-0.0761711841568908,2.01408248620285e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,39730,0.0286371575267125,0.00286732987610353,0.0230171909695495,0.0342571240838754,2.02936628659334e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.105295747558919,0.010546798432389,-0.125967472486402,-0.0846240226314365,2.10494428293808e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37368,-0.0653071166013731,0.00654158828352337,-0.0781286296370789,-0.0524856035656673,2.17208805240858e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0682469980382792,0.00684997947414157,-0.0816729578075967,-0.0548210382689617,2.6692948883577e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0870083747290835,0.00874975986158714,-0.104157904057794,-0.0698588454003727,3.23180320930837e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0365823694312452,0.00368101889583705,-0.0437971664670859,-0.0293675723954046,3.4133113992013e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0644303826802676,0.00649388832861984,-0.0771584038043625,-0.0517023615561727,3.901815920688e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.0242985002862681,0.00244999375832987,-0.0291004880525946,-0.0194965125199415,4.0627424421588e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0465338136698761,0.00470032453430714,-0.0557464497571181,-0.0373211775826341,4.97868936976174e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39489,0.0740623139271527,0.00749561187965746,0.0593709146430241,0.0887537132112814,5.89051517034499e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0395948478086489,0.00401460993005325,-0.0474634832715533,-0.0317262123457445,7.04626271732479e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0844569638492126,0.00858288145020873,-0.101279411491622,-0.0676345162068035,8.77194438953929e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0706618378016978,0.00718091156521962,-0.0847364244695282,-0.0565872511338673,8.77563206469727e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0253912690357259,0.00258152301362213,0.0203314839290265,0.0304510541424252,9.1648275226692e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0878210726463709,0.00893745790705205,-0.105338490144193,-0.0703036551485489,1.00782111773994e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.0391725319888414,0.00398897665633063,-0.0469909262352495,-0.0313541377424334,1.06649623505392e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0576846993582231,0.00587414306279344,-0.0691980197612983,-0.046171378955148,1.07207489216184e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0370708710101991,0.00378189586236784,-0.04448338690044,-0.0296583551199581,1.30979388150076e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,39858,-0.0246560462667061,0.00252162789755597,-0.0295984369459158,-0.0197136555874964,1.62097977241935e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0803201209250167,0.00821662950177739,-0.0964247147485004,-0.064215527101533,1.66137833790519e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0921710619367842,0.00942896207592699,-0.110651827605601,-0.0736902962679673,1.66737659609399e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0298067298558264,0.00305343209804851,-0.0357914567680014,-0.0238220029436513,1.89865635846465e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0879870093747799,0.00902795807460052,-0.105681807200997,-0.0702922115485628,2.21473240579687e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0912481203436544,0.00936629052854506,-0.109606049779603,-0.0728901909077061,2.36991232072268e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0704648484392303,0.00723695813799723,-0.0846492863897049,-0.0562804104887557,2.42291956881726e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.019740661602076,0.0020273334918542,-0.0237142352461102,-0.0157670879580418,2.47589382342609e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39489,-0.0670008070563704,0.0068980936341496,-0.0805210705793036,-0.0534805435334371,3.06922813684522e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0520269452149881,0.00535684981108985,-0.0625263708447242,-0.041527519585252,3.159842259134e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,39913,-0.0545474874706919,0.00562174079878851,-0.0655660994363174,-0.0435288755050664,3.37048869392099e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0876560352771809,0.00903344606436882,-0.105361589563344,-0.069950480991018,3.45561315879832e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0644051167593538,0.00664786592677304,-0.077434933975829,-0.0513752995428787,3.9981454184926e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,39866,-0.0323659171810629,0.00334235565274628,-0.0389169342604456,-0.0258149001016802,4.07249915843137e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,39788,-0.0532879292177804,0.0055081465201361,-0.0640838963972471,-0.0424919620383136,4.45574365658143e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.061266782243905,0.00633720787376569,-0.0736877096764857,-0.0488458548113242,4.76330887682918e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0420726531293159,0.00435256436423039,-0.0506036792832074,-0.0335416269754243,4.81470657171808e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0669845002521808,0.00693017047267762,-0.0805676343786289,-0.0534013661257326,4.97052546261411e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0297172983303328,0.00307601692816718,-0.0357462915095404,-0.0236883051511251,5.19810598834734e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0372388623694497,0.00385940516309599,-0.0448032964891178,-0.0296744282497816,5.70138203865576e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0766580615112074,0.00794724235351775,-0.0922346565241022,-0.0610814664983126,5.87291096141674e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0373420284927558,0.00387391180850448,-0.0449348956374246,-0.029749161348087,6.25651235412971e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0780367175713228,0.00810389145038823,-0.0939203448140837,-0.0621530903285619,6.88546720985235e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,39866,-0.0478496687702102,0.00496922534470111,-0.0575893504458244,-0.038109987094596,6.90093663520465e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.020611835899276,0.00214095434143789,0.0164155653900578,0.0248081064084943,7.22918663023588e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0666920497287161,0.00692965993297276,-0.0802741831973427,-0.0531099162600895,7.42723930296635e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0601570791777868,0.00625350227594302,-0.0724139436386352,-0.0479002147169385,7.55892070119936e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0822689050845546,0.00855303458495381,-0.0990328528710641,-0.0655049572980452,7.83369279708523e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0659293435711273,0.0068564962670093,-0.0793680762544655,-0.0524906108877891,8.10405508714011e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0313319247075665,0.00325999763322948,0.0249423293464368,0.0377215200686963,8.46613681920396e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.102549147162566,0.0106762582926905,-0.123474613416239,-0.0816236809088925,8.69005782810184e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0892052030869834,0.00928458552560903,-0.107402990717177,-0.0710074154567897,8.69251061108715e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.036998183471831,0.00385650017045532,-0.0445569238059235,-0.0294394431377386,9.96293285044109e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REN,Renin,39868,-0.0643001277313656,0.00670813237133345,-0.0774480671791791,-0.051152188283552,1.05326579069678e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0562012205454216,0.00586344542720332,-0.0676935735827401,-0.0447088675081031,1.05724652204784e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37162,-0.0221451445469052,0.00231162523860392,-0.0266759300145689,-0.0176143590792416,1.14103828496524e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.03677831357813,0.00384653062588482,-0.0443175136048643,-0.0292391135513958,1.35937470756696e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,39868,-0.0519282774663437,0.00543304239499798,-0.0625770405605397,-0.0412795143721476,1.37267301825498e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0349677603536931,0.00365789337096861,-0.0421372313607916,-0.0277982893465946,1.38425482267151e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.117004564167526,0.0122415266488069,-0.140997956399188,-0.0930111719358645,1.40404376713994e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.0540056069488409,0.00565068787454069,-0.0650809551829407,-0.0429302587147412,1.41764703432227e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0586400417372701,0.00614066790207004,-0.0706757508253274,-0.0466043326492128,1.4864281633235e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0542802717908286,0.00568489891330587,-0.0654226736609081,-0.0431378699207491,1.51038028989329e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0868990087885951,0.00910200666337566,-0.104738941848811,-0.0690590757283787,1.55730955384401e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C3,Complement C3,36816,-0.0449907842051846,0.00471494110329532,-0.0542320687676434,-0.0357494996427257,1.64585475509253e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0789926672290159,0.00827933354174194,-0.0952201609708301,-0.0627651734872016,1.66076853198925e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.087131889573035,0.00916248430368894,-0.105090358808265,-0.0691734203378047,2.18044479121722e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37382,-0.0767383689514453,0.00806789067695576,-0.0925514346782786,-0.060925303224612,2.19051677506034e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0469194629854074,0.00493833143772823,-0.0565985926033547,-0.03724033336746,2.3702247673368e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,39931,-0.089827511800787,0.00946333415590957,-0.10837564674637,-0.0712793768552042,2.57343068970895e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.0313973528127898,0.00331530805424162,-0.0378953565991034,-0.0248993490264763,3.24323881066916e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.0231897903494328,0.00245091998877553,-0.0279935935274328,-0.0183859871714328,3.5218697157921e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0334832892028232,0.0035408997641303,-0.0404234527405186,-0.0265431256651278,3.62838715367925e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0816773782473865,0.00865544935096531,-0.0986420589752785,-0.0647126975194945,4.38793275736284e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.105382599885174,0.01119480447399,-0.127324416654195,-0.0834407831161539,5.43335350174338e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0646674076641421,0.00687020757456285,-0.0781330145102852,-0.0512018008179989,5.6170683593379e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0935173609155782,0.00994813708674606,-0.1130157096056,-0.0740190122255559,6.16855225777822e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0511884692096789,0.00544863147867842,-0.0618677869078886,-0.0405091515114691,6.66079769013538e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0593994759036154,0.00632480643522566,-0.0717960965166577,-0.0470028552905731,6.69413613932101e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0430421855536202,0.00458236555452495,-0.0520236220404891,-0.0340607490667513,6.77580137101856e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0448069192491486,0.00477080326414145,-0.0541576936468658,-0.0354561448514314,6.81803217839287e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0736174135512478,0.00784041664242469,-0.0889846301704002,-0.0582501969320954,6.9799403493004e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.104767008654184,0.0111611466456085,-0.126642856079576,-0.0828911612287912,7.18139235366421e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0252934955060097,0.00269650643207233,0.0200083428991479,0.0305786481128715,7.45978817635733e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0478821879950984,0.00510837572150331,-0.0578946044092449,-0.037869771580952,7.94060725392689e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0389191919535328,0.0041532201960612,0.0307788803692528,0.0470595035378127,8.13184480685046e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0449971644258366,0.00480506829352723,-0.0544150982811499,-0.0355792305705232,8.62494847323822e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0827354550815286,0.00883423559315844,-0.100050556844119,-0.0654203533189381,8.79167311184252e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0902894756908528,0.00965192261481145,-0.109207244015883,-0.0713717073658223,9.48876137723622e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0918970764733783,0.00982596435227087,-0.111155966603829,-0.0726381863429274,9.67090812499551e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0481667464407859,0.00515022108632297,-0.0582611797699789,-0.0380723131115929,9.70922082255363e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.088046537993805,0.00942817413433208,-0.106525759297096,-0.0695673166905141,1.10350248659089e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.116626185138065,0.0124963801616728,-0.141119090254944,-0.0921332800211862,1.16793332290133e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0643924168470969,0.00690469636320755,-0.0779256217189837,-0.0508592119752101,1.24099373302563e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0713846589835024,0.0076558417902542,-0.0863901088924007,-0.0563792090746042,1.26113513968137e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0556410799526473,0.00598367748785612,-0.0673690878288453,-0.0439130720764493,1.64069794766287e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0635717257850562,0.00685516906401323,-0.0770078571505221,-0.0501355944195902,2.07762500398406e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37445,-0.0652222807300412,0.0070337068100005,-0.0790083460776422,-0.0514362153824402,2.08249210177684e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0618154891981681,0.006673921235832,-0.0748963748203988,-0.0487346035759374,2.24838636197155e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0677740038540937,0.00732227856913696,-0.0821256698496021,-0.0534223378585852,2.44003650856966e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.074120475366319,0.00801450449336034,-0.0898289041733053,-0.0584120465593327,2.5698108121407e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,39812,-0.0448277808356158,0.00485035082726951,-0.054334468457064,-0.0353210932141676,2.7141161301312e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0330991226904827,0.0035814009139066,0.0260795768992258,0.0401186684817396,2.7869170039074e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.036959640116513,0.00400483226442827,-0.0448091113547924,-0.0291101688782336,3.1505080141477e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0415072757544875,0.00449953392467655,-0.0503263622468536,-0.0326881892621215,3.19753528722787e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.042062679926249,0.00456237226588187,-0.0510049295673774,-0.0331204302851205,3.359279917051e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37437,-0.0795305281383572,0.00862768393478741,-0.0964407886505406,-0.0626202676261739,3.46416268772099e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,39715,-0.068149249484543,0.00739856751841446,-0.0826504418206354,-0.0536480571484507,3.62276637061629e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0346860974671015,0.00376620611960177,-0.0420678614615209,-0.027304333472682,3.66325192837053e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0334915187309586,0.00363861200726776,-0.0406231982652034,-0.0263598391967138,3.85025436631262e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,39858,0.022339944471825,0.00242730069496662,0.0175824351096904,0.0270974538339595,3.88032650944095e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0802058038616882,0.00872252837834928,-0.0973019594832528,-0.0631096482401236,4.28152596028451e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0749637561040253,0.00816504166893109,-0.0909672377751303,-0.0589602744329204,4.78978490142988e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0389270158504392,0.00424358066649834,-0.047244433956776,-0.0306095977441025,5.26324930046737e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0350880730146915,0.00382618529046428,-0.0425873961840015,-0.0275887498453815,5.26968949270221e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0607627247197763,0.00662849569431592,-0.0737545762806355,-0.0477708731589171,5.44567670391238e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.07149774535313,0.00780987302245666,-0.086805096477145,-0.0561903942291149,6.08961806677876e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0369270157717855,0.00403794169495737,-0.0448413814939019,-0.029012650049669,6.82940804663569e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37388,-0.0199050262125185,0.00217824760472818,-0.0241743915177857,-0.0156356609072512,7.24896301067979e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,39788,-0.027000565316613,0.0029566421259225,-0.0327955838834211,-0.0212055467498049,7.50485807859432e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0256404432327441,0.00280820601319606,-0.0311445270186084,-0.0201363594468798,7.61618380371319e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0559341805296565,0.00612543644194322,-0.0679400359558652,-0.0439283251034478,7.73055841207292e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0497076977536814,0.00544744040884246,-0.0603846809550126,-0.0390307145523502,8.17914873780732e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.086442784012414,0.00947843268015165,-0.105020512065511,-0.0678650559593167,8.408857223441e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.0991534390539444,0.0108754541317719,-0.120469329152217,-0.0778375489556714,8.80175635821563e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0405285148173498,0.00445037672464525,-0.0492512531976545,-0.0318057764370451,9.69529800978595e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0549424569463619,0.00603730315314278,-0.0667755711265217,-0.043109342766202,1.00580721645517e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0347972296922372,0.00382404939810556,0.0273020928719503,0.0422923665125241,1.0315907007822e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0445862186806654,0.00489983984547412,-0.0541899047777947,-0.0349825325835362,1.03248091937408e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0264698405518793,0.002909859987392,0.020766514976591,0.0321731661271676,1.03955503379771e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37411,-0.0475093520578224,0.00522364516266687,-0.0577476965766494,-0.0372710075389953,1.07526780941981e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0441316400327585,0.00485244688229029,-0.0536424359220475,-0.0346208441434696,1.07825570512915e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.0313790142124315,0.00345125122351676,-0.0381434666105244,-0.0246145618143387,1.08648423613529e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0630561868486933,0.00693654043855586,-0.0766518061082628,-0.0494605675891238,1.10014947911249e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0630493013354806,0.00693913283757542,-0.0766500016971284,-0.0494486009738328,1.16789102062128e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0522804386164204,0.00575516886562271,-0.0635605695930409,-0.0410003076397999,1.16791953167211e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0536159118855664,0.00590822302924975,-0.0651960290228959,-0.0420357947482369,1.27225929589597e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0347734934452458,0.0038365943417555,-0.0422932183550865,-0.027253768535405,1.40509565457108e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0523089703640056,0.00577981945820177,-0.0636374165020811,-0.0409805242259301,1.58703247481495e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0491034260944417,0.00544072472804921,-0.0597672465614181,-0.0384396056274652,2.03351683709933e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.107431353864068,0.0119086176785549,-0.130772244514036,-0.0840904632141006,2.06661067257018e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0640245338890936,0.00709830263347528,-0.0779372070507051,-0.0501118607274821,2.14212724815787e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,39749,0.0232815867257769,0.00258343783829255,0.0182180485627235,0.0283451248888303,2.25230601800064e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0328424899989931,0.00364423291272144,-0.0399851865079271,-0.025699793490059,2.28652135781555e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAX,Protein max,39489,-0.0967455411235631,0.0107419253034961,-0.117799714718415,-0.0756913675287108,2.37194567819291e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.0707845323165693,0.00786218833843479,-0.0861944214599015,-0.0553746431732371,2.4355559950643e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.111178356251463,0.0123502851709731,-0.13538491518657,-0.0869717973163552,2.51442383528949e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37388,-0.126080666282434,0.0140192905168766,-0.153558475695512,-0.0986028568693554,2.71246691527834e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0232013980841428,0.00258186293471709,-0.0282618494361883,-0.0181409467320973,2.83733402965912e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.0239424675074038,0.00266697961451192,-0.0291697475518472,-0.0187151874629605,3.0760041872706e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,39858,0.023475597720575,0.00261617082333548,0.0183479029068375,0.0286032925343126,3.19228933382605e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.0486120028904015,0.00541772583716861,-0.059230745531252,-0.037993260249551,3.20357716156931e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0571526997033457,0.00636810867366148,-0.0696341927037222,-0.0446712067029692,3.20588743113838e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0818247411486359,0.0091275004802027,-0.0997146420898332,-0.0639348402074386,3.45102043193368e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0778758695897724,0.00869248758063843,-0.0949131452478238,-0.0608385939317211,3.64075284148581e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0551613811665081,0.0061629659648231,-0.0672407944575614,-0.0430819678754548,3.92227600878588e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0469766891907591,0.0052537793851606,-0.0572740967856738,-0.0366792815958443,4.25139153495914e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.0211347450659856,0.00236432637141005,-0.0257688247539493,-0.0165006653780219,4.34311870387114e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0437787893774456,0.0048988336920002,-0.053380503413766,-0.0341770753411252,4.54119856199796e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0786030870936777,0.00880352450054466,-0.0958579951147452,-0.0613481790726101,4.87583889630945e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.041285849574344,0.00462556357721862,-0.0503519541856925,-0.0322197449629955,5.012626689038e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.0339811948753323,0.00381182368592137,-0.0414523692997382,-0.0265100204509265,5.41094743087642e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.0354549010863276,0.00397748549791326,0.0276590295104176,0.0432507726622376,5.44907744344046e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,39913,-0.0352153607740805,0.00395709635071818,-0.0429712696214881,-0.0274594519266729,6.21023745610762e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.046417220611616,0.00521593220570532,-0.0566404477347985,-0.0361939934884336,6.35580563642712e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,39555,-0.0343371511717709,0.00385952299825501,-0.0419018162483507,-0.026772486095191,6.3687378754163e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.04885095692292,0.00549114313283288,-0.0596135974632724,-0.0380883163825675,6.49736844551156e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0551641932015531,0.00620583135287067,-0.0673276226531796,-0.0430007637499265,6.80671059871635e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPART,Spartin,37124,-0.07097049471903,0.00798234299049431,-0.0866158869803988,-0.0553251024576612,6.83405789425736e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37021,-0.0540061025375016,0.00608615357660221,-0.065934963547642,-0.0420772415273613,7.98682647259063e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.0202868653820271,0.00228884971257972,-0.0247730108186834,-0.0158007199453709,8.71992649823058e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0223260281338604,0.00251966777030462,0.0173874793040633,0.0272645769636574,8.76341035625074e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0355172515013451,0.00401178316580366,0.0276541564963699,0.0433803465063202,9.36717367957919e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSG,Basigin,40040,-0.017526201288627,0.0019804567171837,-0.021407896454307,-0.0136445061229469,9.67880881645555e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0496696416576825,0.00561544427369719,-0.060675912434129,-0.038663370881236,1.02879410227462e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0586544321551712,0.00663855137742181,-0.071665992854918,-0.0456428714554245,1.11881217195228e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0270222906656245,0.00306005578754824,0.0210245813220299,0.033020000009219,1.14643542060548e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.094500503363707,0.0107017103616121,-0.115475855672467,-0.0735251510549473,1.17244120738626e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0321661061169759,0.00364931934680757,-0.0393187720367187,-0.0250134401972331,1.33365038255424e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0874227690242177,0.00991969972156206,-0.106865380478479,-0.067980157569956,1.34126080529722e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,37453,-0.0239203752009349,0.00272045182344423,-0.0292524607748856,-0.0185882896269842,1.63228887546286e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0587965065428385,0.00668832693011763,-0.071905627325869,-0.0456873857598079,1.63580602076393e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0469276243927464,0.00533907018966223,-0.0573922019644844,-0.0364630468210085,1.65294965000799e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.031791398974397,0.00361777195839966,0.0247005659359337,0.0388822320128604,1.67954153805307e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0431955159313795,0.00491448869847052,-0.0528279137803817,-0.0335631180823773,1.68233893764801e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0500380325790742,0.00569669858712632,-0.0612035618098418,-0.0388725033483066,1.73829338268779e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0362907720812583,0.00413607560488371,0.0281840638956862,0.0443974802668303,1.89293243844518e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0191307121093679,0.00218062046995792,0.0148566959882503,0.0234047282304854,1.91453840439013e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0665908529495632,0.00759416829730482,-0.0814754228122807,-0.0517062830868457,2.02571247927085e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37357,-0.028511747506479,0.00325581545505197,-0.0348931457983809,-0.0221303492145772,2.23782271250526e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0380405675235566,0.00434909878938281,-0.0465648011507469,-0.0295163338963663,2.41078446877132e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0596039191515881,0.00681516275919577,-0.0729616381596118,-0.0462462001435644,2.48119929570111e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0359763395826872,0.0041161241186366,-0.0440439428552149,-0.0279087363101594,2.59470074962466e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,39858,-0.0645387495099439,0.00739532969192155,-0.0790335957061102,-0.0500439033137777,2.87023660562598e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0741237539869665,0.00849625915850593,-0.0907764219376381,-0.0574710860362948,2.93850809234585e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.0209067986834508,0.00239733158466099,-0.0256055685893864,-0.0162080287775153,3.03091124366282e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0688816637549681,0.00790337172329632,-0.0843722723326289,-0.0533910551773073,3.17509523274503e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0392375745873653,0.00450339203298392,-0.0480642229720138,-0.0304109262027168,3.24844291246178e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RETN,Resistin,39790,-0.0361592447785048,0.00415028438296794,-0.044293802169122,-0.0280246873878877,3.26127689268876e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,39777,-0.0251019382328367,0.00288476297142559,-0.0307560736568309,-0.0194478028088426,3.58941064384777e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0784406869038805,0.00902179901015966,-0.0961234129637934,-0.0607579608439675,3.8796970299367e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0753891878178434,0.00867797045613717,-0.0923980099118722,-0.0583803657238145,4.06159128192566e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0838137450776145,0.0096622090411892,-0.102751674798345,-0.0648758153568836,4.55462542454697e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0704603803507053,0.00813665491150272,-0.0864082239772506,-0.0545125367241599,5.18044559507172e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.0199108167816337,0.00230118397455217,-0.0244211373717559,-0.0154004961915114,5.52269553710111e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0636387006229722,0.00735532057461634,0.0492222722967242,0.0780551289492202,5.62183763356926e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.0768942687884106,0.00889019137174219,-0.0943190438770253,-0.059469493699796,5.66335073031813e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.0276912317978451,0.0032008958348763,-0.0339649876342026,-0.0214174759614876,5.68643910556772e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.0415045486930928,0.00480785861411939,-0.0509279515767668,-0.0320811458094188,6.67784338902591e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.0235075578755579,0.00272530771530791,-0.0288491609975614,-0.0181659547535544,7.07279271892066e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37382,-0.0912344676711855,0.0105794183789153,-0.111970127693859,-0.0704988076485116,7.19295703549424e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0505658913284272,0.00586496817149002,-0.0620612289445477,-0.0390705537123068,7.34346862906551e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0611809557945175,0.00709769937617637,-0.0750924465718232,-0.0472694650172118,7.46338938662395e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.103602123742391,0.0120302317674021,-0.127181378006499,-0.0800228694782829,8.00108788038567e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0686991369141193,0.00798615314634011,-0.0843519970809459,-0.0530462767472927,8.66566603362761e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0438257992584391,0.00509870350585992,-0.0538192581299246,-0.0338323403869537,9.2089656434172e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.112380787327208,0.0130798646070215,-0.13801732195697,-0.0867442526974454,9.3336929094815e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,39788,-0.0518477234848656,0.00603461430104867,-0.063675567514921,-0.0400198794548102,9.35161802931252e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0383140728568673,0.00445946751446903,-0.0470546291852266,-0.029573516528508,9.53127205171335e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.0168751245079698,0.00196460160072547,-0.0207257436453918,-0.0130245053705479,9.67102678657226e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0721343722934214,0.00842377225764332,-0.0886449659184023,-0.0556237786684404,1.21493581921935e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0593430436396016,0.00693334275330425,-0.072932395436078,-0.0457536918431253,1.23966440126176e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.0430966075259754,0.00503784081452981,-0.0529707755224538,-0.033222439529497,1.31261037010525e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,39857,0.0510440793056095,0.00597641735121352,0.0393303012972311,0.062757857313988,1.45000189392649e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.058881931814628,0.00689491822537245,-0.072395971536358,-0.045367892092898,1.46564098373018e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0436072464440955,0.00510655362177757,-0.0536160915427795,-0.0335984013454114,1.47076180364544e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,39868,-0.0291450928126537,0.00341357965417191,-0.0358357089348307,-0.0224544766904768,1.48698963573644e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37411,-0.0668704023925834,0.00783720310369352,-0.0822313204758227,-0.0515094843093441,1.58389279836066e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.0240536457232314,0.00282013014442377,-0.029581100806302,-0.0185261906401608,1.6029574686636e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,39862,-0.0215475079949133,0.00252732767707088,-0.0265010702419722,-0.0165939457478544,1.65136609231691e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0563465896285184,0.00660982720469433,0.0433913283073175,0.0693018509497193,1.66825947819558e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.0248488957911134,0.00291840554426155,-0.030568970657866,-0.0191288209243608,1.84665243101882e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.0286875985161754,0.00337248834439487,-0.0352976756711894,-0.0220775213611615,1.95171159139229e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40052,0.0264036204740261,0.00310424708999856,0.0203192961776289,0.0324879447704233,1.96176995191588e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.10014217093182,0.0117761327995661,-0.123223391218969,-0.07706095064467,1.99306987495016e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,39858,-0.0311623319525227,0.00366655605810078,-0.0383487818264003,-0.0239758820786452,2.07758131489974e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.0551487345657072,0.00649377513853496,-0.0678765338372358,-0.0424209352941787,2.23074387231787e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0628777846281281,0.00740687815011578,-0.077395265802355,-0.0483603034539012,2.26219621008359e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0522013206727231,0.00615347891463017,-0.0642621393453983,-0.040140502000048,2.38462136029852e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0318440139858727,0.00375405492439891,-0.0392019616376945,-0.0244860663340508,2.39662944923362e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0466392973321382,0.00550172622812721,-0.0574226807392675,-0.0358559139250089,2.50318876737451e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37422,-0.0402014911772731,0.00474233526520851,-0.0494964682970817,-0.0309065140574644,2.54406328165373e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0625929071917522,0.00739496570105092,-0.077087039965812,-0.0480987744176924,2.79790095248508e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.0393606841356112,0.00465309122134946,-0.0484807429294561,-0.0302406253417662,2.92328214538431e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0770025431517934,0.0091087852960002,-0.0948557623319538,-0.059149323971633,3.06452866003836e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0350017568958185,0.00414036478766119,-0.0431168718796344,-0.0268866419120026,3.11414492570849e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.024413904120063,0.00289153909000986,0.0187464875036437,0.0300813207364823,3.40532051082436e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0416218870587056,0.00493426734413112,-0.0512930510532026,-0.0319507230642086,3.59032484515148e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFP,Properdin,37453,-0.0199491451544489,0.00236507860833735,-0.0245846992267901,-0.0153135910821077,3.64730151702756e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39477,-0.0400976869594983,0.00475738666933867,-0.049422164831402,-0.0307732090875945,3.80311436125668e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0452702178353348,0.00537536350481111,-0.0558059303047646,-0.034734505365905,4.08575583634911e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0844226839367307,0.0100264707358451,-0.104074566578987,-0.0647708012944743,4.08918226716598e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.096269406991591,0.0114403630112127,-0.118692518493568,-0.073846295489614,4.25992975199771e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.045239417174439,0.00537727413719557,-0.0557788744833423,-0.0346999598655357,4.33613813080399e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.0323380007125096,0.00384727737383336,-0.039878664365223,-0.0247973370597962,4.62704464001917e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0526182278359848,0.00626247614686082,-0.0648926810838321,-0.0403437745881376,4.81594707895686e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.0264271298699752,0.00314536303856268,-0.0325920414255581,-0.0202622183143924,4.82430454495341e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37287,-0.085690374565027,0.0102007352552022,-0.105683815665223,-0.0656969334648307,4.89255551437508e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0847802604944675,0.0100939723984025,-0.104564446395336,-0.0649960745935986,4.94214463108304e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0228731922520221,0.00272695185675125,-0.0282180178912545,-0.0175283666127896,5.36237230192504e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0772615054992569,0.00921449243811795,-0.0953219106779681,-0.0592011003205458,5.59378184508833e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,39901,-0.025124712127125,0.00299827822679024,-0.0310013374516339,-0.0192480868026161,5.74063721908211e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0544439738151944,0.0064989186039171,-0.0671818542788719,-0.0417060933515169,5.95497129431698e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0578984273176967,0.0069253954258099,-0.0714722023522841,-0.0443246522831093,6.87968635820878e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.024174136425172,0.00289391203128546,-0.0298462040064915,-0.0185020688438525,7.16934072633302e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.05398302666268,0.00647913699521206,-0.0666821351732957,-0.0412839181520644,8.59286204671175e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0858739282363165,0.0103191014517074,-0.106099367081663,-0.0656484893909699,9.35768401265645e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.0382564528120694,0.00459730240520496,0.0292457400978676,0.0472671655262711,9.51028830374243e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0581106225929689,0.00698762630237785,-0.0718063701456295,-0.0444148750403083,9.80573306687897e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0385611073759086,0.00463863152980922,-0.0476528251743347,-0.0294693895774826,1.02363789374434e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0210989125767856,0.00254077742470373,-0.0260788363292049,-0.0161189888243663,1.08493406731e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.035427795077558,0.00426888084628343,-0.0437948015362735,-0.0270607886188424,1.13153412661038e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37388,-0.0715479875700571,0.00862174463590508,-0.0884466070564311,-0.0546493680836832,1.15298634113832e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,39985,-0.0588715013631598,0.00711190259938292,-0.0728108304579503,-0.0449321722683693,1.35108439160749e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37340,-0.0399766845628806,0.00483085886765204,-0.0494451679434786,-0.0305082011822825,1.40116326498358e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0391846308994908,0.00473605760225291,-0.0484673037999065,-0.0299019579990751,1.40276804858491e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.0471996065264708,0.00571297783555189,-0.0583970430841525,-0.0360021699687891,1.54658199238705e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.078175983183266,0.0094673523331865,-0.0967319937563115,-0.0596199726102204,1.62931335574824e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0843691376639379,0.0102291258770313,-0.104418224382919,-0.0643200509449567,1.75935733978824e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0182996039297649,0.0022206491275501,0.0139471316397667,0.0226520762197631,1.86858631204325e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.076769135066486,0.00931715969892858,-0.095030768076386,-0.058507502056586,1.89068685956573e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0874777547038635,0.0106198172407809,-0.108292596495794,-0.066662912911933,1.92715961771923e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,39892,-0.0314745762278801,0.00382787968060163,-0.0389772204018593,-0.0239719320539009,2.14510801243634e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0545078309857157,0.00663483081081504,-0.0675120993749132,-0.0415035625965183,2.31076930822585e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0546752835122005,0.00667236169402593,-0.0677531124324914,-0.0415974545919097,2.75281355106766e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0190167031264183,0.00232270113641302,-0.0235691973537879,-0.0144642088990488,2.87214866632375e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.0286714558144874,0.0035028846753913,-0.0355371097782543,-0.0218058018507204,2.92491972222991e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.071581758641055,0.00874794047927316,-0.0887277219804304,-0.0544357953016796,3.02146807703496e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0350449207611073,0.00428287303837437,-0.043439351916321,-0.0266504896058935,3.02547459434666e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,39789,-0.0625923638335315,0.00765625795197084,-0.0775986294193943,-0.0475860982476686,3.17106970324658e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0487339413677053,0.00596311692732602,-0.0604216505452643,-0.0370462321901463,3.2857962542124e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0333010017415113,0.00408487190152577,-0.0413073506685018,-0.0252946528145208,3.88237060448785e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0593323913556122,0.00727867900764552,-0.0735986022105974,-0.045066180500627,3.90783847042782e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0602445875756175,0.00740656101443754,-0.0747614471639151,-0.0457277279873199,4.45756296837378e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0561268795810572,0.00690899846481574,-0.0696685165720961,-0.0425852425900184,4.84864627060237e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37124,0.0418661152440765,0.00515628731004832,0.0317597921163818,0.0519724383717712,5.09475380816299e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.0245168602900442,0.00302720729548594,-0.0304501865891966,-0.0185835339908917,5.94116991616472e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0406137610402349,0.0050146065864441,-0.0504423899496654,-0.0307851321308045,6.00645807458485e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0530902622194418,0.00655738607999267,-0.0659427389362275,-0.0402377855026562,6.06742809962608e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0456817821803947,0.00564270417087709,-0.0567414823553137,-0.0346220820054756,6.18056266284464e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0239527212701226,0.00295872877508383,-0.0297518296692869,-0.0181536128709583,6.19166000011612e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0581548957317129,0.00718622635770811,-0.0722398993928208,-0.044069892070605,6.26328654492927e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37437,-0.0463109255632753,0.00572533941448961,-0.057532590815675,-0.0350892603108757,6.53553494483096e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37056,-0.0408000287348875,0.00504595539174485,-0.0506901013027074,-0.0309099561670676,6.71740311100411e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0307628750670421,0.00380794708642036,-0.038226451356426,-0.0232992987776582,7.11824243701187e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0589228605633864,0.00729862072233305,-0.0732281571791592,-0.0446175639476136,7.33047307719343e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.046963610645663,0.00582330460660846,-0.0583772876746156,-0.0355499336167104,7.86624205840452e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0807648468811138,0.0100176020685792,-0.100399346935529,-0.0611303468266987,8.11295887431336e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPTC,Opticin,39788,0.0361452894577152,0.00449246940323103,0.0273400494273824,0.044950529488048,9.17139538241321e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0396180588628855,0.00492483611168415,-0.0492707376417864,-0.0299653800839846,9.37092551210183e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0235124117468741,0.00292504638278629,0.017779320836613,0.0292455026571352,9.73313375718259e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0387566678945223,0.00483001138890629,-0.0482234902167786,-0.029289845572266,1.10845173592142e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0417894136715663,0.00521365488449232,-0.0520081772451713,-0.0315706500979613,1.18766254550287e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37437,-0.0249480009846452,0.00311357551828935,-0.0310506090004923,-0.018845392968798,1.2136712062391e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,39858,0.0257160029326831,0.00321016179396299,0.0194240858165156,0.0320079200488506,1.21748918193253e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0461239892027978,0.00576242395107878,-0.0574183401469123,-0.0348296382586834,1.28409987755762e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,39868,-0.0350091494683839,0.00437399139785616,-0.043582172608182,-0.0264361263285858,1.28713073934777e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0272645007343536,0.00341198253338849,0.0205770149689121,0.033951986499795,1.43034583664151e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0217647358429337,0.00272453561507251,-0.0271048256484758,-0.0164246460373916,1.45983507068969e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0536463876366071,0.00672115362558905,-0.0668198487427616,-0.0404729265304525,1.56156811920873e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,39868,-0.0194011288385548,0.00243297276269986,-0.0241697554534465,-0.014632502223663,1.63599119080774e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0675538139656635,0.00847149973938291,-0.084157953454854,-0.050949674476473,1.65809565221188e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,39862,0.0176266058347501,0.00221157309506552,0.0132919225684217,0.0219612891010785,1.69076310128909e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0896193514875161,0.0112548394668174,0.067559866132554,0.111678836842478,1.79584408399195e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,39563,-0.0400149892274872,0.00502539366979783,-0.0498647608202909,-0.0301652176346834,1.79984725905867e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0690591055475644,0.00867612332181137,-0.0860643072583147,-0.0520539038368141,1.84280477090037e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,39970,-0.048759987566733,0.00612781076554204,-0.0607704966671954,-0.0367494784662706,1.8766280983941e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0769194490509665,0.00967599545462415,-0.0958844001420299,-0.0579544979599032,2.02031785432864e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.036586067314796,0.00460318414319909,0.0275638263941258,0.0456083082354662,2.02079054267111e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,39829,-0.0541641928380498,0.00681667251734964,-0.0675248709720551,-0.0408035147040445,2.05667413242881e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0685104440735973,0.00862306213336943,-0.0854116458550014,-0.0516092422921932,2.07225416553174e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40058,-0.0445031657232176,0.00560993596399047,-0.055498640212639,-0.0335076912337963,2.27949096876062e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0552211779751428,0.0069686299170908,-0.0688796926126408,-0.0415626633376449,2.47876218500165e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0563696591938994,0.00712503189934125,-0.0703347217166082,-0.0424045966711905,2.70927241867852e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0791556485608193,0.0100156415604212,-0.0987863060192449,-0.0595249911023937,2.92761759134588e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.0599064413348741,0.00758587328309049,-0.0747747529697314,-0.0450381297000167,3.04328810979452e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0776725807239312,0.00983749772919376,-0.096954076273151,-0.0583910851747114,3.07824300802949e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00723965607262508,0.000917495074948217,0.00544136572572658,0.00903794641952359,3.19645967757402e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0618434978641827,0.00783904693448963,-0.0772080298557824,-0.046478965872583,3.24275491463311e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37220,-0.0266045298872914,0.00337517181477362,-0.0332198666442477,-0.0199891931303351,3.45867095908173e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0397610966536798,0.00504706985528573,-0.0496533535700399,-0.0298688397373198,3.57737730492166e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0758847334395057,0.00963742135362599,-0.0947740792926127,-0.0569953875863988,3.65484378180722e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.053430310836327,0.00678593958783296,-0.0667307524284796,-0.0401298692441744,3.66309514528815e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0342755433174587,0.00435376151456289,0.0257421707489154,0.0428089158860019,3.74295823272399e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.0365136083134386,0.00464060351302508,-0.0456091911989677,-0.0274180254279094,3.82283893426885e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0378886995586018,0.00481954064590452,-0.0473349992245746,-0.0284423998926289,4.04279964554778e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0605727515706379,0.00770572096672189,-0.0756759646654128,-0.045469538475863,4.06137899569147e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37342,-0.0773897444029818,0.00984627761649631,-0.0966884485313146,-0.058091040274649,4.13819863764484e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0293016821784699,0.00372905820815958,-0.0366106362664627,-0.0219927280904771,4.21559418484107e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40058,-0.062207370703782,0.00792663413780226,-0.0777435736138744,-0.0466711677936895,4.49375958288536e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0466710391739274,0.00594802685229313,-0.058329171804422,-0.0350129065434329,4.5471997402619e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0865798553932459,0.011038296373955,-0.108214916286198,-0.0649447945002941,4.70581955385384e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0503459262909594,0.00642652586438558,-0.0629419169851552,-0.0377499355967637,5.01690139983461e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.0205294793351449,0.00262314872860045,0.015388107827088,0.0256708508432017,5.33802719887863e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0512409550905877,0.00656453733289978,-0.0641074482630713,-0.0383744619181041,6.28930380551549e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0285396300563546,0.00366281462886159,-0.0357187467289233,-0.0213605133837859,7.00965683761264e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.086691271603914,0.0111306984021708,0.0648751027356593,0.108507440472169,7.30541486348106e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0528843849617495,0.00679797495562265,-0.0662084158747699,-0.0395603540487292,7.72734060247016e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0204088915371244,0.00262654070220303,0.0152608717608064,0.0255569113134423,8.39454582732006e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0765179495358341,0.00985768724275085,-0.0958390165316258,-0.0571968825400424,8.93991553940578e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASN,Vasorin,39642,0.0216079880689014,0.0027857877748128,0.0161478440302683,0.0270681321075345,9.26122351941446e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37347,-0.0221681016913908,0.00285814042126792,-0.0277700569170759,-0.0165661464657057,9.38256639899892e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0429071108578953,0.00553323808518506,-0.053752257504858,-0.0320619642109325,9.39955218802789e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0291127191172453,0.00375691376423036,-0.0364762700951368,-0.0217491681393537,9.81739237906159e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.0705476158512599,0.0091110608779426,-0.0884052951720274,-0.0526899365304924,1.03889058179262e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0515263984148892,0.00665487267027086,-0.0645699488486201,-0.0384828479811583,1.04254148469552e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.0240335046788508,0.00310872220728938,-0.030126600205138,-0.0179404091525636,1.14269427450509e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0279390712492085,0.0036174092968845,-0.0350291934711021,-0.0208489490273149,1.21069946936096e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0220576478749752,0.00285754515500803,-0.0276584363787909,-0.0164568593711594,1.24003159913017e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0942993788339084,0.0122235742383065,-0.118257584340989,-0.0703411733268277,1.30054122933211e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0682500938463247,0.00884791833273785,-0.0855920137784909,-0.0509081739141585,1.30930951383961e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37382,-0.0262168414296518,0.00339907190660224,-0.0328790223665922,-0.0195546604927114,1.31525695053474e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0332501694002961,0.00431373417661927,-0.0417050883864699,-0.0247952504141224,1.36896514038998e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0263726163293014,0.00342401905334272,-0.0330836936738531,-0.0196615389847497,1.41501265461239e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0260769006263454,0.00338709640274344,-0.0327156095757225,-0.0194381916769682,1.4516344568366e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0281274990362487,0.00365381342235557,-0.0352889733440656,-0.0209660247284318,1.47631988274657e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0693954014814211,0.00902892026425943,-0.0870920851993696,-0.0516987177634727,1.62367372600285e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0263485760188633,0.00343871183943564,-0.0330884512241571,-0.0196087008135695,1.95290014325936e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40052,-0.0693607874157263,0.00906167182505834,-0.0871216641928407,-0.051599910638612,2.0528280715185e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0738134352338304,0.00965161308281127,-0.0927305968761405,-0.0548962735915203,2.16080478878367e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0464156883312731,0.00607177599953344,-0.0583163692903586,-0.0345150073721875,2.23837631244659e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.0284610436046954,0.00372686606512993,-0.0357657010923501,-0.0211563861170408,2.38160761402048e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0778644960846715,0.0101973178420363,-0.0978512390550625,-0.0578777531142804,2.39942712544742e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0448698864689557,0.00587850080576399,-0.0563917480482531,-0.0333480248896583,2.42570429737544e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0428712511153865,0.00562504319069851,-0.0538963357691556,-0.0318461664616174,2.67321621639225e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0243548311179293,0.00320096976251169,0.0180809303834064,0.0306287318524522,2.92527833798018e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.0376916494018709,0.00495500035974109,-0.0474034501069635,-0.0279798486967784,2.96848298204977e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0477645129203264,0.00627888514501926,-0.0600711278045642,-0.0354578980360887,2.9857205925741e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37056,0.0231001977894496,0.0030371319323276,0.0171474192020875,0.0290529763768117,3.01987952907272e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39489,-0.0477582476816965,0.00628226587287082,-0.0600714887925232,-0.0354450065708697,3.07938306790511e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,39882,-0.0711598087898685,0.00938493881913301,-0.0895542888753692,-0.0527653287043678,3.57928136186459e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0180036043767847,0.00237433793226576,-0.0226573067240255,-0.0133499020295438,3.60707609822247e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0622529371851531,0.00821328943538787,-0.0783509844785134,-0.0461548898917929,3.69893932628714e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0772398347925019,0.0101910406398415,-0.0972142744465913,-0.0572653951384126,3.7025753508909e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0356779620152295,0.00471002804022116,-0.0449096169740629,-0.026446307056396,3.83333759377822e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.07413171306531,0.00979313409524874,-0.0933262558919975,-0.0549371702386224,3.94266927202318e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,39858,0.035332360783412,0.00467728840714617,0.0261648755054055,0.0444998460614185,4.44764886050696e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0280198176113777,0.00370965698061468,-0.0352907452933825,-0.020748889929373,4.48289089969383e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0428995569844788,0.00568482922484567,-0.0540418222651763,-0.0317572917037813,4.77241777195642e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0418992916886981,0.00556017739190367,-0.0527972393768292,-0.0310013440005669,5.12158596933776e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,39931,0.0493566709174431,0.00655179368973307,0.0365151552855662,0.0621981865493199,5.20978225705435e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.0584965035931262,0.00777810810787887,-0.0737415954845688,-0.0432514117016836,5.74150999122135e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0195218017038075,0.0025981749015434,-0.0246142245108326,-0.0144293788967825,6.05211767702951e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.0584757390027944,0.00778980896123476,-0.0737437645668146,-0.0432077134387743,6.38115038209297e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,39750,-0.0504523146943704,0.00673191124641624,-0.0636468607373462,-0.0372577686513946,7.00520964884329e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0224526877504923,0.00299667949567297,0.0165791959389733,0.0283261795620113,7.17517912825665e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0473607279343403,0.00632606784583325,-0.0597598209121735,-0.0349616349565071,7.51736189576212e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0334646576054175,0.00447105409955599,-0.0422279236405473,-0.0247013915702878,7.61227212849709e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0594539222939832,0.00794774657238628,-0.0750315055758603,-0.0438763390121061,7.78176974614885e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0386323108474144,0.00516633029657195,-0.0487583182286954,-0.0285063034661334,7.95339014463501e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0289394563888175,0.00387486291126627,0.0213447250827356,0.0365341876948994,8.53373448073033e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0405501188323917,0.00543251624704448,-0.0511978506765989,-0.0299023869881845,8.79832729903606e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0318298979693135,0.00426525258307818,-0.0401897930321468,-0.0234700029064803,8.91290939548113e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.0220092247279686,0.00294932385702632,-0.0277898994877402,-0.016228549968197,8.92259196594832e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0502472461760117,0.00673358800198265,-0.0634450786598977,-0.0370494136921257,8.95487460417906e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,39788,-0.0630339926842239,0.0084575816042395,-0.0796108526285333,-0.0464571327399144,9.59546029879984e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0517522427180513,0.00695832812171212,-0.0653905658366071,-0.0381139195994955,1.07974318256785e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0428754832393582,0.00576852139631525,-0.0541817851761361,-0.0315691813025803,1.13031032082506e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0370891252961284,0.00500490885759359,-0.0468987466570118,-0.027279503935245,1.32036647739167e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0510338557301913,0.00688614469854759,-0.0645306993393445,-0.037537012121038,1.32678257162514e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0227176834161012,0.00306609289268073,0.016708141346447,0.0287272254857555,1.33198394778885e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.0131245405813796,0.00177208693486766,0.00965125018903894,0.0165978309737202,1.36389106027506e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.0193058099991847,0.0026071339914399,-0.0244157926224069,-0.0141958273759625,1.38913461843058e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0429766896229,0.00580952456031943,-0.0543633577611261,-0.0315900214846739,1.454922130972e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0404906251510621,0.00547578062544116,-0.0512231551769268,-0.0297580951251974,1.50258844161862e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,39713,0.0356161717283834,0.00482543554587331,0.0261583180584717,0.0450740253982951,1.64989971323633e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0584629707708855,0.00792985080222701,0.0429204631985205,0.0740054783432504,1.75617462580641e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,39866,-0.0490344991145718,0.00665145059065366,-0.0620713422722529,-0.0359976559568906,1.76299530290135e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,-0.0101602448224863,0.00137955001116153,-0.0128641628443629,-0.00745632680060975,1.87662449557519e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0554002521939107,0.00753074041994231,-0.0701605034169977,-0.0406400009708238,1.99881623744456e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37445,-0.0690053525444043,0.00938322268061279,-0.0873964689984054,-0.0506142360904033,2.0318753098773e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0266105158646866,0.0036201587656785,-0.0337060270454165,-0.0195150046839568,2.06792641006138e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37043,-0.0389687092553769,0.00530438755550009,-0.0493653088641571,-0.0285721096465967,2.15415520240333e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,39615,-0.0559047771857735,0.00762135817195759,-0.0708426392028104,-0.0409669151687366,2.32032194826111e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0520310861766809,0.00709435172291352,-0.0659360155535914,-0.0381261567997704,2.33974264196336e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,36991,-0.0481502222855956,0.00657337375393778,-0.0610340348433136,-0.0352664097278775,2.52757767870871e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37382,-0.0251557294405893,0.00343522652875651,-0.0318887734369521,-0.0184226854442266,2.56436688817345e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0211716582123476,0.00289438284723965,-0.0268446485929374,-0.0154986678317579,2.72712636267682e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0217247218732466,0.00297167609513349,-0.0275492070197082,-0.0159002367267849,2.78622241983527e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0549098955990862,0.00752336885741413,-0.0696556985596179,-0.0401640926385545,3.07311480508924e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0265939911240662,0.00364650014850648,-0.0337411314151389,-0.0194468508329935,3.17270811588012e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39405,-0.0879122623488447,0.0120607493477805,-0.111551331070495,-0.0642731936271949,3.26993011721575e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.0189346539372406,0.00259810736704984,0.0138423634978229,0.0240269443766583,3.3227378318517e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.060921748005475,0.00836247114845449,-0.0773121914564457,-0.0445313045545042,3.36315920537521e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,39858,-0.090529373127517,0.0124353814219572,-0.114902720714553,-0.066156025540481,3.49380047878176e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,39866,-0.0506571691826425,0.00697056013376457,-0.0643194670448211,-0.0369948713204639,3.83656994927836e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0619340300797463,0.00852311975719177,-0.0786393448038422,-0.0452287153556505,3.85623225472434e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.0671674859434503,0.00924170805136102,-0.0852812337241179,-0.0490537381627827,3.85768110584367e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0452652221227178,0.00623079807384154,0.0330528578979884,0.0574775863474472,3.94075039163696e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0337764310993579,0.00465033258825508,-0.0428910829723379,-0.0246617792263779,3.9861972609931e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.0245661503361894,0.00338532010992414,-0.0312013777516407,-0.0179309229207381,4.14933448220894e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0442413729861922,0.00610262215753698,-0.0562025124149647,-0.0322802335574197,4.37300933656075e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0271410170103932,0.00374675375881626,0.0197973796431133,0.034484654377673,4.59625911442866e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0826296769324724,0.0114240098218519,-0.105020736183302,-0.0602386176816428,4.94275559168422e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0466151650034476,0.00646052178270599,-0.0592777876975513,-0.0339525423093438,5.61954273089675e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,39788,-0.0520292031960896,0.00721475028270454,-0.0661701137501905,-0.0378882926419887,5.78247912586661e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.053120241118429,0.00736897285582696,-0.0675634279158498,-0.0386770543210081,5.95013790858465e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0559388969712845,0.007762178870627,-0.0711527675577134,-0.0407250263848555,6.04076980893613e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.0452952530946564,0.00628582304215205,-0.0576154662572744,-0.0329750399320384,6.06941516898035e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0215587145181388,0.0029936574143154,-0.027426283050197,-0.0156911459860806,6.23281412668074e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37056,-0.0425106196004066,0.00591228120302677,-0.0540986907583391,-0.0309225484424742,6.81685235184195e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40009,-0.0219219005871613,0.00305063446422017,-0.0279011441370329,-0.0159426570372898,6.96259273262992e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGMN,Legumain,39931,-0.0262287678188897,0.0036564638603776,-0.0333954369852298,-0.0190620986525496,7.64258641390427e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0246109079227759,0.00343163411054204,-0.0313369107794383,-0.0178849050661135,7.78633697677299e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0414389044039412,0.00578126689788904,-0.0527701875238037,-0.0301076212840787,8.02709083329482e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0173627936067168,0.00242684893690982,0.0126061696903735,0.02211941752306,8.76384908121946e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0821072504998684,0.011496567625233,-0.104640523045325,-0.0595739779544118,9.61128087279742e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.0237143508406363,0.00332060472483486,-0.0302227361013126,-0.01720596557996,9.6248563394373e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0583409083629715,0.00817298918203643,-0.0743599671597629,-0.0423218495661801,9.94772385110248e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.0421430221159194,0.00591686033104934,-0.0537400683647761,-0.0305459758670627,1.10509521374688e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.0184778305038734,0.00259797266019664,0.013385804089888,0.0235698569178588,1.18840463686651e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0636400625987684,0.00894814031551709,-0.0811784176171819,-0.0461017075803549,1.20186149186928e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40058,-0.0251839496659409,0.00354363059054265,-0.0321294656234045,-0.0182384337084773,1.23695055667083e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0854326549732926,0.0120305164353239,-0.109012467186527,-0.0618528427600578,1.28824506545267e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.063692245553876,0.00898719152426204,-0.0813071409414296,-0.0460773501663224,1.4381091973854e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39489,-0.0210475138313149,0.00297460162333959,-0.0268777330130605,-0.0152172946495693,1.5496475527031e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.0191383513769708,0.00270498994800625,-0.024440131675063,-0.0138365710788785,1.56545493089953e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37186,0.127105119729307,0.017979891987615,0.091864531433582,0.162345708025033,1.63479259318002e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39344,-0.0551232852372676,0.0078027661467033,-0.0704167068848061,-0.0398298635897291,1.6796373287397e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0235677088339173,0.00333872140960798,0.0170238148710857,0.0301116027967489,1.76169556358002e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40009,-0.0248996800338153,0.00352890306542288,-0.0318163300420442,-0.0179830300255865,1.7841950993439e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,39749,0.0300732696515851,0.00427431041659373,0.0216956212350614,0.0384509180681088,2.06183848427495e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,39826,-0.0188738700867725,0.00268274801202317,-0.024132056190338,-0.0136156839832071,2.06945854414617e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0634720644004794,0.00903188996995144,-0.0811745687415842,-0.0457695600593746,2.1868504404496e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0275191521933961,0.0039161074031597,-0.0351947227035891,-0.0198435816832031,2.19197258174411e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0331155875295294,0.00472010130445624,0.0238641889727952,0.0423669860862636,2.37689803274864e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0473243619522373,0.00674943342894216,-0.0605532514729639,-0.0340954724315107,2.45270700863624e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37388,-0.0195709299763826,0.00279646143721785,-0.0250519943933296,-0.0140898655594356,2.70973628327517e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0325655776268051,0.00465407515494222,-0.0416875649304918,-0.0234435903231183,2.71353122740347e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0417755135730895,0.00597191013899053,-0.053480457445511,-0.0300705697006681,2.7704312130391e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0309938185072535,0.00443118474164906,-0.0396789406008856,-0.0223086964136213,2.78970530034916e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0319497564000813,0.00457108958286109,-0.0409090919824891,-0.0229904208176736,2.86754523469391e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0336729754412437,0.00481979118798883,-0.0431197661697018,-0.0242261847127856,2.95202048447988e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0235251931664733,0.00336932000939304,-0.0301290603848837,-0.016921325948063,3.01943791946574e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.0232331092648496,0.00332806844479281,-0.0297561234166435,-0.0167100951130556,3.04685814807212e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0437808812070012,0.00627819326045571,-0.0560861399974944,-0.031475622416508,3.23927242960839e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0715842504409877,0.0102754396766129,-0.091724112207149,-0.0514443886748265,3.37487073456072e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37021,-0.0279602028743605,0.00401436351103321,-0.0358283553559856,-0.0200920503927354,3.43908826094852e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0649345528532486,0.00933544471065508,-0.0832320244861326,-0.0466370812203647,3.64760445875042e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.029418798588313,0.00423102531305449,-0.0377116082018998,-0.0211259889747262,3.71227235696395e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37445,-0.0442261746551669,0.00636481528467172,-0.0567012126131235,-0.0317511366972103,3.85902444875033e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0359021357093538,0.00516882580408198,-0.0460330342853544,-0.0257712371333531,3.93702237994446e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37056,-0.0320668911977859,0.00462521844628492,-0.0411323193525043,-0.0230014630430674,4.31007771146797e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0425102618803071,0.00613295117595558,-0.05453084618518,-0.0304896775754342,4.359512085938e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0396301610588294,0.00572428313895498,-0.0508497560111812,-0.0284105661064777,4.61911179999053e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.0429274708376841,0.00621118761974355,-0.0551013985723815,-0.0307535431029867,5.02125473147494e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0667236648467428,0.00967361449618299,-0.0856839492592615,-0.0477633804342242,5.49205302118013e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0469663329928621,0.00681017502792638,-0.0603142760475978,-0.0336183899381264,5.56595601607547e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0194280128219721,0.00282557943160124,-0.0249661485079105,-0.0138898771360337,6.44411978553026e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0229957473475267,0.00334668430950071,-0.0295552485941481,-0.0164362461009053,6.60100368218582e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,39788,-0.0204736806233929,0.00298729357762668,-0.0263287760355412,-0.0146185852112446,7.46616253177554e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0533922167132069,0.00779189486423541,-0.0686643306471083,-0.0381201027793055,7.58821491141574e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0504789434985492,0.00737142282434091,-0.0649269322342574,-0.036030954762841,7.77040889152307e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0518151650178112,0.00758077043715435,-0.0666734750746337,-0.0369568549609886,8.54582949727252e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0428100928544275,0.00626578413491577,-0.0550910297588624,-0.0305291559499926,8.71191236942704e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0481789999029045,0.00705343135444372,-0.0620037253576142,-0.0343542744481948,8.81818759705588e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0367452531385945,0.00538759908568044,-0.0473049473465282,-0.0261855589306609,9.41359798617764e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0298282412916718,0.00437732270426198,-0.0384077937920252,-0.0212486887913183,9.80909034811706e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.0471845896466879,0.00692643304076608,-0.0607603984065895,-0.0336087808867864,1.00261557146641e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2,Brorin,39684,-0.026726949852802,0.00392456571466398,-0.0344190986535434,-0.0190348010520606,1.00994536352378e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0538262295906906,0.00790398566132028,-0.0693180414868783,-0.0383344176945028,1.01821244037935e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0433354642162385,0.00636721728582136,0.0308557183360286,0.0558152100964483,1.04702293588498e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,39749,-0.0231664152852587,0.00340687514158187,-0.0298438905627591,-0.0164889400077582,1.08421324957769e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.0382930510078518,0.00563257931474444,-0.0493329064647509,-0.0272531955509527,1.10288898403932e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,39868,-0.0479486892002456,0.00706713673318305,-0.0618002771972843,-0.0340971012032068,1.20371748689931e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0363894269101547,0.0053669371149392,-0.0469086236554355,-0.0258702301648739,1.24198690570459e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0480669428703715,0.00710107000124722,0.0341488456679269,0.061985040072816,1.34205189478801e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0265444504090802,0.00392643111229691,-0.0342402553891821,-0.0188486454289783,1.42351235334332e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCN,Decorin,39585,0.0149110679315088,0.00220910358519351,0.0105812249045295,0.0192409109584881,1.53197035298293e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0479236206021743,0.00710101229468693,-0.0618416046997606,-0.0340056365045879,1.55269592398293e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0322637105428032,0.00479981525576532,-0.0416713484441032,-0.0228560726415031,1.85419451833381e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNC,Tenascin,39931,0.0322271129310024,0.0047979257127561,0.0228231785340004,0.0416310473280043,1.91878439935752e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0245751648630776,0.00365904025005982,-0.0317468837531948,-0.0174034459729603,1.94071108944268e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,39585,-0.0317427448935655,0.00473289332496191,-0.0410192158104909,-0.0224662739766402,2.05667946001682e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0872895893039843,0.0130190162842516,-0.112806861221117,-0.0617723173868513,2.09704301769999e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37169,-0.0370419925084619,0.00553066916732446,-0.0478821040764178,-0.0262018809405059,2.20439195745496e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.032208977001689,0.00481682092514446,-0.0416499460149722,-0.0227680079884059,2.37088349777914e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0506834882552184,0.00758157040732217,-0.0655433662535699,-0.035823610256867,2.39981774957029e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0229371753497712,0.00343154239593138,-0.0296629984457967,-0.0162113522537457,2.41412804009327e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.054983852152775,0.00824167394540916,-0.071137533085777,-0.0388301712197731,2.63415430645126e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39477,-0.0396481710761207,0.00594437531134992,-0.0512991466863665,-0.0279971954658748,2.64640114011932e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0483012099405965,0.0072416649635856,-0.0624948732692243,-0.0341075466119687,2.65917081395521e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0550358657249532,0.00827048602486298,-0.0712460183336847,-0.0388257131162218,2.93743938173518e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.044803291879178,0.00673240121057859,0.031607785506444,0.057998798251912,2.94458839808997e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0587733536814497,0.0088346884014195,-0.0760893429482319,-0.0414573644146674,2.99385001299667e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0276779986449085,0.00416195346049582,0.0195205698623367,0.0358354274274803,3.01985720258419e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0697100052008092,0.0104904041958682,-0.0902711974247109,-0.0491488129769076,3.14875882071702e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0297307712607658,0.0044872276709362,-0.0385257374958007,-0.0209358050257308,3.56767436191041e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.0184829864057394,0.0027920071302748,-0.023955320381078,-0.0130106524304008,3.70750178444371e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.042199702474847,0.00638349596580464,-0.0547113545678241,-0.0296880503818699,3.94462742161899e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,39749,0.0223028897311564,0.00338047128142789,0.0156771660195577,0.0289286134427551,4.31164140030672e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0747653775138383,0.0113324140398997,-0.0969769090320417,-0.0525538459956348,4.31649978096653e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0388879697581246,0.00590312274369825,-0.0504580903357732,-0.0273178491804761,4.60988628494614e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0161248921068191,0.00244861415309633,0.0113256083667503,0.0209241758468879,4.67989143937897e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0261312341006896,0.00398354215790921,0.0183234914711876,0.0339389767301917,5.55621706329218e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0515464731579601,0.00786314785447047,-0.0669582429527222,-0.0361347033631979,5.754811592069e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,39858,-0.0430079012615689,0.00656728055593881,-0.0558797711512089,-0.0301360313719288,5.97628956075449e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.064152371150448,0.00980618043659271,-0.0833724848061697,-0.0449322574947263,6.29148268064209e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2,Complement C2,39908,-0.0157500213201035,0.00240982963124141,-0.0204732873973366,-0.0110267552428703,6.52029993428903e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.0194884041776649,0.00298450987094081,-0.0253380435247089,-0.0136387648306209,6.7849142562931e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0221469924037072,0.00339609334764845,-0.0288033353650982,-0.0154906494423162,7.17563479032781e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0791250426902607,0.0121317290485567,-0.102903231625432,-0.0553468537550896,7.17676423314326e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37411,0.0299840181447656,0.00460062566667318,0.0209667918380862,0.039001244451445,7.4077926129779e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40042,-0.0214871921209392,0.0032982684246983,-0.0279517982333478,-0.0150225860085305,7.49895610889387e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0446843535334891,0.00686057514629467,-0.0581310808202267,-0.0312376262467515,7.62062501297946e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0256026309581847,0.00393324666376483,-0.0333117944191638,-0.0178934674972057,7.81710967169134e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0843738842647615,0.0129622068621206,-0.109779809714518,-0.0589679588150051,7.82585243366446e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0473319593687157,0.00727305693553455,-0.0615871509623634,-0.033076767775068,7.89254701294578e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.0323525680836995,0.00497698689503397,-0.0421074623979661,-0.0225976737694329,8.29025712937646e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37257,0.0713562360116034,0.0109947930104765,0.0498064417110694,0.0929060303121374,8.88559184500443e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,39858,-0.0299445982235813,0.00461660617280213,-0.0389931463222734,-0.0208960501248891,9.05627117280899e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.0570118086881537,0.00879945258910705,-0.0742587357628035,-0.0397648816135039,9.50298661639063e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0299194463460461,0.00461792166787353,-0.0389705728150782,-0.020868319877014,9.50623354374167e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0337175895518255,0.00520856586944896,-0.0439263786559455,-0.0235088004477055,9.86220969734262e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.0254177821693779,0.00392615185023434,-0.0331130397958373,-0.0177225245429186,9.87612974181578e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0432678726636706,0.00670048559458733,-0.0564008244290618,-0.0301349208982795,1.10138708276676e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0799208470220588,0.0124014477001764,-0.104227684514405,-0.055614009529713,1.20041975696077e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0215406116352165,0.00334711497355745,-0.0281009569833891,-0.0149802662870439,1.27257874956108e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40009,0.0193656827078433,0.0030126285967472,0.0134609306582188,0.0252704347574678,1.32772166425001e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0443958267774511,0.00690933365992031,-0.0579381207508949,-0.0308535328040073,1.35969985553081e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.0462064722088026,0.00719465422477544,-0.0603079944893625,-0.0321049499282427,1.38813776574972e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0325063340961497,0.0050629256530814,-0.0424296683761893,-0.0225829998161102,1.4054533285918e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0315607496847492,0.00492398958372816,-0.0412117692688564,-0.021909730100642,1.50093190671823e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,39858,-0.0251023356074583,0.00391988383013118,-0.0327853079145154,-0.0174193633004012,1.55734927607179e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.0174334349471428,0.00272295400610909,-0.0227704247991166,-0.012096445095169,1.57163479700667e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.0242569826033386,0.00379061271430408,-0.0316865835233746,-0.0168273816833026,1.60613894550382e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0237221506227511,0.00370681939978854,-0.0309875166463366,-0.0164567845991656,1.61053645717421e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37437,-0.0645623327928347,0.0101046039449628,-0.0843673565249619,-0.0447573090607076,1.71975353926854e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0330646890870689,0.00517500206928619,-0.0432076931428699,-0.022921685031268,1.72096828200934e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0195104392648319,0.00305699480900661,0.013518729439179,0.0255021490904849,1.79418826263014e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0234258601933993,0.00367074923453168,0.0162311916937172,0.0306205286930814,1.7990665686851e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0465508696590034,0.00730616170986644,-0.0608709466103416,-0.0322307927076652,1.93287843270027e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.0171309475039856,0.00269729972601761,-0.0224176549669801,-0.0118442400409911,2.19481298932679e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0536090428460178,0.0084860942298412,-0.0702417875365065,-0.036976298155529,2.73235399661518e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0246882662718094,0.00390931446615631,-0.0323505226254757,-0.017026009918143,2.77027513597494e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.0150651584818415,0.00238667016456875,0.0103872849592867,0.0197430320043962,2.82239771011433e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.0180639618485022,0.00286206334419635,-0.0236736060031271,-0.0124543176938774,2.8517089975387e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0397110871716005,0.0062947656785676,0.027373346441608,0.052048827901593,2.88992429142882e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.034106350750037,0.00541404868871523,-0.0447178861799188,-0.0234948153201551,3.06205330319329e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.0226214278892711,0.00359089736662523,-0.0296595867278566,-0.0155832690506857,3.07693530524026e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0582454473985709,0.00925961014634691,-0.0763942832854109,-0.040096611511731,3.26653930982252e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0266966308211129,0.00425005822229322,-0.0350267449368076,-0.0183665167054182,3.44204077560813e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0275684141974739,0.00438889231193793,-0.0361706431288722,-0.0189661852660755,3.44343988804467e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.0567452425842834,0.00903582205478941,-0.0744554538116706,-0.0390350313568961,3.4906837597652e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELL,L-selectin,37453,0.0145181475473993,0.00231437234305778,0.00998197775500601,0.0190543173397925,3.64798698228784e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0352904288311452,0.00562682271694153,-0.0463190013563506,-0.0242618563059398,3.6772301399883e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0259540602688205,0.00414267481579471,-0.0340737029077781,-0.0178344176298629,3.82260233071056e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.0160072068195172,0.00255529342941144,-0.0210155819411636,-0.0109988316978707,3.83905790418354e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.0183722887340832,0.00293575468684591,-0.0241263679203012,-0.0126182095478653,4.01414713437521e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0311082000784418,0.00497643623501733,-0.0408620150990757,-0.0213543850578078,4.1983109380262e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0308403590468589,0.00493986738169077,-0.0405224991149728,-0.021158218978745,4.39912109440756e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,39818,-0.0255000441938075,0.00409140950083529,-0.0335192068154446,-0.0174808815721703,4.7033240855673e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37056,-0.0249394635797045,0.00400194588065658,-0.0327832775057914,-0.0170956496536176,4.75030928774421e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0210139555919839,0.00337506088623284,-0.0276290749290003,-0.0143988362549675,4.91802539766238e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0364614898653081,0.0058626725718334,-0.0479523281061015,-0.0249706516245146,5.12045298390899e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.0214142250135305,0.0034440492119635,0.014663888558082,0.0281645614689789,5.19120988655878e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,39490,-0.0267581881026589,0.0043075999277553,-0.0352010839610592,-0.0183152922442585,5.36879552438919e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0763149184738978,0.0122891786345352,-0.100401708597587,-0.0522281283502088,5.43116957082754e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0445148144571064,0.00717076175601371,-0.0585695074988932,-0.0304601214153195,5.50831948673516e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0413561687123425,0.0066676911382226,-0.0544248433432588,-0.0282874940814262,5.69728100158009e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,39866,-0.019713690582322,0.00317894617167551,-0.025944425078806,-0.013482956085838,5.7362656457387e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.055653570708808,0.00898564409198826,-0.073265433129105,-0.038041708288511,6.02321769096411e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0326595662522249,0.00527406609506085,-0.0429967357985442,-0.0223223967059056,6.06952429126435e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0205190188205318,0.00331507792025993,0.0140214660968223,0.0270165715442412,6.20512482254629e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.0352358671346837,0.00570018203060407,-0.0464082239146677,-0.0240635103546998,6.53290294913022e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0262969561122315,0.00425487307960854,-0.0346365073482643,-0.0179574048761988,6.54682166508342e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0221563094328776,0.00358899131724129,-0.0291907324146705,-0.0151218864510847,6.8797509363559e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0315653487688766,0.00511962065729395,-0.0415998052571728,-0.0215308922805805,7.19137446533367e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,39788,-0.0262230605538461,0.00425667220150508,-0.0345661380687961,-0.0178799830388961,7.42768631588358e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,39587,-0.0715769194135959,0.0116536741905733,-0.0944181208271195,-0.0487357180000723,8.34467581508597e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0750551407679378,0.0122535125545927,-0.0990720253749395,-0.0510382561609361,9.31539634700607e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0254352210301693,0.0041533795868763,-0.0335758450204469,-0.0172945970398918,9.37973484296343e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0667713983599931,0.0109110320601084,-0.0881570211978055,-0.0453857755221806,9.63871567744641e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0457659544273418,0.00748067682906317,-0.0604280810123056,-0.031103827842378,9.70506405275124e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0247594864832929,0.00405097570248587,-0.0326993988601652,-0.0168195741064206,1.01160048794967e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0746678572921627,0.0122233648639842,-0.0986256524255717,-0.0507100621587537,1.02819431234611e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.019633242599381,0.00321726987762307,-0.0259390915595223,-0.0133273936392398,1.06870182913337e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0207988224923247,0.00341154794256933,0.0141121885248888,0.0274854564597606,1.10860735095273e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0331768775283528,0.00544461562771154,-0.0438483241586674,-0.0225054308980382,1.13532312072548e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.016683628853254,0.00274234510061383,0.0113086324560509,0.0220586252504571,1.20098765430278e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.0331493378377997,0.00545089112125179,-0.0438330844354532,-0.0224655912401462,1.22294878745538e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.0385465036146833,0.00633833691882434,-0.050969643975579,-0.0261233632537876,1.22366812422382e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.0614942025481059,0.0101337338493177,-0.0813563208927685,-0.0416320842034432,1.32752692799217e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0586768463546921,0.00967483534507035,-0.07763952363103,-0.0397141690783542,1.35035599051583e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0500233473913592,0.00825888792798903,-0.0662107677302178,-0.0338359270525007,1.42586239694463e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0470925647506204,0.00778911969187921,0.0318258901545372,0.0623592393467037,1.51854833817329e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0234507091937132,0.00388036927273021,-0.0310562329682645,-0.015845185419162,1.54837482462544e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37056,-0.0264336830998679,0.00437395676189835,-0.0350066383531887,-0.0178607278465472,1.54941600746969e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0380191076020641,0.00629439109787696,-0.0503561141539029,-0.0256821010502253,1.58110381712959e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAT,Catalase,37252,-0.0326482838145865,0.00540805286907294,-0.0432480674379695,-0.0220485001912035,1.61180823424152e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.029575718948169,0.00490423174998189,-0.0391880131781335,-0.0199634247182045,1.66918562864952e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0287820179786074,0.00477471911124874,-0.038140467436655,-0.0194235685205599,1.69642361521209e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.0352119510836211,0.00584286337265749,-0.0466639632940298,-0.0237599388732125,1.72029985458741e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0208122419141782,0.00345839218207711,-0.0275906905910493,-0.014033793237307,1.81272936428901e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0294868593302766,0.00490067551999503,-0.0390921833494669,-0.0198815353110864,1.82386174562345e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,39585,-0.0232969984167182,0.00387798453413159,-0.0308978481036161,-0.0156961487298203,1.92557939636756e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.0237283321559496,0.00395009570299943,-0.0314705197338285,-0.0159861445780707,1.9379626818451e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0321127523502674,0.0053603578179182,-0.0426190536733871,-0.0216064510271478,2.14272383670857e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0356835523677859,0.00595794876382869,-0.0473611319448902,-0.0240059727906817,2.15482014729311e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.025576849526795,0.00427100575058635,-0.0339480207979442,-0.0172056782556457,2.17165992809085e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0352014680036294,0.0058918009936142,-0.0467493979511133,-0.0236535380561456,2.35590225653945e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.0195479817959927,0.00327547039387386,-0.0259679037679855,-0.013128059824,2.46175977706248e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0340493682694629,0.00571173088587244,0.0228543757331529,0.0452443608057729,2.55435398257461e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.0280035585280559,0.00471061664640291,-0.0372363671550056,-0.0187707499011062,2.83653986800875e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0292995350520878,0.00493281751641563,-0.0389678573842625,-0.0196312127199132,2.92550290083538e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.029343512965965,0.00494745627311972,-0.0390405272612796,-0.0196464986706503,3.08386513405575e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0426474241146697,0.00720324199942104,0.0285290697958044,0.0567657784335349,3.28571942306981e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0180981827393665,0.00306354653895428,-0.0241027339557169,-0.0120936315230161,3.55455209454727e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40012,0.0270789332968642,0.0045855168289526,0.0180913203121171,0.0360665462816113,3.59028534665416e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0171663410488939,0.00291580997975195,0.01145135348858,0.0228813286092077,4.00240133623956e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.052745694019437,0.00896360458313465,-0.0703143590023809,-0.0351770290364931,4.08884974439089e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37056,-0.0315368160557624,0.00536330629258558,-0.0420488963892302,-0.0210247357222947,4.19918700837362e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0262289821537676,0.00446140978095063,0.0174846189831043,0.0349733453244308,4.20761763666037e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.0323303339747487,0.00550153816899555,-0.04311334878598,-0.0215473191635174,4.27139217079207e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0255119464523395,0.00434280657381007,-0.0340238473370073,-0.0170000455676718,4.3426468790814e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.0144044971266253,0.00245361978298489,-0.0192135919012757,-0.00959540235197495,4.42569988139993e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0146839342498622,0.00250690583961196,0.00977039880422277,0.0195974696955017,4.81331713116301e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.0423017972200745,0.00724504717019055,-0.0565020896736479,-0.028101504766501,5.36469085924957e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0539798845157881,0.00925167470248038,0.0358466020989265,0.0721131669326496,5.49877737249337e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.01734343633005,0.0029750382009391,-0.0231745112038907,-0.0115123614562094,5.66025828004106e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0299947256795075,0.00514958472503436,-0.0400879117405749,-0.0199015396184402,5.85203597325763e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0673969058516566,0.0115809730627529,-0.0900956130546523,-0.0446981986486609,6.03430104460104e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37424,-0.0134387188849502,0.00230982115335185,-0.0179659683455198,-0.00891146942438059,6.08715534150024e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0246966282148273,0.00424652679366564,-0.0330198207304119,-0.0163734356992426,6.17718556397801e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.0279865207690182,0.00481306004970836,-0.0374201184664466,-0.0185529230715899,6.19070018344257e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0154294096450858,0.00265784508206837,-0.0206387860059398,-0.0102200332842318,6.5488426295157e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,37453,-0.0430023733121281,0.00741766619211909,-0.0575409990486815,-0.0284637475755747,6.88908315892753e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.0451903633282532,0.00780206408758575,-0.0604824089399213,-0.0298983177165851,7.08491208600948e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0695829098768785,0.012022609320116,-0.0931472241443058,-0.0460185956094511,7.29910325628151e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.0204073013667597,0.00353107915384428,-0.0273282165082945,-0.0134863862252249,7.64003014894808e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0421698211736005,0.00729719060535204,-0.0564723147600905,-0.0278673275871105,7.68694522298412e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0304145018947841,0.00526440231260284,-0.0407327304274856,-0.0200962733620825,7.73122366862022e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37056,-0.018858516862028,0.00328407413413277,-0.0252953021649282,-0.0124217315591278,9.5392631356836e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.0518844448848781,0.00903790397983738,-0.0695987366853593,-0.0341701530843968,9.62788858824694e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0642582769206877,0.0111946751782174,-0.0861998402699939,-0.0423167135713815,9.63536260070048e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0362957904192672,0.00633175274577735,-0.0487060258009909,-0.0238855550375436,1.01165849445161e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.0197979247997607,0.00346359661951567,-0.0265865741740114,-0.01300927542551,1.1101198252721e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.0230272649851448,0.00402997309356768,-0.0309260122485374,-0.0151285177217521,1.12314383572316e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39477,-0.0397501135301946,0.00695992798392207,-0.0533915723786819,-0.0261086546817073,1.14169117056816e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0409701822643133,0.00718165927545205,-0.0550462344441994,-0.0268941300844273,1.18896068494402e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37124,-0.0211203867323209,0.00370643624080863,-0.0283850017643059,-0.013855771700336,1.2358164629816e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.026310288599285,0.00462357256454689,0.0172480863727731,0.0353724908257969,1.28903356010501e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.0256428584435667,0.00450995748095831,-0.034482375106245,-0.0168033417808884,1.32506175647966e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39477,-0.0429208228870649,0.00755416842050773,-0.0577269929912601,-0.0281146527828698,1.35709226005681e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0252489216711523,0.00444395808921779,-0.0339590795260192,-0.0165387638162855,1.3625180915925e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0165351280109414,0.0029116849492392,0.0108282255104326,0.0222420305114502,1.37921911862327e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.01503777140792,0.00264916411920006,0.00984540973428785,0.0202301330815521,1.3989786139511e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0511297393065137,0.009019636660641,-0.0688082271613701,-0.0334512514516574,1.46399075110362e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37382,-0.0331368813425698,0.0058593868905211,-0.0446212796479911,-0.0216524830371484,1.58678991224688e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0302330755361792,0.00535728490982175,-0.0407333539594299,-0.0197327971129286,1.69661897137858e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0606970606467052,0.0107641911138534,-0.0817948752298578,-0.0395992460635527,1.74151558494248e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.0373108868062607,0.00661677440029149,-0.050279764630832,-0.0243420089816894,1.74719307237436e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0221427997977845,0.0039334930255789,-0.0298524461279191,-0.0144331534676498,1.83950975656631e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0378244618901053,0.00671970346998418,-0.0509950806912743,-0.0246538430889363,1.84416698831998e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.0709808866958124,0.0126160131975676,-0.0957082725630449,-0.0462535008285799,1.88030475939397e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0167211065387693,0.00297215486497621,-0.0225465300741227,-0.0108956830034159,1.88186406700599e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0427043274022333,0.00759150696625357,-0.0575836810560903,-0.0278249737483763,1.88943243359128e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39238,0.0176375813900875,0.00314116506633228,0.0114808978600762,0.0237942649200987,1.99984370988015e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,39720,0.0178880043971311,0.00319283699231608,0.0116300438921916,0.0241459649020706,2.14741593773142e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0188981179269242,0.00337401286702777,-0.0255111831462986,-0.0122850527075498,2.16520304000388e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0134076081255339,0.00239459446532053,-0.0181010132775621,-0.00871420297350564,2.1894868863311e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.024091406518815,0.00430822115781059,-0.0325355199881238,-0.0156472930495063,2.28851212499665e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0244400723497364,0.00437736077582565,-0.0330196994703547,-0.0158604452291181,2.4067664947069e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,39858,0.010870672982823,0.00195047202519345,0.00704774781344382,0.0146935981522021,2.5391393396349e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F3,Tissue factor,39931,0.0154329610073882,0.00276954033425092,0.0100046619522564,0.02086126006252,2.55302411776e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.0144227791789414,0.00258919002103785,-0.0194975916201756,-0.00934796673770725,2.5824162751994e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0251953983359826,0.00452311421448011,-0.0340607021963636,-0.0163300944756016,2.59191398236629e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,39868,-0.0436309446700927,0.00784027371323271,-0.0589978811480289,-0.0282640081921566,2.66392138739731e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.014879554217987,0.00267751668647438,-0.0201274869234768,-0.0096316215124972,2.78457753633819e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0366792565659748,0.00660067753050254,-0.0496165845257598,-0.0237419286061898,2.79106397236788e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39489,-0.0377884827778236,0.00682163790332027,-0.0511588930683313,-0.0244180724873158,3.08227109002968e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0153673253635543,0.00277414469746506,-0.0208046489705858,-0.0099300017565228,3.09032159434745e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.0158427260018368,0.00286101948823559,0.010235127804895,0.0214503241987786,3.11751946760791e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39520,-0.0504178132612132,0.00910934099245037,-0.0682721216064159,-0.0325635049160105,3.16698140681654e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,37453,-0.0118529470884406,0.00214203478083143,-0.0160513352588702,-0.00765455891801099,3.19711287345803e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0290778042872128,0.00526053249218496,-0.0393884479718953,-0.0187671606025302,3.29953297974013e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,39866,0.0237901028945974,0.00431191072758604,0.0153387578685287,0.032241447920666,3.49588321670256e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0264651576714331,0.00481218015682628,-0.0358970307788126,-0.0170332845640536,3.86589172361698e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0413526223320117,0.00752089787529704,-0.0560935821675939,-0.0266116624964294,3.89343661369267e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0388496013545331,0.00706526410847966,-0.0526975190071532,-0.0250016837019129,3.89601606254994e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.040875176763268,0.00743727858759865,-0.0554522427949614,-0.0262981107315747,3.9449959380698e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0214254174406037,0.00389927437542584,-0.0290679952164383,-0.013782839664769,3.98526288397722e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0230093925728347,0.00419142195926508,-0.0312245796129942,-0.0147942055326751,4.10023823492874e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,39858,0.0266165624591263,0.0048577119956562,0.0170954469476402,0.0361376779706125,4.33612751660348e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.0409523571777651,0.00747363466529587,-0.055600681121745,-0.0263040332337852,4.33937994818992e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0371371334210406,0.00678361509574015,-0.0504330190086913,-0.0238412478333899,4.46469064819215e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.0266314532061431,0.00486838781114506,-0.0361734933159874,-0.0170894130962988,4.56064558281292e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,-0.0113940417238974,0.00209048984829224,-0.0154914018265502,-0.0072966816212446,5.09987034454355e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,39587,-0.026598948153922,0.00489229678764077,-0.0361878498576979,-0.0170100464501461,5.50226011811734e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.0195488636138284,0.00361352059261202,-0.026631363975348,-0.0124663632523089,6.41233642747602e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0329998386973459,0.00610586171803277,-0.0449673276646901,-0.0210323497300017,6.60498987146867e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.0121188441899402,0.00224294594087973,-0.0165150182340645,-0.00772267014581591,6.66107888518578e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0267267573995831,0.00495123323693841,-0.0364311745439824,-0.0170223402551839,6.85293522764677e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.0165367516284082,0.00306435222954663,0.0105306212584968,0.0225428819983196,6.89194375571511e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.0182011569591569,0.00337368442590035,0.0115887354843922,0.0248135784339215,6.94873877095712e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0289890317791148,0.00537391974516171,-0.0395219144796318,-0.0184561490785979,6.9750113201723e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.0478707763032921,0.00889580360762499,-0.065306551374237,-0.0304350012323471,7.50002158629007e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0270393027694839,0.00502462937051015,0.017191029203284,0.0368875763356838,7.51880816505761e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.0145517911293068,0.00270742113006945,-0.0198583365442429,-0.00924524571437068,7.77392098538296e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0277536463511812,0.0051740321390177,-0.0378947493436559,-0.0176125433587065,8.27640833980718e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.016711027418067,0.00311663730737271,-0.0228196365405175,-0.0106024182956165,8.37505690436243e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.0226050699139197,0.0042178271322656,-0.0308720110931603,-0.0143381287346792,8.48979792742242e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.030852815491568,0.00576502137347328,-0.0421522573835757,-0.0195533735995604,8.8542877470777e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39419,-0.0374354150468392,0.00699967257369189,-0.0511547732912753,-0.0237160568024031,9.01054833962407e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.0222478291668415,0.00416197354057032,-0.0304052973063593,-0.0140903610273237,9.16691543893423e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,39866,-0.0306212982864408,0.00574244932409661,-0.0418764989616702,-0.0193660976112115,9.82147788843655e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0228380234044157,0.00428597071343665,0.0144375208060799,0.0312385260027515,1.00585970373462e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGN,Mimecan,39858,-0.0214233174259788,0.00402324165719584,-0.0293088710740827,-0.013537763777875,1.02379369705835e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,39585,-0.0272406614757637,0.00512432545262387,-0.0372843393629065,-0.0171969835886209,1.07551102862702e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.023204411783366,0.00437176664926203,-0.0317730744159195,-0.0146357491508124,1.12762449084159e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0276755817490225,0.00521609531657988,-0.0378991285695191,-0.0174520349285259,1.13949243645671e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAYN,Layilin,39713,-0.0174307445874951,0.00328853873753818,-0.0238762805130699,-0.0109852086619202,1.17063090470296e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0205690917327884,0.0038823331767808,-0.0281784647592788,-0.0129597187062981,1.18530630446729e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00781788955301652,0.00148021992114433,0.00491665850757363,0.0107191205984594,1.30061193365267e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0323855424994838,0.00613560985559305,-0.0444113378164461,-0.0203597471825214,1.3210719843819e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0159227493681598,0.00301812431278455,-0.0218382730212176,-0.0100072257151021,1.3428402783778e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0450282593115756,0.00854161169895751,-0.0617698182415323,-0.0282867003816189,1.37294477593052e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0649412833679919,0.0123356371515057,-0.0891191321849431,-0.0407634345510407,1.42367303944357e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40058,-0.0240788395589662,0.00457395387297255,-0.0330437891499924,-0.0151138899679401,1.42491133670698e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.0150764144567238,0.00286847139731528,0.00945421051798584,0.0206986183954618,1.49172035761329e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.06569385414222,0.0125108018607751,-0.0902150257893393,-0.0411726824951008,1.53234939623155e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0501895706872165,0.00956535564489682,-0.0689376677512142,-0.0314414736232187,1.5653602975005e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39173,-0.011308673069254,0.00215524747389533,-0.0155329581180888,-0.00708438802041913,1.56621900637515e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.0318895472024918,0.00608468040408999,-0.0438155207945082,-0.0199635736104755,1.61753548046245e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI3,Elafin,39594,-0.0282985968355784,0.00540037907651776,-0.0388833398255532,-0.0177138538456036,1.62549784532136e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0527695898983527,0.0100890814056419,-0.0725441894534108,-0.0329949903432945,1.71769155355415e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0387291153597133,0.00742717104235269,-0.0532863706027245,-0.024171860116702,1.8664771619309e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.0288254339228722,0.00552936099551354,-0.0396629814740787,-0.0179878863716656,1.88376683817505e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.0244793404966474,0.00470146324519715,-0.0336942084572339,-0.015264472536061,1.95068418912586e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37382,-0.0191269878392486,0.00367482054661774,-0.0263296361106194,-0.0119243395678779,1.96968106173388e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.0313431625756921,0.00602554306161153,0.0195330981749335,0.0431532269764507,1.99866887703426e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0282546458189646,0.00545001154351881,-0.0389366684442615,-0.0175726231936678,2.19999280426768e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0266647511245874,0.00515294280804114,-0.036764519028348,-0.0165649832208268,2.316737263812e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.0340602162826971,0.00658339322663016,-0.0469636670068922,-0.021156765558502,2.32904434775582e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0404987862311484,0.00784836854316766,-0.055881588575757,-0.0251159838865398,2.49770376538344e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0206237308875952,0.00400161880238728,-0.0284669037402743,-0.0127805580349161,2.58257594065257e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.0315825850930257,0.0061409398110102,-0.0436188271226056,-0.0195463430634457,2.74220579029167e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0210744576789912,0.00410648383732846,-0.029123166000155,-0.0130257493578274,2.90100547682496e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,39868,-0.0236678472744248,0.00462653690233763,-0.0327358596030066,-0.0145998349458431,3.16237664483748e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37039,-0.0228377770819772,0.00447561616338906,-0.0316099847622198,-0.0140655694017346,3.39479649696641e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40009,-0.0344064033014159,0.00674840744599869,-0.0476332818955734,-0.0211795247072585,3.46321259493632e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0132773464677463,0.00260532731686448,0.00817090492669189,0.0183837880088006,3.50429657967356e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.0140273357496209,0.00275287327302138,0.00863170413449898,0.0194229673647428,3.52484413899907e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40030,-0.0139885328132452,0.0027464020795974,-0.0193714808892561,-0.00860558473723429,3.55648332901727e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0307986438815927,0.00604645414420494,-0.0426496940042343,-0.018947593758951,3.55923746393753e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,39885,0.0167665028530512,0.00330370778958503,0.0102912355854645,0.0232417701206378,3.91716725182587e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.0318753026643608,0.00628360536407817,-0.044191169177954,-0.0195594361507676,3.96445667278684e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.00962339542715943,0.00189787903974337,-0.0133432383450564,-0.00590355250926243,4.01770944677185e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0416750739140312,0.00822736832882142,-0.0578007158385212,-0.0255494319895412,4.12016288672094e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.0131296256931947,0.00259441990100231,-0.0182146886991592,-0.00804456268723015,4.23140320097001e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.0382727758827248,0.00756590428623698,-0.0531019482837493,-0.0234436034817004,4.26994915339019e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0225533526161435,0.00445941547613628,0.0138128982829164,0.0312938069493706,4.29680649421805e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.0277470207317132,0.0054880425138714,-0.0385035840589011,-0.0169904574045252,4.331078884804e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.0176570399615588,0.00349363407955307,0.0108095171656348,0.0245045627574828,4.3813978228104e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.0255929480431612,0.00507430653396046,0.0156473072365987,0.0355385888497237,4.61767376431463e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.0203182827140129,0.00403108636041164,-0.0282192119804197,-0.0124173534476061,4.69678495619261e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0304841996412967,0.00605984446609974,-0.0423614947948522,-0.0186069044877412,4.9454862756291e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0432087685891906,0.00859199185629123,-0.0600490726275214,-0.0263684645508598,4.98421721797588e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40030,0.0233062282270095,0.00463702295006174,0.0142176632448885,0.0323947932091305,5.05852134672069e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.0185036755405945,0.00368490599137879,-0.0257260912836969,-0.0112812597974921,5.19495098493028e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37043,-0.0156738689780132,0.00312252148653972,-0.021794011091631,-0.00955372686439533,5.24495942355721e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRN,Progranulin,39787,-0.0126257712847343,0.00251591004190597,-0.01755695496687,-0.00769458760259857,5.26731246885386e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,-0.0469362854464363,0.00935369302321069,-0.0652695237719293,-0.0286030471209434,5.28901063045184e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.0120378338078745,0.00239930179440794,0.0073352022908349,0.016740465324914,5.29856620888595e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0350460644864339,0.00702771021657616,-0.0488203765109232,-0.0212717524619446,6.21559662471279e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37043,-0.0143332706971597,0.00287871367768907,-0.0199755495054303,-0.00869099188888914,6.47037833076819e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.0178907113300171,0.00359418055404499,-0.0249353052159452,-0.0108461174440889,6.50336774794067e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0113553242632266,0.00228965024844608,-0.0158430387501809,-0.00686760977627229,7.14323891223607e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39455,-0.0439741903949547,0.00887824072007978,-0.061375542206311,-0.0265728385835983,7.38315314376515e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.0396852140471667,0.00801446130023377,-0.0553935581956249,-0.0239768698987085,7.44534261557636e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0420603189614761,0.00849688089616953,-0.0587142055179683,-0.0254064324049838,7.49475146253095e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0211309777708368,0.00427001552061605,-0.0295002081912443,-0.0127617473504293,7.54945479716693e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,39585,-0.022611199939319,0.00457268549797776,-0.0315736635153554,-0.0136487363632826,7.69921954562074e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.034137898696561,0.00691201169934954,-0.0476854416272861,-0.0205903557658359,7.93470043710477e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.0369325107529132,0.00748253291207478,-0.0515982752605798,-0.0222667462452467,8.06053073538954e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0430930552448991,0.00873549759737294,-0.0602146305357501,-0.0259714799540482,8.17484923018592e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.0142501126315355,0.00288895579921507,0.008587759265074,0.0199124659979971,8.19532984272125e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.0316425395705916,0.00641830301389273,-0.0442224134778213,-0.0190626656633618,8.31858258936443e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0722419606804591,0.0146910137964025,0.0434475736395103,0.101036347721408,8.87151506133653e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0307316778220477,0.00625286038685607,-0.0429872841802856,-0.0184760714638098,8.99330118238251e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,39856,-0.0196144303717301,0.00401353020671462,-0.0274809495768908,-0.0117479111665695,1.03335602356997e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0182804906526386,0.00374369265721244,-0.025618128260775,-0.0109428530445022,1.05705466668494e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0189027916279417,0.00387273594905614,-0.0264933540880917,-0.0113122291677917,1.06791564823169e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0166858456698134,0.0034205892058019,-0.0233902005131851,-0.00998149082644169,1.08384672771196e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.0215515449027482,0.00443851080916211,-0.030251026088706,-0.0128520637167905,1.21196528165475e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.0264494361397967,0.00544779018929109,-0.0371271049108073,-0.0157717673687862,1.2150471804279e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.0241734040507967,0.00498124106696544,-0.033936636542049,-0.0144101715595444,1.22822818611272e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.0567166216974226,0.0116931236138317,-0.0796351439805327,-0.0337980994143125,1.24569309130316e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0198235394186474,0.0040878515480016,0.0118113503845643,0.0278357284527306,1.25012833524417e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.017122873075811,0.00353502672594316,-0.0240515254586596,-0.0101942206929624,1.28591276168642e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.0454632478823356,0.00938743268830631,-0.063862615951416,-0.0270638798132552,1.29352136615663e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0186236175561301,0.00385984469963919,-0.0261889131674229,-0.0110583219448373,1.41550359182612e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,39868,-0.0326089922657244,0.00677435131113146,-0.045886720835542,-0.0193312636959067,1.49591483169967e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37289,-0.0213116492124768,0.00442716220717009,-0.0299888871385302,-0.0126344112864235,1.49670305548275e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-0.0145947720079986,0.0030341116035423,-0.0205416307509415,-0.00864791326505573,1.52144715930069e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0215760250165823,0.00448789535064908,-0.0303722999038545,-0.0127797501293101,1.54171353678201e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,39587,-0.0387547497409069,0.00806982907588977,-0.0545716147296509,-0.022937884752163,1.58199224064932e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,39984,-0.0301363658752251,0.00628773905560412,-0.0424603344242091,-0.017812397326241,1.65871162907591e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,39868,-0.013282775601934,0.00277338690675507,-0.018718613939174,-0.00784693726469408,1.68803849163376e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39489,-0.0357431363816719,0.00746582537359917,-0.0503761541139263,-0.0211101186494175,1.70361729521234e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,39657,-0.0515219508988955,0.0107707362830286,-0.0726325940136316,-0.0304113077841595,1.73813855196834e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,37453,-0.012622377424267,0.00264581682880267,-0.0178081784087202,-0.00743657643981378,1.85502064563687e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0369823783580328,0.00775523268948448,-0.0521826344294223,-0.0217821222866432,1.87405842756271e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0196090416981379,0.00411387741486356,-0.0276722414312705,-0.0115458419650053,1.89406648779356e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,39559,-0.0263347852157733,0.00553377260696718,-0.0371809795254289,-0.0154885909061176,1.96364692221231e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0249189969978279,0.00524034350220175,-0.0351900702621433,-0.0146479237335125,1.99996937356289e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0130694049286342,0.00275349564299231,-0.0184662563888991,-0.00767255346836925,2.08764194857736e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.0283355232415388,0.00598140081351634,-0.0400590688360308,-0.0166119776470468,2.18490853162898e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.02835349453864,0.00599471778223531,-0.0401031413918213,-0.0166038476854588,2.27131682435745e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.0102155566219291,0.00216032347044934,0.00598132261984839,0.0144497906240098,2.28269913013713e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37072,-0.0211451184250243,0.00447979351511907,-0.0299255137146577,-0.0123647231353909,2.38136195351229e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0297464744987989,0.00631237741128034,-0.0421187342249084,-0.0173742147726894,2.47240343016199e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.0432225346859774,0.00917837470627977,-0.0612121491102857,-0.025232920261669,2.51246451691554e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.019014556588955,0.00404084116746874,0.0110945079007163,0.0269346052771937,2.55239589957008e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.010402629034325,0.00221385537212471,-0.0147417855636895,-0.00606347250496058,2.63785954326518e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0204236886256923,0.00434664406757619,0.0119042662532429,0.0289431109981416,2.63958533302651e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,39731,0.0137340357717571,0.0029301320343039,0.00799097698452144,0.0194770945589927,2.79306815930631e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.0330790510451361,0.00705993975367045,-0.0469165329623302,-0.0192415691279421,2.8160577711566e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,39868,-0.0166970304907758,0.00356627803626047,-0.0236869354418463,-0.00970712553970524,2.86531057564479e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.0174154499267462,0.00373659520129117,-0.0247391765212769,-0.0100917233322155,3.18079528680483e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.022582732671082,0.00485183867831728,-0.0320923364805838,-0.0130731288615801,3.2749126703931e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.0251092265187433,0.00539798298395254,-0.0356892731672903,-0.0145291798701963,3.32581839683016e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.0285238335426505,0.00613540185927849,-0.0405492211868363,-0.0164984458984646,3.36185110557893e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37411,-0.0329837981113773,0.00710034132275531,-0.0469004671039777,-0.0190671291187769,3.42641303744582e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0231200982436983,0.00499420682489208,-0.0329087436204868,-0.0133314528669099,3.70168494121399e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.0251241769975504,0.00543331554474846,-0.0357734754652574,-0.0144748785298435,3.79775310596585e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.0109417714354616,0.00236705364482023,-0.0155811965793093,-0.006302346291614,3.82080359246871e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.0143691445640115,0.00311351289156512,0.0082666592965439,0.0204716298314792,3.96652368774716e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.0434720147654593,0.00945648596586008,-0.0620067272585451,-0.0249373022723736,4.317750044475e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0227316749283898,0.00495139879125771,-0.0324364165592549,-0.0130269332975247,4.45290773148796e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.031508359721521,0.00687563607994274,-0.0449846064382088,-0.0180321130048333,4.62738693745436e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.0113535280421955,0.00247926588390684,-0.0162128891746529,-0.00649416690973806,4.69849828173439e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0189587005197704,0.00414009148212484,-0.0270732798247351,-0.0108441212148058,4.70145625128782e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37056,-0.029624116555222,0.00648376492728605,-0.0423322958127026,-0.0169159372977413,4.94573835412135e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.0182385238057546,0.00401586215576658,-0.0261096136310571,-0.0103674339804521,5.63063662569059e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.0141118161785107,0.00310970350829677,0.00801679730224903,0.0202068350547724,5.72154037356236e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.0156746564104207,0.00345451003372658,0.00890381674431655,0.0224454960765248,5.74376299650887e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.0313315548688463,0.00693914016953418,-0.0449322696011333,-0.0177308401365593,6.3811099998866e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.0129253245571717,0.00286877595681568,-0.0185481254325304,-0.00730252368181299,6.67802732555178e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0122562240071586,0.00272333573914031,0.00691848595844357,0.0175939620558736,6.8391224115732e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.0144599723965939,0.00321405595978344,0.00816042271541834,0.0207595220777694,6.88652546589647e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0194301040862086,0.00432144207056136,-0.0279001305445088,-0.0109600776279083,6.97518452065462e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.041361023606719,0.00921360895279797,0.023302350059235,0.059419697154203,7.2125850822338e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.0165207284869513,0.00368433565322279,-0.023742026367268,-0.00929943060663462,7.3748574056089e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.0155042964478868,0.00346170337639567,-0.0222892350656223,-0.00871935783015131,7.55908976598262e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.0214499995473724,0.00478946845027966,-0.0308373577099205,-0.0120626413848243,7.56753093717557e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0369294201209162,0.00826189519117331,-0.0531227346956159,-0.0207361055462165,7.88258537081635e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0211164199751809,0.00473645272715352,-0.0303998673204018,-0.01183297262996,8.31847915008772e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0305184531613367,0.00685165402407587,-0.0439476950485254,-0.017089211274148,8.49059126859701e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0202141419323355,0.00454028615547576,-0.0291131027970679,-0.011315181067603,8.56868752835931e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,39703,-0.0205525866272928,0.00463179474695555,-0.0296309043313256,-0.0114742689232599,9.17157246695675e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0141295636877152,0.00318806232304868,0.00788096153453982,0.0203781658408906,9.41072014242215e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,37453,-0.00874725775342625,0.00197949253390734,-0.0126270631198846,-0.00486745238696787,9.9954186466953e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.0118600180934084,0.00268430161161899,0.00659878693463516,0.0171212492521816,1.00284307352738e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCT,Secretin,37039,-0.0200018151611278,0.004530098215055,-0.0288808076626356,-0.01112282265962,1.0166536674046e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40058,-0.0180215575595678,0.00409207897244741,-0.0260420323455647,-0.0100010827735709,1.06949037413394e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0265918144568411,0.00604552744371129,-0.0384410482465152,-0.0147425806671669,1.09801305075781e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.0210829593191344,0.00479413320212086,-0.0304794603952913,-0.0116864582429775,1.10149704131356e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.0493531437895498,0.011222781667936,-0.0713497958587043,-0.0273564917203953,1.10341731795057e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.0125900518120959,0.00286964732577702,0.00696554305357298,0.0182145605706189,1.15496626396789e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0252018364618581,0.00574443302150342,-0.0364609251840048,-0.0139427477397114,1.15565975188922e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0199283601910079,0.00454529527206071,-0.0288371389242469,-0.0110195814577689,1.17187573990401e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0233228449341277,0.00532084392150833,-0.033751699020284,-0.0128939908479714,1.17800584160644e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39489,-0.0349751934650887,0.0079969763894381,-0.0506492671883874,-0.01930111974179,1.23031790314452e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.0118985727685589,0.00272070005486912,-0.0172311448761024,-0.00656600066101543,1.23126261182455e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37021,0.0185297944210443,0.00423951379934913,0.01022034737432,0.0268392414677686,1.24777943157439e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.0232013550738762,0.00531083015232442,-0.0336105821724321,-0.0127921279753204,1.25801495795547e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.0165499328533229,0.00379191602409981,-0.0239820882605585,-0.00911777744608729,1.28359958424751e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.0140389864642407,0.00322458990929489,-0.0203591826864587,-0.00771879024202274,1.34673785130097e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0234390400861071,0.00540634657181826,-0.0340354793668708,-0.0128426008053433,1.46523292295483e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.105985449754672,0.0244666223161564,-0.153940029494338,-0.0580308700150054,1.48935314975297e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.0246557929761933,0.00569226676717477,-0.0358126358398558,-0.0134989501125307,1.49051826934292e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0186491896150063,0.0043143110826763,-0.0271052393370519,-0.0101931398929608,1.55279770221011e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.0472467814745023,0.0109590689400735,-0.0687265565970463,-0.0257670063519583,1.63343395378167e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.0099698959765318,0.00231854338147555,0.00542555094883972,0.0145142410042239,1.71746965514336e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,39788,0.0127507179344792,0.00296589728824529,0.00693755924951841,0.0185638766194399,1.72504860776205e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0574605316414792,0.0133914633887666,-0.0837077998834619,-0.0312132633994966,1.79054526926765e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.0173690196765706,0.00405250845934538,-0.0253119362568875,-0.00942610309625362,1.83007874147616e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.0130581574112824,0.00304810811414284,0.0070838655075624,0.0190324493150023,1.84845945594525e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0213459763615339,0.00498895338590497,-0.0311243249979077,-0.0115676277251602,1.89150313877566e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.0196429073529964,0.00459185449233729,-0.0286429421579775,-0.0106428725480153,1.9007466849081e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.0121168839925025,0.00283334357469039,-0.0176702373988957,-0.00656353058610936,1.90921729107041e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0274526871892313,0.00642423655345552,0.0148611835444585,0.0400441908340041,1.93726386040331e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0181504852102908,0.00424848412909052,0.00982345631727338,0.0264775141033082,1.9489097221385e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0227824962795584,0.00533371571012309,-0.0332365790713997,-0.0123284134877171,1.95348308011425e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.0113276766564235,0.00266459960656724,-0.0165502918852953,-0.00610506142755172,2.14116687571155e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.0123230235568713,0.00290662346240285,0.0066260415705617,0.0180200055431809,2.25399086835348e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0116491113481163,0.00274907734321109,-0.01703730294081,-0.00626091975542256,2.27552809873425e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0259580435505924,0.00612690852000113,0.0139493028513901,0.0379667842497946,2.28302510141615e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.015842604101821,0.00373977049669849,0.00851265392829194,0.02317255427535,2.28829636931944e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0169565458967023,0.0040033454029219,-0.0248031028864292,-0.00910998890697536,2.29458265986094e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LXN,Latexin,39682,0.0288035604308632,0.00681889676268399,0.0154385227760025,0.0421685980857238,2.41261953925586e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,39908,-0.0124622257024269,0.00295081881655491,-0.0182458305828745,-0.00667862082197927,2.42066218947228e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.0145757811505373,0.00347154398638642,-0.0213800073638547,-0.00777155493721989,2.69975136536069e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.011900115473416,0.00283649834789615,0.00634057871153953,0.0174596522352924,2.74211693208017e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0218710599598555,0.0052307489974889,-0.0321233279949338,-0.0116187919247773,2.91493938106675e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.0153421437216062,0.00367527570780053,-0.0225456841088952,-0.00813860333431717,3.00662953531479e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.0188208570115426,0.00451160123794539,-0.0276635954379156,-0.00997811858516965,3.04331566080595e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0123147893527764,0.00295442830159409,0.00652410988165201,0.0181054688239008,3.08917900109479e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,39967,0.0173857723505023,0.00417507939423618,0.00920261673779937,0.0255689279632052,3.14103077008177e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0153883209358567,0.00369622876525353,-0.0226329293157536,-0.00814371255595982,3.1569414513223e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37382,-0.0192476876430787,0.00462969943564038,-0.0283218985369338,-0.0101734767492235,3.23820523224937e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37368,-0.0342681315268989,0.00824989172748208,-0.0504379193127638,-0.018098343741034,3.29056733933308e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.0108444114126244,0.00261086252231896,-0.0159617019563695,-0.00572712086887924,3.2933140449972e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.025913889219791,0.00624134655823712,-0.0381469284739357,-0.0136808499656462,3.31698499487414e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.012011189917557,0.00290230380680759,0.00632267445621408,0.0176997053788998,3.51708616783641e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00853834356293634,0.00206392023348311,0.00449305990530945,0.0125836272205632,3.54133678721151e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0255328528769586,0.00617542327710673,-0.0376366825000878,-0.0134290232538294,3.57789048071279e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.00981349661758194,0.00237516550052005,-0.0144688209986012,-0.00515817223656264,3.61887802774343e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0296214028035285,0.00720702185078018,-0.0437471656310576,-0.0154956399759993,3.97486643089076e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.0100455863787772,0.00244553829329293,0.00525233132392305,0.0148388414336314,4.01925988242467e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.0116933888505231,0.00285043202868584,0.00610654207429887,0.0172802356267474,4.11487359837804e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.0272849683575822,0.00665985160745605,-0.0403382775081961,-0.0142316592069683,4.20701846469434e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.0355630161742662,0.00869562318335899,-0.0526064376136498,-0.0185195947348826,4.34368058950978e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.0141602169687297,0.00346455006638876,0.00736969883860774,0.0209507350988517,4.3925840293694e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0130189907606654,0.00319342459402476,-0.019278102964954,-0.00675987855637689,4.5875502894717e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37437,-0.0359560602881367,0.00884409014229625,-0.0532904769670374,-0.0186216436092361,4.81902138354063e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0216635266731224,0.00533603856205259,-0.0321221622547455,-0.0112048910914993,4.93431929397586e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.0111684614616965,0.00275338051430644,0.00577183565365586,0.0165650872697371,5.00977473963095e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,37453,0.0125522674527874,0.00310352844429055,0.00646935170197796,0.0186351832035969,5.27210604794627e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,39783,-0.0298261697290131,0.00739679367939364,-0.0443238853406247,-0.0153284541174016,5.54884228059087e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40058,-0.0250698659630453,0.00621777690315253,-0.0372567086932242,-0.0128830232328663,5.55653750707495e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0173310398811906,0.00430173916971694,-0.0257624486538358,-0.00889963110854538,5.63151090061643e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.0175081668205415,0.00435842518807755,-0.0260506801891734,-0.00896565345190946,5.91980266601655e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,39868,-0.0470862800585062,0.0117507159308861,-0.0701176832830429,-0.0240548768339696,6.1747290995094e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37437,0.0207123970790354,0.00518567490678784,0.0105484742617312,0.0308763198963395,6.5267232351673e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.0219480623014617,0.00549868052700582,-0.0327254761343931,-0.0111706484685303,6.5997938491105e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0233921671946733,0.00587065482188738,-0.0348986506455726,-0.0118856837437741,6.78954089063587e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.0156153184574037,0.00392600631976556,-0.0233102908441442,-0.00792034607066321,6.99852850396733e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0202090598482985,0.00510223341846296,-0.0302094373484859,-0.0102086823481111,7.50838496768911e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0276370596984264,0.00699268445709172,-0.0413427212343262,-0.0139313981625267,7.78015868811799e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,39788,-0.0113763097670449,0.00288925173131777,-0.0170392431604278,-0.0057133763736621,8.26994816940808e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,39587,-0.0172918193072074,0.00439483662151839,-0.0259056990853834,-0.0086779395290313,8.37018532213525e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,36962,0.0124581217598625,0.00317324800251611,0.00623855567493095,0.0186776878447941,8.68178764043877e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39421,-0.0184975198372826,0.00471594624247991,-0.0277407744725432,-0.00925426520202196,8.80715068491315e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40030,0.0240571022077991,0.00613414032240102,0.0120341871758931,0.0360800172397051,8.8239057289619e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,39868,-0.0306170476607409,0.00782671017012126,-0.0459573995941785,-0.0152766957273032,9.19637560362266e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.0107045939838341,0.00274463645513202,-0.0160840814358929,-0.00532510653177537,9.65079554731664e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0182462077379635,0.00467990058502146,-0.0274188128846056,-0.00907360259132148,9.71322488444112e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0244659880966997,0.00628032954585689,-0.0367754340065792,-0.0121565421868202,9.84210324883697e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0383871889720874,0.00986086441721788,-0.0577144832298344,-0.0190598947143404,9.95355595962767e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.0119074270008377,0.00306498138538588,0.00590006348548135,0.017914790516194,0.000102836776029198
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0283684946282697,0.00730304701476388,-0.0426824667772069,-0.0140545224793325,0.000103048082876397
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,39891,0.0110460516420593,0.00284954427292003,0.00546094486713604,0.0166311584169826,0.000106423861800735
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,-0.0241669433826932,0.00625580870048022,-0.0364283284356345,-0.011905558329752,0.000112392056654657
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.0079615881053293,0.0020614273028815,0.00392119059168156,0.012001985618977,0.000112823220117031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.0150746632285191,0.00390599755465129,-0.0227304184356356,-0.00741890802140254,0.000114131348570394
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.0283701133393071,0.00736404206959414,-0.0428036357957117,-0.0139365908829026,0.000117457231589095
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.023358155595124,0.00606879815762686,-0.0352529999840726,-0.0114633112061753,0.000119196407017136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.024383110271415,0.00633547840465757,-0.0368006479445438,-0.0119655725982862,0.000119326377024651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.0330743432189417,0.00860035981641239,-0.04993104845911,-0.0162176379787734,0.000120772366112094
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37021,-0.0236731048221433,0.00616085805123678,-0.0357483866025674,-0.0115978230417192,0.00012235886953011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0346352827820428,0.0090188575110244,0.0169583220604349,0.0523122435036506,0.000123348614413408
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00958692617968642,0.00249723193372349,-0.0144815007697844,-0.00469235158958839,0.000124086939443146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39397,0.0253360830715311,0.00660246383567478,0.0123952539536086,0.0382769121894537,0.000124852292167622
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.0235691564706139,0.00617215107246422,-0.0356665725726437,-0.011471740368584,0.000134794529929036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.0208646552311545,0.00547444836688863,-0.0315945740302562,-0.0101347364320528,0.000138862613081675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37169,0.0128476984644863,0.00337743777748241,0.00622792042062077,0.0194674765083518,0.00014302765837159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37437,0.0117738694574049,0.00309548917717713,0.00570671067013773,0.0178410282446721,0.000143258116940198
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0134140896484839,0.00353794153514138,0.00647972423960681,0.020348455057361,0.000150292605027382
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.0127990841159298,0.00337693089146174,0.00618029956866481,0.0194178686631948,0.000151116466276844
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0254898634188336,0.0067351920324922,-0.0386908398025183,-0.0122888870351489,0.000154530685845838
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0246419798407951,0.00651635339474757,-0.0374140324945004,-0.0118699271870899,0.000156414831923711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0235711651650833,0.00624609762502741,-0.035813516510137,-0.0113288138200296,0.000161407106509063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.00977928493109242,0.00259690020488236,-0.0148692093326618,-0.004689360529523,0.000166765048010733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.0139344742874772,0.00370161884575023,-0.0211896472251476,-0.00667930134980674,0.000167648508015695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.0188902703461787,0.00502126877223225,0.00904858355260349,0.0287319571397539,0.000169125789055401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.0213377428676952,0.00567502744822159,-0.0324607966662095,-0.0102146890691809,0.000170690087319759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.0146148933239446,0.00388894903016618,0.00699255322481887,0.0222372334230703,0.000171979063758872
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.032249912214436,0.00861153107350555,-0.0491285131185069,-0.0153713113103652,0.000181165059848982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.0117370229746754,0.00313517264093599,0.00559208459844089,0.01788196135091,0.000181993120797822
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.016426815189392,0.0043932470805228,0.00781605091156729,0.0250375794672167,0.000185458781096261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.015478072820336,0.00414366871552537,-0.0235996635027657,-0.00735648213790629,0.000188117568181047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.0152523094645098,0.00409080485279426,-0.0232702869759866,-0.00723433195303307,0.00019335148007132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.0114830345759407,0.00308414866877109,-0.0175279659667321,-0.0054381031851494,0.000197361037066198
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.0129105970887295,0.0034687050380922,0.00611193521406876,0.0197092589633902,0.000198310379392438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37021,0.0181649914496379,0.00489034043344494,0.00857992420008582,0.02775005869919,0.000204477045221109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0115167259360531,0.0031013863071458,0.00543800877404735,0.0175954430980589,0.000205304899617411
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,39831,-0.0100064278412265,0.00269820312791949,-0.0152949059719487,-0.00471794971050428,0.000209153197777528
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.00920396170256538,0.00248190472841114,-0.0140684949702512,-0.00433942843487954,0.000209406517438372
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00983514702366311,0.00265265546578837,0.0046359423107179,0.0150343517366083,0.000210041330257814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.0138800129944269,0.00375365978746171,0.00652283981100191,0.0212371861778518,0.000218421967189938
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.0165583331875862,0.00447829010638226,-0.0253357817960955,-0.007780884579077,0.000218488197414271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,39858,0.0127138906618852,0.00343924004625735,0.00597298017122078,0.0194548011525496,0.000219136568661601
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,39913,-0.010697413221712,0.00289595257108046,-0.0163734802610297,-0.00502134618239432,0.000221557296029114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.020347070412764,0.00550954018115812,-0.0311457691678339,-0.00954837165769406,0.000222325074612452
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.0154587502068658,0.00418824876674299,-0.023667717789682,-0.00724978262404949,0.00022414564578125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40052,-0.0120422282520178,0.00326347796354252,-0.0184386450605612,-0.00564581144347447,0.000224990397735117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.0152147460044332,0.00414202874127311,-0.0233331223373285,-0.00709636967153789,0.00024042553071997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.0105363833483788,0.00287027060527232,0.00491065296204503,0.0161621137347125,0.00024251122222386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.0135551245658657,0.0037040589283857,-0.0208150800655016,-0.00629516906622972,0.000253638746774853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0281782659850132,0.00770207587385186,-0.0432743346977629,-0.0130821972722636,0.000254650157874789
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.0157524338918714,0.00433456308143603,-0.0242481775314861,-0.00725669025225682,0.000279936929549421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.0151096692391673,0.00417540149266121,-0.0232934561647832,-0.00692588231355129,0.000296951910155746
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.0113868267322188,0.00314750720556373,0.00521771260931391,0.0175559408551238,0.00029831257637276
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37056,0.0198849224146632,0.0054966620034831,0.00911146488783636,0.0306583799414901,0.00029841617757802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.0203045425961323,0.00561553235521021,-0.0313109860123444,-0.00929809917992032,0.000300384663597083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0234459786795902,0.00649859633641316,-0.0361832274989599,-0.0107087298602204,0.000309885784397978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C5,Complement C5,37453,-0.0056193870151758,0.00155776186647184,-0.0086726002734606,-0.002566173756891,0.00031045362209602
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37424,-0.00537737538039806,0.00149072597708984,-0.00829919829549415,-0.00245555246530198,0.000310608290658568
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.0134927431537644,0.00374518138574922,-0.0208332986698329,-0.00615218763769597,0.000316067007889896
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.0115296305020093,0.00320691317550857,-0.0178151803260061,-0.00524408067801254,0.00032527180664285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.031152230317367,0.00867074533578193,-0.0481468911754996,-0.0141575694592344,0.000328343342918086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.0120879829863323,0.00336862351223132,0.00548548090235893,0.0186904850703057,0.000333697386957614
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0239254175924076,0.0066764662801185,-0.0370112915014398,-0.0108395436833753,0.000339972732819017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.020657273040211,0.0057689421903393,-0.031964399733276,-0.009350146347146,0.000343813285190907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0158176499703194,0.00442264300103967,0.00714926968828169,0.0244860302523572,0.000349450670443362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.0134568035547164,0.00376492937513306,-0.0208360651299772,-0.00607754197945555,0.000352455825183796
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,39788,-0.0152672559288147,0.00427512389638367,-0.0236464987657267,-0.00688801309190266,0.000356417651303867
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.0133094981084047,0.00372764157838928,-0.0206156756020477,-0.0060033206147617,0.00035737999833273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0352815689264439,0.00990648822787454,-0.054698285853078,-0.0158648519998098,0.000370097142322929
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0212276165871289,0.00597293170708073,-0.0329345627330071,-0.00952067044125067,0.000380575473233127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.0221461140470001,0.00623496662652497,-0.034366648634989,-0.00992557945901114,0.000383742378965195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,36962,0.0129574964173867,0.00364975682917823,0.00580397303219737,0.020111019802576,0.000386235583609035
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0395389221030561,0.0111622843803241,0.0176608447176207,0.0614169994884914,0.000398152314444113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37149,0.0116272842651767,0.00328496392652708,0.0051887549691836,0.0180658135611698,0.000402183835724664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.00911791816846726,0.00258287032672899,0.00405549232807843,0.0141803440088561,0.000416477937260821
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.0118101689074675,0.00334627771561345,-0.0183688732300698,-0.00525146458486512,0.000417972665445029
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.0101509318446026,0.00288840503943436,0.00448965796731125,0.0158122057218939,0.000442277956425693
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.011090294274538,0.00315596668107796,0.0049045995796252,0.0172759889694508,0.000442760728241168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.0207586801903451,0.00591062483662151,0.00917385551056698,0.0323435048701233,0.000445807672337465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSPN,Persephin,39866,-0.0337542366768035,0.00962341352577283,-0.0526161271873182,-0.0148923461662888,0.000453558282980932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.0190548964757203,0.0054330273859183,-0.0297036301521202,-0.00840616279932041,0.000454253714221634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,39868,0.013603204513882,0.00388040025152221,0.00599762002089845,0.0212087890068655,0.000456793158677444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0167626313333166,0.00478422274916758,-0.0261397079216851,-0.00738555474494817,0.00046007085704977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40030,0.015777988499508,0.00451799680272502,0.00692271476616699,0.024633262232849,0.000480242863305292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0178942355882785,0.00512594060110634,-0.027941079166447,-0.00784739201011011,0.000482899830331567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.0117957662314356,0.00338143713786813,0.00516814944121409,0.0184233830216572,0.000487270186678131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FST,Follistatin,39908,-0.0182899524156898,0.00524494740325049,-0.0285700493260608,-0.00800985550531887,0.000489491758252219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.010172627763891,0.00291840047791489,-0.0158926927006042,-0.0044525628271778,0.000492214865467376
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00727641534596668,0.0020880789720856,-0.0113690501312545,-0.0031837805606789,0.000493917464777911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0205110986879538,0.00589795480624072,0.00895110726772199,0.0320710901081856,0.000507439341963802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,35640,-0.0360303894319702,0.0103606324451441,-0.0563372290244526,-0.0157235498394877,0.000507703721535553
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0124268198045089,0.00360281779424237,-0.0194883426812239,-0.00536529692779384,0.000563719925896618
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.0208032350765639,0.00603722506028907,0.00897027395839735,0.0326361961947305,0.000570774839749694
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.0119433537996851,0.00347049601374438,0.00514118161274615,0.0187455259866241,0.000580510999145559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.0162470586565855,0.00472492638468898,-0.0255079143705759,-0.00698620294259512,0.0005862412894175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39315,-0.0120879456745769,0.00354022694289657,-0.0190267904826542,-0.00514910086649962,0.000640738969488336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0342044773979754,0.010035477569145,-0.0538740134334997,-0.0145349413624511,0.000655522300282717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0207457498661152,0.00608707493057059,-0.0326764167300335,-0.00881508300219684,0.000655631697473445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37138,0.00738237639691857,0.00216945375625562,0.00313024703465754,0.0116345057591796,0.000668780532418793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.0126761842679126,0.00372691617876399,-0.01998093997829,-0.00537142855753513,0.000672720780182741
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.015197523221987,0.0044736165780044,-0.0239658117148756,-0.00642923472909834,0.000682893102320679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,39585,-0.0260321460002575,0.00766494893075283,-0.0410554459045331,-0.011008846095982,0.000684829303062872
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.0104279409417779,0.00307544559179615,-0.0164558143016983,-0.00440006758185744,0.000699110908881203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.0125328484420316,0.00370204737623268,-0.0197888612994476,-0.00527683558461551,0.000712876330618955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.0106801027906718,0.00315797225461804,0.00449047717162049,0.0168697284097232,0.000721440977140373
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00951122763480613,0.00281993447425466,0.003984156065267,0.0150382992043453,0.000745713783139316
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.00951350682626157,0.00282159572009597,-0.0150438344376497,-0.00398317921487346,0.000749205991837676
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.017632029326379,0.00523950152260407,-0.0279014523106829,-0.00736260634207499,0.000766973820833734
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,39868,-0.0136373023623271,0.00405315083855554,-0.0215814780058959,-0.00569312671875821,0.00076829790943318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37095,-0.0489401084038129,0.0145527933755042,-0.077463583419801,-0.0204166333878247,0.000773369455848444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0145696222837598,0.00433790786790248,-0.0230719217048487,-0.00606732286267098,0.000784990978915992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,37453,0.00763911773623713,0.00227500533535664,0.00318010727893811,0.0120981281935361,0.000787679438845115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0158351494068689,0.00471669782687561,-0.0250798771475451,-0.0065904216661927,0.000789052011310386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0170982249787262,0.00509282573250107,0.00711628654302408,0.0270801634144283,0.000789201495795084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.0287462925953055,0.00858494620160317,-0.0455727871504477,-0.0119197980401633,0.000814558958308844
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.0114650411235526,0.00342827569135059,-0.0181844614785997,-0.00474562076850539,0.000826913808534419
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.0161553342378479,0.00483575742496767,-0.0256334187907845,-0.00667724968491122,0.000837309555517969
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.01048210479434,0.0031382926394499,-0.0166331583676619,-0.00433105122101824,0.000839507955514616
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,0.0314801152125106,0.00945831941152241,0.0129418091659267,0.0500184212590946,0.000875750760289441
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.0140557288234124,0.00422676264143267,-0.0223401836006204,-0.00577127404620435,0.000885288704493844
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0236888749993473,0.00713408742336066,-0.0376716863491342,-0.00970606364956043,0.000900878741907995
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.015497812685989,0.00466732894793071,-0.0246457774239332,-0.00634984794804481,0.000901037536809964
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.0142592888838828,0.00430086545091308,-0.0226889851676724,-0.00582959260009313,0.000917371937373406
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,39673,-0.0112484147920791,0.00339567831375297,-0.0179039442870349,-0.00459288529712326,0.00092651073672496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39489,-0.0131377585520587,0.00398784664084584,-0.0209539379681166,-0.00532157913600087,0.000988340544654667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.0108329912122254,0.00328878932680308,0.00438696413169141,0.0172790182927595,0.000990629711083737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.0111662485193847,0.00339115230069735,0.00451959001001794,0.0178129070287515,0.00099424483782532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0248389557842305,0.00756939890902191,-0.0396749776459134,-0.0100029339225475,0.00103527823898907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.00756566868553605,0.00230849536563094,-0.0120903196021727,-0.00304101776889941,0.00105062886594022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.0157488117614165,0.00480988649457066,-0.025176189290775,-0.00632143423205804,0.00106170135099722
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0189506415741987,0.00581258894831323,-0.0303433159128926,-0.00755796723550473,0.00111540713376022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,39788,0.00499671700069659,0.00153409769156516,0.00198988552522888,0.00800354847616431,0.00112790332824271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.0224711065280269,0.00691038138943885,-0.036015454051327,-0.00892675900472673,0.00114919708235922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0973642759869837,0.0299757836016346,-0.156116811846187,-0.03861174012778,0.00116418811013379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,36962,0.0155446706552407,0.00478653720534444,0.00616305773276563,0.0249262835777158,0.00116683114618662
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,-0.00917087131255849,0.00282587611235758,-0.0147095884927794,-0.00363215413233763,0.00117602987563044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.0120949240067207,0.00374396387554869,-0.0194330932027961,-0.00475675481064525,0.00123871852634554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.0141256716538419,0.00437715766660934,-0.0227049006803962,-0.00554644262728756,0.00125343151687051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37169,0.0138939450332133,0.00432466767854791,0.00541759638325939,0.0223702936831672,0.00131797522207841
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,39587,-0.021759089712329,0.00677513254420541,-0.0350383494989716,-0.00847982992568643,0.00132258517934511
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37368,-0.0214503193617066,0.00669972691214244,-0.0345817841095058,-0.00831885461390746,0.00136949485733649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0487197035989786,0.0152459472336639,-0.0786017601769599,-0.0188376470209974,0.00139818976597677
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0165681075353094,0.00519664797160163,0.00638267751097018,0.0267535375596486,0.00143481745292563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.0177047917109379,0.00555424522355048,0.00681847107277896,0.0285911123490968,0.00143728220374241
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.0206021850450133,0.0064655481337813,-0.0332746593872246,-0.00792971070280197,0.00144357442547453
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,39779,-0.00943359429675903,0.00296479256365044,-0.0152445877215139,-0.00362260087200417,0.00146606806862417
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37169,0.00945437122712495,0.0029744676158131,0.00362441470013127,0.0152843277541186,0.0014837350419323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.0117512921767975,0.00370202859716678,0.00449531612635057,0.0190072682272443,0.00150553788566445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0457356897113944,0.0144399228361849,-0.0740379384703169,-0.017433440952472,0.0015415292420449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0329614899453293,0.0104318555995925,-0.0534079269205306,-0.0125150529701281,0.00158230089084993
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00860786894140218,0.00272609135391923,-0.0139510079950839,-0.0032647298877205,0.00159377951150376
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,-0.0284928686623485,0.00903317517944047,-0.0461978920140518,-0.0107878453106452,0.00161210952419814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40052,0.00542782469504123,0.00172810105753843,0.00204074662226591,0.00881490276781655,0.0016872200916543
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.0111251963525726,0.0035450385780576,0.00417692073957974,0.0180734719655655,0.00170339394477043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00835413432328881,0.00266560945472322,0.0031295397920313,0.0135787288545463,0.00172793830173455
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0232238114473737,0.00742690929967843,-0.0377805536747434,-0.00866706922000396,0.00176927755575609
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.0104209404880074,0.00333353925634068,-0.0169546774304351,-0.00388720354557961,0.00177472576499036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.0209858934967924,0.00671636116008452,-0.0341499613705581,-0.00782182562302679,0.00178438235064319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0152335594753236,0.00488979790911937,0.00564955557344963,0.0248175633771975,0.00184105369065367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0220006834386172,0.00708365806883862,0.00811671362369352,0.0358846532535409,0.0019008326626544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.0209039562446396,0.00674955582281997,-0.0341330856573667,-0.00767482683191241,0.00195843533008029
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.010468362079041,0.00338440812452411,0.00383492215497374,0.0171018020031083,0.00198482301435372
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.00867037881658756,0.00280954429454608,-0.0141770856338979,-0.00316367199927725,0.00203247399156926
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.00988631224741721,0.00320794898564281,-0.0161738922592771,-0.0035987322355573,0.00206165007924356
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37043,0.0206665196581395,0.00671123494793602,0.00751249916018486,0.033820540156094,0.00207850425735145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,39749,-0.0175578950422667,0.00570400431454694,-0.0287377434987787,-0.00637804658575472,0.00208630818683997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0203912844928013,0.00663110625766531,-0.0333882527578253,-0.00739431622777725,0.00210861617643411
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.0136657307354551,0.0044448238576499,-0.0223775854964489,-0.00495387597446132,0.0021126725616875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.01069481558873,0.00349815340828868,-0.0175511962689758,-0.00383843490848415,0.00223734452185828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0159766308147335,0.00522718503026227,-0.0262219134740476,-0.00573134815541947,0.00224353391741362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.0105566210895611,0.00346479446693145,0.00376562393437549,0.0173476182447468,0.00231730734752628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37411,0.0109973176621544,0.00361117023315059,0.00391942400517925,0.0180752113191295,0.00232847356166608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0273123142251583,0.00898006172731896,-0.0449132352107035,-0.00971139323961318,0.00235916484367441
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.01425060878031,0.00468696629940607,0.00506415483347412,0.0234370627271459,0.0023658976371437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.0102592175851501,0.00338575754965051,0.00362313278783508,0.0168953023824651,0.00244924801644745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.021840429534675,0.00720868423441531,-0.035969450634129,-0.00771140843522099,0.00245226715609261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0172463785663807,0.00569711989930178,-0.0284127335690122,-0.00608002356374924,0.00247215185529358
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.00665646565945162,0.00220811074739414,-0.0109843627243441,-0.00232856859455911,0.00257760668554499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,39546,-0.0221972677478933,0.00736529583910952,-0.0366332475925479,-0.00776128790323863,0.0025843998415054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0224940153487365,0.00749087809912388,-0.0371761364230193,-0.00781189427445373,0.0026796511749686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.0155028884348321,0.0051838365008173,-0.025663207976434,-0.00534256889323015,0.00278913110880011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,39766,-0.0160170845783734,0.00535796929504724,-0.026518704396666,-0.00551546476008081,0.00279958198198999
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0165711984746521,0.00554657254250577,0.00569991629134074,0.0274424806579634,0.00281652823738171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.00680087566027338,0.0022808253797676,-0.0112712934046179,-0.00233045791592887,0.00287104419762609
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.0147421343600678,0.00494806739129181,-0.0244403464469997,-0.00504392227313581,0.00289351744486958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00852348126930376,0.00286832922854135,-0.0141454065572448,-0.00290155598136272,0.00296788025889373
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,36962,0.0133560046243343,0.00449977897873319,0.00453643782601728,0.0221755714226514,0.00300143012905209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37382,-0.0348102561714647,0.0117436148323909,-0.0578277412429509,-0.0117927710999784,0.00304014203800153
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.00693834948096691,0.00234290050219029,-0.0115304344652599,-0.00234626449667394,0.00306661144202044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37021,0.0215275741304467,0.00727112899547616,0.00727616129931343,0.03577898696158,0.00307496212739194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00751826897018676,0.00254094958962326,-0.0124985301658483,-0.00253800777452517,0.00309329599818549
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.00778299839335968,0.00263320619160949,0.00262191425780508,0.0129440825289143,0.00312484335205461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.0110229376722454,0.00374017321840061,-0.0183536771803106,-0.00369219816418017,0.0032125555885876
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.0143817153488844,0.0048804902498927,-0.0239474762386741,-0.00481595445909471,0.00321667987748148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0139282075352844,0.00472727760957813,0.00466274342051126,0.0231936716500575,0.00322113402698139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.0122614018743183,0.00416525443055305,0.00409750319043435,0.0204253005582023,0.00324744391451295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00951615516708854,0.00324740156799835,0.00315124809381178,0.0158810622403653,0.00339022962974378
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.0138401358666136,0.00472882634159173,-0.0231086354961334,-0.00457163623709383,0.00343093382455173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.0115737093867637,0.00395938105090583,-0.0193340962465392,-0.00381332252698831,0.00347127580304539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.0309248687109324,0.0105858629226844,-0.0516731600393938,-0.010176577382471,0.00349109437242011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00910859962221701,0.00312760292950922,-0.0152387013640551,-0.00297849788037894,0.00359252269730067
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,39558,-0.0125649098014873,0.00432038938918937,-0.0210328730042985,-0.00409694659867615,0.00363930002950567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,39862,0.00657296448569427,0.00226128100616827,0.00214085371360446,0.0110050752577841,0.00365713334951294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,-0.0140772815448862,0.00485261268649567,-0.0235884024104177,-0.00456616067935471,0.0037262767821046
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0217894447508428,0.00751551432337011,-0.0365198528246483,-0.00705903667703742,0.00374641559997875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37411,-0.00865588698296599,0.00299851423026299,-0.0145329748742815,-0.00277879909165053,0.0038988905588475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00643125717046782,0.00223534015668706,0.00204999046336118,0.0108125238775745,0.00402014632103425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00605526781634529,0.00211285497455433,-0.0101964635664718,-0.0019140720662188,0.00416347251798123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0171281517178091,0.00597812007036916,0.00541103637988553,0.0288452670557326,0.00417361900752285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37021,0.0151879551250164,0.00531978935479193,0.00476116798962417,0.0256147422604085,0.00431052138930042
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.0159361449673767,0.00558496327688954,-0.0268826729900802,-0.00498961694467319,0.00433106962741828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.0107104590703753,0.00376709704983826,0.00332694885269235,0.0180939692880583,0.00447373520069457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.0169219546682618,0.00595893582167288,-0.0286014688787406,-0.0052424404577829,0.00452052422011322
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0230399941413932,0.00812269131733214,-0.0389604691233642,-0.00711951915942223,0.00456791085596419
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00806239602614131,0.00284274188027832,0.0024906219407958,0.0136341701114868,0.00457328311254811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40009,-0.00737290489454783,0.00259993738716463,-0.0124687821733905,-0.00227702761570515,0.00457677525831983
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.0125532230021243,0.00444027955731419,-0.0212561709344601,-0.00385027506978852,0.00470279301314782
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37388,-0.0109939229402103,0.00389214636172915,-0.0186225298091994,-0.00336531607122115,0.00474026142476985
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.0159477496394871,0.00566218891644837,-0.0270456399157259,-0.00484985936324833,0.00486151416607935
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.0126260511990061,0.00449251074960365,-0.0214313722682292,-0.0038207301297829,0.00495419754816172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.0120716256437794,0.0043031678154502,-0.0205058345620618,-0.00363741672549701,0.00503434711862007
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.0172273614211351,0.00614439922071741,-0.0292703838937412,-0.00518433894852898,0.00505732552860518
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0222872019795352,0.0079616313750581,-0.037891999474649,-0.00668240448442129,0.00512722247792034
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00659934911426281,0.00235932055136315,0.00197508083359104,0.0112236173949346,0.0051619207510224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.0101588096527226,0.00363555020432741,-0.0172844880532044,-0.00303313125224091,0.00520759641148219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0160401703465601,0.00574533040825183,0.00477932274638652,0.0273010179467337,0.00524815818512177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.00957736490581197,0.00343357529146299,-0.0163071724770794,-0.00284755733454452,0.00528803241277345
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.0134457651546341,0.00482566642886276,0.00398745895406308,0.0229040713552051,0.00533760599827647
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00832055914573396,0.00299182010166526,0.00245659174647005,0.0141845265449979,0.00542514116905829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.0167421765350124,0.00602518073577956,0.00493282229288446,0.0285515307771403,0.00546538692165606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,36991,0.0273996332112191,0.00986835768080423,0.00805765215684285,0.0467416142655954,0.00550231094047931
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00772583337653933,0.0027832559381739,-0.0131810150153602,-0.00227065173771849,0.00551271927814023
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,-0.00659648516012076,0.00237964142579653,-0.011260582354682,-0.00193238796555955,0.00557691468130524
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37124,-0.0105552213050747,0.00380903071193074,-0.018020921500459,-0.00308952110969046,0.00559443346728672
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0169118650979034,0.0061155660669172,0.00492535560674568,0.0288983745890611,0.0056920956427216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37043,-0.0244018789285406,0.0088292186172482,-0.041707147418347,-0.00709661043873407,0.00572181044600091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.0131622494712838,0.00477168432986029,-0.02251475075781,-0.00380974818475765,0.00581614835530352
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.0148510749300322,0.00538497757772223,-0.0254056309823677,-0.00429651887769659,0.00582573040723977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.00795644716176927,0.00288599224644754,-0.0136129919648065,-0.00229990235873208,0.00584285560276038
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_DRA,,39799,0.00995698164335269,0.00362442514963219,0.0028531083500736,0.0170608549366318,0.00601759651727733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.0121788670101294,0.00444030069232124,0.00347587765317973,0.020881856367079,0.006099952707805
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37021,0.00974366337885395,0.00357741198777331,0.00273193588281826,0.0167553908748896,0.00646475770290861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00840827052588094,0.00309326528143333,-0.0144710704774903,-0.00234547057427161,0.00657004633924622
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00340291924475624,0.00125394572792836,0.000945185618016651,0.00586065287149583,0.00665942351366143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37124,0.0258956025185311,0.00960136181945964,0.00707693335239017,0.044714271684672,0.00700396873301035
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.010871973735519,0.00403814796402881,-0.0187867437450154,-0.00295720372602253,0.00710315510245038
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39477,0.0229958870822705,0.00857305945996414,0.00619269054074075,0.0397990836238002,0.00731853588446114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.0119207259535343,0.00444575439640062,0.00320704733658907,0.0206344045704795,0.00734120399133195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.00982818742452387,0.00367133911979221,-0.0170240120993166,-0.00263236274973114,0.00743609391183077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,0.0108638084966792,0.00406626895508756,0.00289392134470754,0.0188336956486508,0.00755481638220784
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37124,-0.00919945636425911,0.0034485552056929,-0.0159586245674172,-0.00244028816110103,0.00764819811251148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.0237757142936083,0.00891960623674322,-0.041258142517625,-0.00629328606959161,0.00769548568414148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.0164507801428202,0.00619059746187491,-0.0285843511680951,-0.00431720911754541,0.00788450771365433
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.00814080780690632,0.00306389399857232,-0.0141460400441081,-0.00213557556970456,0.00789164641353964
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.0111020774574437,0.0041847508874976,0.00289996571794846,0.019304189196939,0.00798623828650985
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37021,0.00959937674255973,0.00362519184190121,0.00249400073243336,0.0167047527526861,0.00810747505673587
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.0211361153085556,0.00798285853247798,-0.0367825180322125,-0.00548971258489878,0.00811408212697801
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,-0.00861017798113345,0.00325226958430425,-0.0149846263663698,-0.00223572959589712,0.0081184912000304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.0129501242329814,0.00490485792689689,0.00333660269626349,0.0225636457696993,0.0082938740064146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00927309752216127,0.00352235325894848,0.00236928513462226,0.0161769099097003,0.00848221135258476
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.00737195661224195,0.0028007432427995,0.00188249985635493,0.012861413368129,0.00849293338474785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.00602109961172206,0.00229244625836139,-0.0105142942781104,-0.00152790494533374,0.00863517066386845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00694172632012954,0.00265262291947312,0.00174258539796224,0.0121408672422968,0.00888266355149663
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,39691,0.0127190487848866,0.00486091672930503,0.00319165199544877,0.0222464455743245,0.00888960986776239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,-0.00737705405593682,0.00282464967353773,-0.0129133674160708,-0.00184074069580287,0.00901851399378845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37437,-0.00983237213244436,0.00376803488596256,-0.017217720508931,-0.00244702375595775,0.00907962801249129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00713491424793269,0.00273787118669925,-0.0125011417738632,-0.00176868672200217,0.00916906668889904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00712000702872795,0.0027338067036048,0.00176174588966254,0.0124782681677934,0.00921116184760864
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37388,0.0071553657842049,0.002749795690439,0.00176576623094447,0.0125449653374653,0.00927437807930027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.0160401162451479,0.00618212349701242,0.0039231541910035,0.0281570782992922,0.00948072626006961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.0224373246156096,0.00867088690236374,0.00544238628697662,0.0394322629442425,0.00967199091573111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0155895155939105,0.00603172780106952,0.00376732910381428,0.0274117020840068,0.00975848962493034
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00880544900922977,0.00342493460569718,0.00209257718206331,0.0155183208363962,0.0101519125282681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0161229307582073,0.00628513270660056,0.00380407065327024,0.0284417908631444,0.0103211812942477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.00859540479184659,0.0033518371237372,-0.0151650055543715,-0.00202580402932168,0.0103467554524869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.0128936409321157,0.00503312296775513,-0.0227585619489157,-0.00302871991531561,0.0104236989708431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37437,0.0130701312142739,0.00511065131952896,0.00305325462799718,0.0230870078005507,0.0105556562636971
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.00972220893254214,0.00380502600076113,-0.017180059894034,-0.00226435797105031,0.0106250034517747
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.0308693207331366,0.0120956965661018,-0.054576886002696,-0.00716175546357717,0.0107170593411513
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,39862,0.00915235948724182,0.00358776464148686,0.00212034078992758,0.0161843781845561,0.0107508974494961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.0100025440318523,0.00393303342173099,-0.017711289538445,-0.00229379852525956,0.0109951205011432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.00497713678141189,0.00196184314218754,0.00113192422272431,0.00882234934009946,0.0111927446883848
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.00605152663547596,0.00239150226713696,0.00136418219188752,0.0107388710790644,0.0114017899292594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.0104700872284679,0.00414120706320634,0.00235332138458345,0.0185868530723523,0.0114742288727482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.00645817048745399,0.00255505989881216,-0.0114660878891258,-0.00145025308578217,0.0114957927591905
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,36991,-0.0288608019068931,0.0114257705147069,-0.0512553121157186,-0.0064662916980676,0.0115506038780482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,39564,-0.0139027162471896,0.00550642771296719,-0.0246953145646053,-0.00311011792977392,0.0115856562049866
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.00952936846124633,0.00377598040401875,0.00212844686936958,0.0169302900531231,0.0116248807059209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.0115529532599509,0.00458340414163504,-0.0205364253775556,-0.00256948114234618,0.0117251859095107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.00926847713433444,0.00368320435478355,-0.0164875576697102,-0.00204939659895869,0.0118652515135326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.0115758346661067,0.00460033955959931,0.00255916912929209,0.0205925002029214,0.0118712658204349
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0123153100778593,0.00489909466484653,0.00271308453476008,0.0219175356209585,0.0119559152802785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2,Prothrombin,37453,-0.00377921252293399,0.00150386485575391,-0.00672678764021165,-0.000831637405656323,0.0119824049991244
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.00818847271534212,0.00326797882430732,-0.0145937112109845,-0.00178323421969978,0.0122336338882275
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00757602207142358,0.00303211986863003,-0.0135189770139384,-0.00163306712890871,0.012481024986256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37368,-0.0134378739026955,0.00537906750800025,-0.023980846218376,-0.00289490158701504,0.0124951035524068
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.0158103117017671,0.00633341980158695,-0.0282238145128775,-0.00339680889065668,0.0125607096776146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37411,-0.0158368077175139,0.00635659381082073,-0.0282957315867226,-0.00337788384830528,0.0127360018723222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.00821635706768224,0.00330036464957209,0.00174764235452094,0.0146850717808435,0.0128015331669555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,-0.0251005421499574,0.0100910483791371,-0.0448789969730661,-0.00532208732684874,0.0128778902977016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00801802727305879,0.00322412014929706,0.00169875178043655,0.014337302765681,0.0128965724091511
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,39587,0.0072236199568605,0.00291069649040183,0.00151865483567292,0.0129285850780481,0.0130842728003426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.0142392855089631,0.00578979214665175,0.00289129290152563,0.0255872781164005,0.0139306104991364
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00924074559342432,0.00377124287847013,0.00184910955162287,0.0166323816352258,0.0142859224805859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00931633813560416,0.0038201374786283,0.00182886867749269,0.0168038075937156,0.0147515240502374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00639080865459457,0.00262146171408703,0.00125274369498399,0.0115288736142051,0.0147868856426865
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.00941878646122192,0.00387290664669483,-0.0170096834887438,-0.00182788943370006,0.015030228953368
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.0177255004059016,0.00732843671667095,0.00336176444122654,0.0320892363705767,0.0155883579625283
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40009,0.00710451704720255,0.00294032801158956,0.001341474144487,0.0128675599499181,0.0156930489376181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,39754,-0.0127281361070651,0.00527449614119825,-0.0230661485438137,-0.00239012367031655,0.0158266666621934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0117711473097487,0.00488069978004665,0.00220497574085727,0.0213373188786401,0.0158883034983105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.0121711261567821,0.00505484204207646,0.0022636357543122,0.0220786165592519,0.0160619645016783
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00783037140174961,0.00325795773613976,0.00144477423891568,0.0142159685645835,0.0162544652383786
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.0172294092298909,0.00718220992860737,0.00315227776982044,0.0313065406899613,0.0164585353409563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.0150985134671497,0.00632242094350169,0.00270656841788638,0.027490458516413,0.0169502169054357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00971203135049327,0.0040757272968153,0.00172360584873529,0.0177004568522513,0.0171910290943179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.0144005973362425,0.00604768996699576,-0.0262540696715542,-0.00254712500093079,0.0172694250205077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00741174317920643,0.00311862629206005,-0.0135242507116441,-0.00129923564676874,0.0174847635456861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0210057221352118,0.00884370523457894,-0.0383393843949865,-0.00367205987543705,0.017552924852002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00877160546666898,0.00370258263398955,0.00151454350404946,0.0160286674292885,0.0178481417713878
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.0120067857760151,0.00506971570057266,-0.0219434285491375,-0.00207014300289267,0.0178826858763416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0101509098261618,0.00429803030455915,0.00172677042922591,0.0185750492230978,0.0182029247099054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0163051629251922,0.00691488676834843,-0.0298583409911551,-0.00275198485922928,0.0183888678582035
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0151425669953886,0.00643703070375308,0.00252598681603259,0.0277591471747447,0.0186665810373103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.0137067454784607,0.0058426320069721,-0.025158304212126,-0.00225518674479538,0.0189887011972479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00876113264075547,0.0037414705602117,0.00142785034274053,0.0160944149387704,0.0192146703394338
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37382,-0.0147238907752143,0.00628823936410505,-0.0270488399288602,-0.00239894162156845,0.0192210446330308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40018,-0.00495773384535051,0.00212251761837624,-0.00911786837736795,-0.000797599313333079,0.0195148866202371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37056,0.00642406956017526,0.00275454208288838,0.00102516707771404,0.0118229720426365,0.0197065374000482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37088,0.007346462662616,0.00315896287990522,0.00115489541800178,0.0135380299072302,0.0200553034394236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39344,-0.0141965140149417,0.00610837407509202,-0.0261689272021221,-0.00222410082776138,0.0201326406053557
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40030,0.0102362917861045,0.00441393478711491,0.00158497960335927,0.0188876039688497,0.0204028040038789
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00604318172398242,0.00261085192107381,0.000925911958677758,0.0111604514892871,0.0206474966993466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,39866,-0.0151246136657058,0.00654567050433491,-0.0279541278542023,-0.00229509947720943,0.0208660249871112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0146332102255076,0.00633357363977129,0.0022194058915559,0.0270470145594593,0.0208803431206512
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.00600345515907633,0.00261269574659052,-0.0111243388223938,-0.000882571495758912,0.0215883049201485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0121791024330503,0.00530639095194402,0.00177857616724007,0.0225796286988606,0.0217386820990018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.00659317965963873,0.00290409132402358,-0.0122851986547249,-0.000901160664552507,0.0232049970274393
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37382,-0.00712076100314383,0.00313915045465375,-0.0132734958942652,-0.000968026112022476,0.0233222398550231
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.0100026167000138,0.00444266223424699,0.00129499872088971,0.0187102346791379,0.0243703692756813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.0105728026622345,0.00469940415766447,0.00136197051321214,0.0197836348112569,0.0244769291132533
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0055902967478383,0.00248566854089557,0.000718386407682981,0.0104622070879936,0.0245253209130095
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37169,-0.0167407025128445,0.00745410373367125,-0.0313507458308401,-0.0021306591948488,0.0247307844385255
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0179320214782361,0.00800092924378252,-0.0336138427960498,-0.00225020016042233,0.0250239922707734
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.0111556845077957,0.00500408872022274,0.00134767061615914,0.0209636983994323,0.0258099129212656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0157719247309,0.00711631841741643,0.00182394063276383,0.0297199088290362,0.0266877664001083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.0128235517686845,0.00579910698874457,-0.0241898014666239,-0.00145730207074514,0.0270295609567166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.010812707188918,0.0048921681434846,-0.0204013567501478,-0.0012240576276882,0.0271051023146815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37411,-0.00828925668646271,0.00375066951566869,-0.0156405689371733,-0.000937944435752071,0.0271166861232426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,39587,-0.0139760596837482,0.00634737624526677,-0.0264169171244711,-0.00153520224302536,0.0276893762403008
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.0104959401259558,0.00477018449489452,0.00114637851596256,0.0198455017359491,0.0278013490874923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.00911092855563056,0.00414275507601079,0.000991128606649414,0.0172307285046117,0.02787803822863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00640016529226274,0.00291058020797463,-0.012104902499893,-0.000695428084632461,0.0278997128247501
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,39841,0.0149441550222177,0.0067966218950061,0.00162277610800572,0.0282655339364296,0.0279091170414172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00917909651895599,0.00417900351972622,0.000988249620292606,0.0173699434176194,0.0280750414822743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00664964441038224,0.00302906399136065,0.000712678987315363,0.0125866098334491,0.0281603641756997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARTN,Artemin,39587,-0.0100312571464955,0.0045708502859765,-0.0189901237070094,-0.00107239058598157,0.0282057866225413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37056,0.0229303719808483,0.0104491112747894,0.00245011388226105,0.0434106300794356,0.0282182424651875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00603181572608832,0.00274963062314753,0.000642539704719161,0.0114210917474575,0.0282724282566115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.00930522793361175,0.0042492992807327,-0.0176338545238478,-0.000976601343375657,0.0285514632836145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIM,Vimentin,39585,-0.0260768593202316,0.0119335806740461,-0.049466677441362,-0.00268704119910133,0.0288913549649437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERVV_1,,37021,0.0107578421453489,0.00492530577127666,0.00110424283364662,0.0204114414570511,0.0289653020453342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.010831196447527,0.00497708604161068,-0.020586285089084,-0.00107610780597007,0.0295539398415049
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.00968615217231051,0.00445112323772025,0.000961950626378811,0.0184103537182422,0.0295645321573503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.0173060067984831,0.0079585308777059,-0.0329047273187867,-0.00170728627817953,0.0296836229588871
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0109702168010755,0.00504530007961973,0.00108142864502085,0.0208590049571302,0.0296940337412983
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,0.013082903931359,0.00602234649933345,0.00127910479266543,0.0248867030700526,0.029840759261481
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.00882747898460869,0.0040640676827465,-0.0167930516427918,-0.000861906326425552,0.0298674436601643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37039,0.00771129159236774,0.00355157004335924,0.000750214307383629,0.0146723688773518,0.0299312298592977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00840394710311683,0.00387787963038576,0.000803303027560738,0.0160045911786729,0.0302412897859491
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,39908,-0.0181894733968021,0.00840839820780774,-0.0346699338841053,-0.00170901290949895,0.030536616154991
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESPL1,Separin,36962,0.0118935695227725,0.00550367673607014,0.00110636312007499,0.0226807759254699,0.0307116584468777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37380,-0.00700053181433708,0.00324144900331213,-0.0133537718608289,-0.000647291767845315,0.0308140370465044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0107111859311953,0.0049619740808489,-0.0204366551296591,-0.000985716732731425,0.0308918435634084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.0138336163026648,0.00641309533980373,0.00126394943664953,0.0264032831686802,0.0310165892026158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00945591744809171,0.00440042900497424,0.0008310765983422,0.0180807582978412,0.0316634262029086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.00970786059414275,0.00452092834670277,-0.0185688801536802,-0.000846841034605318,0.0317831995478175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00915977008790442,0.00426560929571107,0.000799175868310728,0.0175203643074981,0.0317833280315075
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0142406323675644,0.0066481001401151,-0.02727090864219,-0.00121035609293877,0.0322068664354657
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.00453705706354374,0.00212407964371817,0.00037386096185613,0.00870025316523135,0.0326937344669445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00897193126156278,0.00421465013695384,0.000711216993133257,0.0172326455299923,0.033293569256098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,36962,0.0130083911424534,0.00611731453691795,0.00101845465009421,0.0249983276348126,0.0334813506877519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37043,-0.0154736990012645,0.00728198417135197,-0.0297463879771144,-0.00120101002541465,0.0336110905399068
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00702426288830327,0.00330670580211835,0.000543119516151302,0.0135054062604552,0.0336680525177701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00819395790676686,0.00386038094184915,0.000627611260742521,0.0157603045527912,0.0338052272492669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00963586358434604,0.00454369424397858,0.000730222866148027,0.018541504302544,0.0339645492802837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00678186759441739,0.00321045999988485,-0.0130743691941917,-0.000489365994643087,0.0346684606268879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40052,-0.0111707704146798,0.00528946934640888,-0.0215381303336412,-0.000803410495718342,0.0347112737536027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37056,-0.00359864188699849,0.00170447594782976,-0.00693941474474481,-0.000257869029252161,0.0347662031001039
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.00490350085279045,0.00234121172359404,0.000314725874546132,0.00949227583103477,0.0362403049964022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.00728082470644906,0.00351119195662431,0.000398888471465408,0.0141627609414327,0.0381320508969508
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0144272031591977,0.00696269603451579,0.000780318931546757,0.0280740873868486,0.0382781622797046
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,39885,-0.00628800823328473,0.00303509723673554,-0.0122367988172864,-0.000339217649283079,0.0383033221137698
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00537469363875324,0.00259500837018161,-0.0104609100443092,-0.000288477233197278,0.0383621497703635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00549416913796211,0.00265716196235607,-0.01070220658418,-0.000286131691744212,0.0386859331192522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,39866,-0.0136633397279227,0.0066148686361296,-0.0266284822547367,-0.000698197201108648,0.038887079788017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39489,-0.0127922638953349,0.00619804488072616,-0.0249404318615582,-0.00064409592911166,0.0390418445970471
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,39587,-0.0104423211174182,0.00506405225124746,-0.0203678635298632,-0.000516778704973141,0.0392195123228815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,36962,0.0125744282788059,0.00609920968664978,0.00061997729297235,0.0245288792646395,0.0392608644631862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00932099957987764,0.00454379111599892,0.000415168992519767,0.0182268301672355,0.0402506177758569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPS,Colipase,39836,0.014467151318707,0.00705682991823557,0.000635764678965282,0.0282985379584487,0.0403717289830257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.0125412645118753,0.00612149103334369,-0.0245393869372289,-0.000543142086521654,0.0405080901509402
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.0103957079395715,0.00508560938595783,0.000427913543094186,0.0203635023360489,0.0409593769037777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0133594735973599,0.00653955177388672,0.000541952120541901,0.0261769950741779,0.0410849826005465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.01100125530261,0.00538803583029117,0.000440705075239261,0.0215618055299806,0.0411920744017203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,39788,-0.0385695406548272,0.0189841553336308,-0.0757784851087435,-0.0013605962009109,0.0422036304725221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00717666750191024,0.00353519267744657,0.000247689854114956,0.0141056451497055,0.0423701732817339
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,39913,-0.0060742590333032,0.00299798834178815,-0.011950316183208,-0.000198201883398434,0.0427698510778925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.00870897611140157,0.00430237489731211,-0.0171416309101333,-0.000276321312669841,0.0429668849273032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00894975396597999,0.00442419219924192,-0.0176211706764942,-0.000278337255465826,0.0430990493400418
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.0123814416400221,0.00615996059412425,0.000307918875538578,0.0244549644045056,0.0444528629417862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39456,-0.00732645233134277,0.00365287705580972,-0.0144860913607298,-0.000166813301955712,0.0449091061371737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00985565396766213,0.00491473432185861,-0.019488533238505,-0.000222774696819259,0.0449479123301494
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.0083692329791975,0.00417656375661121,0.00018316801623953,0.0165552979421555,0.0451060207871271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.0059042681050777,0.00295762072091661,0.000107331492081154,0.0117012047180743,0.0459229241361304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.0071866230924707,0.00360540012742086,0.000120038842725816,0.0142532073422156,0.04624989862645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.0113251136735877,0.00569915558726068,-0.0224954586246186,-0.000154768722556733,0.0469224914252869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,39885,-0.00475962505451854,0.00240748753753439,-0.00947830062808594,-4.09494809511298e-05,0.048057701075718
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,-0.0121378810933472,0.00614190411025454,-0.0241760131494461,-9.97490372482632e-05,0.0481483311219696
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.00846068094551359,0.0042841458102514,6.37551574208389e-05,0.0168576067336063,0.0483025406693047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.00507183028626025,0.00258744652935806,-0.010143225483802,-4.35088718454477e-07,0.0499932566763174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00889103639417318,0.00454231168206637,-0.0177939672910233,1.18945026769107e-05,0.050319843543467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0111774447657186,0.0057123738145813,-1.88079108608009e-05,0.0223736974422979,0.0504024374266529
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.00636186985311638,0.00326543269456269,-0.0127621179344592,3.83782282264858e-05,0.0514064623829144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.015801082595023,0.00811733974179149,-0.0317110684889343,0.000108903298888349,0.0516025371014397
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,-0.0108456956355831,0.00558086176923616,-0.021784184703286,9.27934321197418e-05,0.0519923781608325
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.00160751032674629,0.00082814857624127,-1.56608826866016e-05,0.00323068153617917,0.0522684091040983
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00400284672872581,0.00206292658927762,-0.00804618284370995,4.04893862583364e-05,0.0523556678114847
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,37453,-0.00361878131102548,0.00186979678375392,-0.00728358300718316,4.60203851322056e-05,0.0529634772274366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.0139235220671184,0.00720001096899079,-0.0280355435663404,0.000188499432103549,0.0531566953957548
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.00960556170725908,0.00500401363928022,-0.0194134284402483,0.000202305025730159,0.0549297592385185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00854079114032225,0.00446046879590669,-0.000201727699654861,0.0172833099802994,0.0555429941930362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00757295278241848,0.00396911171674219,-0.0153524117472332,0.000206506182396217,0.0564131813367869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.0058873598495571,0.00308745382501571,-0.0119387693465879,0.000164049647473678,0.0565557125652906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00909552794843884,0.00478100690687704,-0.0184663014859178,0.000275245589040164,0.0571368504339846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.0109415353210507,0.00575643430694142,-0.000341075920554516,0.0222241465626559,0.0573568055018886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0135876788783743,0.00715115289561102,-0.000428580797023251,0.0276039385537719,0.0574422433232362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.00366015821478465,0.00192668642989275,-0.000116147187805132,0.00743646361737444,0.0574915087880147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,-0.00959751279973873,0.0050808141870366,-0.0195559086063305,0.000360883006853011,0.0589169506920099
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.00505784973673127,0.002680735673121,-0.000196392182585892,0.0103120916560484,0.0592173127291873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00647877744129777,0.00343639054560002,-0.000256548028078259,0.0132141029106738,0.0594055498624096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00586234253015197,0.00311227566093987,-0.0119624028255941,0.000237717765290169,0.059635037412846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00746628683462005,0.0039888359411788,-0.000351831610090402,0.0152844052793305,0.0612530072180874
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00565500685451487,0.00303287360766963,-0.0115994391255473,0.000289425416517601,0.0622598021052265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,39796,-0.00612893006002828,0.00328821973540116,-0.0125738407414146,0.000315980621358003,0.0623533854776474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.00888905640211557,0.00477539732266764,-0.000470722350313002,0.0182488351545441,0.0627019783822314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00907498856147198,0.00487522215039536,-0.000480446853302924,0.0186304239762469,0.0627026910917294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.0081450626300236,0.00439590465100361,-0.000470910485943483,0.0167610357459907,0.0639226717129823
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00615141892701541,0.00332732486336176,-0.000370137805173648,0.0126729756592045,0.0645152086521671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.00830626503947585,0.00449352873667456,-0.017113581363358,0.000501051284406293,0.0645492195251969
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37420,0.00669344587381152,0.00365366422089417,-0.000467735999141061,0.0138546277467641,0.0669760733154273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.00742284665555089,0.00406175784684497,-0.00053819872426526,0.015383892035367,0.0676471482988098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37031,0.0130856854476639,0.007161307532644,-0.000950477316318352,0.0271218482116461,0.0676808963216689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00552066056327047,0.00302193218204922,-0.0114436476400869,0.000402326513545991,0.0677427542385302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.0102854564379685,0.0056461022307551,-0.000780903934311513,0.0213518168102485,0.06852443617578
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37056,0.00756290389388679,0.00417126658165808,-0.00061277860616304,0.0157385863939366,0.0698398317076294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00869596470173263,0.00480202290044897,-0.0181079295866126,0.000716000183147353,0.0701761233575868
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00550585757762032,0.00304173297873636,-0.0114676542159436,0.000455939060702939,0.0703021671156958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,36991,0.00870251682347464,0.00483847764518751,-0.00078089936109289,0.0181859330080422,0.0721039218947966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.0066329663636486,0.00370309875656563,-0.00062510719922004,0.0138910399265172,0.073281473704006
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39453,-0.00629360944364115,0.00351719537823576,-0.0131873123849832,0.000600093497700932,0.0735725639553484
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00857383381957643,0.00479190748270707,-0.00081830484652943,0.0179659724856823,0.0735997428998857
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.0110271115138369,0.00617722157060531,-0.0231344657922233,0.00108024276454949,0.0742603399336418
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37043,-0.0133352681860849,0.00747017041623855,-0.0279768022019124,0.00130626582974269,0.0742622862962713
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00989455757691389,0.0055515138542227,-0.000986409577362608,0.0207755247311904,0.0747205967705498
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,36962,0.00746369235767123,0.00421829140919715,-0.000804158804355176,0.0157315435196976,0.0768564309137118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.012929209723111,0.00733618009354011,-0.00144970326022763,0.0273081227064496,0.0780266521917862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.00838756985413396,0.00476581590305743,-0.000953429315858609,0.0177285690241265,0.0784398829372955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.00620526091011816,0.00353923754980625,-0.0131421665077384,0.000731644687502083,0.0795772198184745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.0126262675976276,0.00721158065072614,-0.0267609656730508,0.00150843047779567,0.0799978564055768
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00940836399332818,0.0053788012930348,-0.00113408654102003,0.0199508145276764,0.0802870992807407
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,-0.00756843319444887,0.00433427295153681,-0.016063608179461,0.000926741790563272,0.0807985783238478
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00863734904641062,0.00494647545033554,-0.00105774283624704,0.0183324409290683,0.0808061345945138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40052,-0.00344531642349333,0.00198006866553065,-0.00732625100793341,0.000435618160946746,0.0818782882658816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00772074556798446,0.00444787858189549,-0.0164385875884996,0.000997096452530701,0.0826142230170301
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,39885,0.00563651968141222,0.00324876858642243,-0.000731066747975733,0.0120041061108002,0.0827651463626252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.0100106075185414,0.00577003772643063,-0.0213198814623454,0.00129866642526266,0.0827767387858357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.011687060385065,0.00674052812378177,-0.00152437473754732,0.0248984955076772,0.0829683377862125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39489,-0.00779361873125231,0.00454580001023354,-0.0167033867513101,0.00111614928880542,0.086463035241729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.0105325669845526,0.00614768979144912,-0.0225820389757929,0.00151690500668763,0.0866846201309998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37388,0.00649538207197021,0.0037921980064255,-0.000937326020623777,0.0139280901645642,0.0867671431385588
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.0109934909981721,0.00643256681303093,-0.00161433995536848,0.0236013219517128,0.0874678322410885
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00592425961616461,0.00348340330247914,-0.000903210856694503,0.0127517300890237,0.089021092334606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00572074394356274,0.00336465013198074,-0.000873970315119509,0.012315458202245,0.0891077808242036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,39720,0.0216543171264385,0.0128157483125303,-0.00346454956612079,0.0467731838189979,0.0911117801538902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37124,-0.00857256493041563,0.00507367548548007,-0.0185169688819566,0.00137183902112531,0.0911248813399235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40052,0.0125800046130937,0.00745498968770317,-0.00203177517480451,0.0271917844009919,0.0915339964936787
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.0142764975994038,0.0084745858068847,-0.0308866857808978,0.00233369058209025,0.0920845785394813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.00545667450458101,0.00324214881737644,-0.000897937177476819,0.0118112861866388,0.0923861538669203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLU,Clusterin,37453,0.00547973260373532,0.00326243588361112,-0.000914641728142462,0.0118741069356131,0.0930494779213598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00387516087853173,0.00230714893159509,-0.000646851027394639,0.0083971727844581,0.0930526347183387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSND,Barttin,36962,0.00578708864561909,0.00344942254612545,-0.000973779544786801,0.012547956836025,0.0934299588950812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.00622173259359185,0.00370883972668846,-0.00104759327071753,0.0134910584579012,0.0934602323232358
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00557553937756912,0.00333373804364607,-0.0121096659431154,0.00095858718797717,0.0944539101731741
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.0056296928872491,0.00336867394522479,-0.000972908045391479,0.0122322938198897,0.0947039613590414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.0110693773099305,0.00664838652270738,-0.0241002148944369,0.00196146027457601,0.095941462448963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.0188005829744202,0.0112987603476332,-0.0409461532557813,0.00334498730694081,0.0961460394841828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00587001766487804,0.00353846048024812,-0.00106536487640827,0.0128054002061644,0.0971560377237673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0157081286129632,0.00948669364797347,-0.0343020481629912,0.00288579093706483,0.0977848273467505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37299,-0.00482107807438063,0.00291228501899992,-0.0105291567116205,0.000887000562859207,0.0978610652349547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00972725610329293,0.00588472035980459,-0.0212613080085099,0.00180679580192406,0.098360523489391
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.00904049653166803,0.00547259515652316,-0.0197667830384534,0.00168578997511737,0.0985663862342962
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,-0.0101252216147017,0.00613366244406093,-0.0221472000050611,0.00189675677565775,0.0988108214635423
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00597569386933703,0.00362321742242378,-0.0130772000172876,0.00112581227861357,0.0991107302430905
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.0048234462017409,0.00292589367260021,-0.0105581978000373,0.000911305396555505,0.0992659716577421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39456,-0.0104436534030918,0.00634400750798867,-0.0228779081187496,0.00199060131256595,0.0997379289657451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37021,0.0139606654653248,0.00848563967382758,-0.00267118829537728,0.0305925192260268,0.099950241433634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.00426700584098861,0.00259596506162837,-0.000821085679803006,0.00935509736178022,0.100259985306451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.0111305972720942,0.00677474230600748,-0.0021478976476805,0.0244090921918688,0.100416171058368
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.0123153935153832,0.00752480215935032,-0.00243321871694339,0.0270640057477099,0.101729640497598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.0103655253630045,0.00634252085102523,-0.0227968662310139,0.00206581550500496,0.102217256941019
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.0047274022587231,0.0028967230838564,-0.0104049795030816,0.000950174985635442,0.102702988290987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37169,-0.00721064052378669,0.0044211144299081,-0.0158760248064066,0.00145474375883319,0.102923388773051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,36962,0.00499083856324586,0.00306870277830074,-0.00102381888222359,0.0110054960087153,0.103895542328887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.008069312260575,0.00496653631365007,-0.00166509891417913,0.0178037234353291,0.104242794275266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00707391870912306,0.00436353419896945,-0.0156264457391032,0.00147860832085705,0.105010752720051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39315,-0.00420158059862936,0.00259319198931334,-0.00928423689768349,0.000881075700424784,0.10520219281337
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0130856483558598,0.00808751861133037,-0.00276588812234774,0.0289371848340673,0.105685573863801
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.0166490231358253,0.0102941839906677,-0.0368256237575341,0.00352757748588344,0.105832455024984
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.00650702911432501,0.00402406102925992,-0.0143941887316745,0.00138013050302444,0.105895616078516
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00765473298499315,0.00473568796812673,-0.0169366814025215,0.00162721543253523,0.106033067136026
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.0101989490320533,0.00631562948877731,-0.0225775828300568,0.00217968476595025,0.10635793748274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.00628746253775038,0.00389767399835219,-0.0139269035745207,0.00135197849901992,0.106735649743297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.00989364661325592,0.00613508782802002,-0.0219184187561752,0.00213112552966333,0.106844277696711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.00643001735779929,0.0039886017489102,-0.0013876420700647,0.0142476767856633,0.106964382591124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.011238588984302,0.00704301926351359,-0.0250429067407886,0.00256572877218463,0.110574638993219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40009,0.0123285641866362,0.0077349775433347,-0.00283199179829986,0.0274891201715722,0.11098427532967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00845897569427304,0.00532648639364591,-0.018898889025819,0.00198093763727294,0.11228821918242
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,-0.00651193330163934,0.00410795316295829,-0.0145635215010376,0.00153965489775891,0.112940534990222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00597685110178935,0.00377161991964835,-0.00141552394072142,0.0133692261443001,0.113059954989559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.0137484015664958,0.00870563212088289,-0.00331463739043462,0.0308114405234263,0.11430191375053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37445,0.00366657603762785,0.00232245119064038,-0.000885428296027291,0.00821858037128299,0.114416079227691
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,39971,-0.0183773538914321,0.0116451121049382,-0.0412017736171109,0.00444706583424678,0.114558277097715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00612817193192483,0.00392982546181552,-0.0138306298370832,0.00157428597323358,0.118925653861887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,39964,-0.00528888219764639,0.00340061137853295,-0.011954080499571,0.00137631610427818,0.119900496042914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0132237574206844,0.00853159208475261,-0.0299456779067995,0.00349816306543076,0.121167203644465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00857290653568216,0.00553442076897939,-0.00227455817151744,0.0194203712428818,0.121401964048403
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00735333879732406,0.00475260844665747,-0.0166684513527727,0.00196177375812459,0.121833845403365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.00722109891435828,0.00469907270710195,-0.00198908359156154,0.0164312814202781,0.124384790793963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00496241123622802,0.00323934495767843,-0.00138670488082171,0.0113115273532777,0.125562757989203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,39844,-0.0194341692199799,0.012726644946236,-0.0443783933146024,0.00551005487464254,0.126769419209046
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.00333509804328049,0.0021896514995683,-0.00762681498243435,0.000956618895873368,0.127752521854607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00542332900803673,0.00356251239203816,-0.00155919528035805,0.0124058532964315,0.12794599252743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.0117200572943863,0.00771443347953146,-0.00340023232549536,0.026840346914268,0.128726779725036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,39952,0.00610597474129714,0.00402584719900741,-0.00178468576875739,0.0139966352513517,0.129363825607788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00485373894286543,0.00320301381834709,-0.0111316460268257,0.00142416814109486,0.129699784161992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37368,-0.00528473553043285,0.0034980736335199,-0.0121409598521319,0.00157148879126614,0.130874034636407
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.0055353738592834,0.0036790360976621,-0.0127462846107011,0.00167553689213432,0.13245793792407
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.0185925588533681,0.012361184825739,-0.0428204811118166,0.00563536340508042,0.132573602446598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,-0.00879716822605508,0.00587593940580394,-0.0203140094614308,0.00271967300932065,0.134373801550855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.00615747656293041,0.00411623462505513,-0.00191034330217764,0.0142252964280385,0.134699706925788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.00520942383175334,0.0035049511597147,-0.0120791281047942,0.00166028044128748,0.13721812378633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,39585,-0.00735602771349887,0.0049520223249074,-0.0170619914703174,0.00234993604331964,0.137442238193352
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-0.00342501167869662,0.00231510140188393,-0.00796261042638913,0.00111258706899589,0.139047048790113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37411,-0.012208278142882,0.0082713410125153,-0.028420106527412,0.00400355024164802,0.139974306589452
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.0105532186032905,0.00715240203979782,-0.0245719266012942,0.00346548939471327,0.140103969981447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00235544691420985,0.00159864211272871,-0.000777891626738415,0.00548878545515812,0.140661363794836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00776402013094374,0.00527095104066431,-0.00256704390875831,0.0180950841706458,0.14077897835729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.00906923942590226,0.00621254806671907,-0.0212458336366716,0.00310735478486712,0.144361726330279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00794174509517516,0.00544648360784787,-0.018616852966557,0.00273336277620667,0.144825307092951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00418926131319808,0.00287376240737137,-0.0014433130052498,0.00982183563164596,0.144925803542416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00528289201803707,0.00362700525952453,-0.00182603829063101,0.0123918223267052,0.145266143511847
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.00783697044831218,0.0054117177857467,-0.0184439373083757,0.00276999641175136,0.147599108835259
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37368,0.0160918212079133,0.0111244811564102,-0.00571216185865068,0.0378958042744773,0.148053684142387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,39931,-0.00669414370334762,0.0046281044479874,-0.0157652284214029,0.00237694101470768,0.14808130785505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.00348416974128906,0.0024099031600315,-0.0082075799349508,0.00123924045237268,0.148260805107431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,0.00801404910109442,0.00554438356643993,-0.00285294268912784,0.0188810408913167,0.148355162235636
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.0123606378343377,0.008565247283231,-0.0291485225094705,0.00442724684079502,0.149007964802502
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39477,0.0202287073422182,0.0140667093237241,-0.00734204293228103,0.0477994576167174,0.150438372675296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00399657188002383,0.00278221607712959,-0.00145657163115017,0.00944971539119783,0.150887913015829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37388,0.00547779630691639,0.00381987705195116,-0.00200916271490789,0.0129647553287407,0.151588457386055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.00629934298392244,0.00439705890574164,-0.014917578439176,0.00231889247133117,0.151984491118263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.016961635022982,0.0118605538645317,-0.0402083205974642,0.00628505055150022,0.152714837043831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00635374245918654,0.00444620748126901,-0.00236082420410072,0.0150683091224738,0.15302072888143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00683060176044863,0.00480835916934488,-0.0162549857323646,0.00259378221146734,0.15546600129097
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39489,0.00465276157356637,0.00327650873423141,-0.00176919554552719,0.0110747186926599,0.155617039144077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00667939120679655,0.00472493954865758,-0.00258149030857231,0.0159402727221654,0.157489668978278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00404875895599676,0.00286563075458149,-0.00966539523497649,0.00156787732298296,0.157717446818497
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,0.00564442278070793,0.00401769603117253,-0.00223026144039023,0.0135191070018061,0.16007673544272
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.0058862650362148,0.00419047605397253,-0.00232706802957136,0.014099598102001,0.160136551586588
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0140221859090046,0.00999109844999861,-0.0336047388710018,0.00556036705299271,0.160500346053997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00701374027630703,0.00501951959779948,-0.00282451813537995,0.016851998687994,0.162349048265137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00826823196655952,0.00596383086367175,-0.0199573404593561,0.00342087652623711,0.165649519204251
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.00977059315645244,0.00705602915978199,-0.0236004103096251,0.00405922399672026,0.166162681066099
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_A,,37411,-0.00457378321543284,0.00331107417090734,-0.0110634885904112,0.00191592215954554,0.167191278480036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00588771631608644,0.00426327133463762,-0.0024682954998033,0.0142437281319762,0.167292518783032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.00446480864555204,0.00323507763307718,-0.0108055608063833,0.00187594351527924,0.167567707588918
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,39725,0.00689272747380048,0.00500990069474221,-0.00292667788789424,0.0167121328354952,0.168896425085776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,39587,-0.00727168365296247,0.00529535217965789,-0.0176505739250919,0.003107206619167,0.169703532958157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00525851688322685,0.0038384339936899,-0.0127818475108591,0.00226481374440535,0.170721407434215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.0129739587302011,0.0094837196991941,-0.0315620493406215,0.00561413188021935,0.171327939956179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.0063427808966952,0.00463931257227654,-0.0154358335383572,0.00275027174496681,0.171591268580768
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00899581659754017,0.00659590621739471,-0.0219237927836338,0.00393215958855346,0.172638586612427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.0129367727790924,0.0095354443036676,-0.0057526980560961,0.0316262436142809,0.174898577477112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37056,0.00797447499358453,0.00588384101479768,-0.00355785339541892,0.019506803382588,0.175339494646759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00732512047054896,0.00540878407998919,-0.00327609632622985,0.0179263372673278,0.175663743166633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00450960230632301,0.00335200824303193,-0.00206033385001956,0.0110795384626656,0.178537529486992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,-0.00531141847202723,0.0039602113481741,-0.0130734327144485,0.00245059577039401,0.179876042438567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40030,-0.00424067419929413,0.00316260945576928,-0.0104393887326019,0.00195804033401367,0.179978823655719
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0111633009244534,0.00832969374515139,-0.0274895006649502,0.00516289881604332,0.180209605266888
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,39788,-0.00257719320041975,0.00192395136584681,-0.0063481378774795,0.00119375147664,0.180416862626591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.0100022781804873,0.00747249296357254,-0.0246483643890894,0.00464380802811492,0.180741462195448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39489,-0.00945420157234817,0.00707307322938066,-0.0233174251019343,0.00440902195723792,0.181357371632214
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37445,-0.00836393400488756,0.00629059994505271,-0.0206935098971909,0.00396564188741575,0.183674921895923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,0.00843812073019141,0.00634929617766448,-0.00400649977803098,0.0208827412384138,0.183875168371195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,36962,-0.00973919532419413,0.00733159576639271,-0.0241091230263238,0.00463073237793558,0.184073482318078
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,39587,0.00401754209832745,0.00302655715230929,-0.00191450992019874,0.00994959411685365,0.184385822021175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37056,-0.00396865931061792,0.00299556645771073,-0.00983996956773096,0.00190265094649511,0.185245720936123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.00667203560859308,0.00505659279076202,-0.00323888626130049,0.0165829574784866,0.187030509650498
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,39587,0.00418941887588418,0.0031788001882678,-0.0020410294931207,0.0104198672448891,0.187548095377462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.0060049427954041,0.00456617832739629,-0.00294476672629262,0.0149546523171008,0.188502081494029
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00401710376876909,0.0030573745454627,-0.010009557877876,0.0019753503403378,0.188899927655665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.00357222083769169,0.00272520959694095,-0.00176918997231258,0.00891363164769596,0.189946179916496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00789558004728752,0.00602892990233754,-0.00392112256129406,0.0197122826558691,0.19034885488318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.0113682736378301,0.00868731708331514,-0.0283954151211278,0.00565886784546755,0.190690730191034
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00722165216057177,0.00556105243162388,-0.00367801060541104,0.0181213149265546,0.194099803807071
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00817522654846127,0.00630332097676421,-0.0205297356629191,0.00417928256599658,0.194660080766061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00355229967997545,0.00274556116476919,-0.00182900020297216,0.00893359956292306,0.195744943266159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.0208370460442537,0.0161127163002939,-0.0524179699928298,0.0107438779043224,0.195962195640972
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00851490176815599,0.00659764619990113,-0.0214462883199622,0.00441648478365022,0.19686258136027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37056,0.00363695346256878,0.00282357636445139,-0.00189725621175595,0.00917116313689352,0.197745482791583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,-0.00450898147798259,0.00350853324674391,-0.0113857066416007,0.00236774368563547,0.1987593549982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.00941663748113505,0.00733326244771312,-0.00495655691638267,0.0237898318786528,0.199129802744959
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37039,-0.0050885061027015,0.00398808235903959,-0.0129051475264191,0.0027281353210161,0.202003445043318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,-0.0092262425551468,0.00723672450069251,-0.0234102225765041,0.00495773746621052,0.202356011427875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.00474407636863523,0.00372296991010343,-0.0025529446551675,0.012041097392438,0.202589499621483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,0.00346174476075269,0.00272283555356575,-0.00187501292423619,0.00879850244574156,0.203613736257222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00616037286781483,0.00486793907514496,-0.00338078771946928,0.0157015334550989,0.20571484816375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.00871683578985546,0.00690419328527428,-0.022249054628993,0.00481538304928213,0.206776099879141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00602832929554219,0.00477742819220763,-0.0153920885522691,0.00333542996118477,0.207030286586311
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,0.0048501064694103,0.00384621135111756,-0.00268846777878011,0.0123886807176007,0.20732798854671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00958641331341342,0.00762224915240881,-0.0245260216521347,0.00535319502530785,0.208523323453588
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.00504310396633268,0.00401888789057769,-0.0129201242318649,0.00283391629919959,0.20955524411304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39123,-0.00359784988236575,0.00286876018697883,-0.00922061984884425,0.00202492008411275,0.209807419150702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,39699,-0.00861802082252401,0.00689329208492285,-0.0221288733089728,0.00489283166392477,0.211243533556362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.00592268371650974,0.00474626337967704,-0.0152253599406767,0.00337999250765726,0.212100153893007
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,-0.00451059620456691,0.00362079916604322,-0.0116073625700116,0.0025861701608778,0.212875890760707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37056,-0.00441603437115044,0.00356082803342397,-0.0113952573166614,0.00256318857436054,0.214934337478179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.00792593389220186,0.00642463127585284,-0.0046663434084697,0.0205182111928734,0.217344553552284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,36991,0.00668927924771107,0.00543888830410266,-0.00397094182833015,0.0173495003237523,0.218757241534127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37039,-0.00758347824640079,0.00616710229432845,-0.0196709987432846,0.00450404225048297,0.218844019510994
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.00288879807044447,0.00235178611897006,-0.0074982988636258,0.00172070272273686,0.219340474561544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37368,0.00567248475982051,0.00462070634807552,-0.00338409968240751,0.0147290692020485,0.219609967070638
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37021,0.00740107407203064,0.00604798545116131,-0.00445297741224552,0.0192551255563068,0.221077701030136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.0112327287359675,0.00920549706174835,-0.0292755029769943,0.00681004550505928,0.222403411337622
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00742711124575129,0.00611300999776338,-0.0194086108413675,0.00455438834986494,0.224396556648256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00837704001175984,0.00691620006557458,-0.00517871211676634,0.021932792140286,0.22583283816145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.0107546226084806,0.00888247878322092,-0.00665503580663241,0.0281642810235936,0.226005766526709
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00464945444823428,0.00384778297153697,-0.00289220017597818,0.0121911090724467,0.226935614948787
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.00411540627072578,0.00341007994619456,-0.0107991629652671,0.00256835042381556,0.227513572691335
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.00393968150909723,0.00327579059454589,-0.0103602310744072,0.00248086805621271,0.229127335912193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.00599843334127549,0.00500294742194921,-0.0158042102882959,0.00380734360574496,0.230553943912399
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.00427799072151451,0.00357087400441936,-0.0112769037701765,0.00272092232714744,0.230926063108618
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,0.00378240798966197,0.00315908310432149,-0.00240939489480815,0.00997421087413209,0.231206308361873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,0.0073858202812053,0.00617647660868125,-0.00472007387180995,0.0194917144342206,0.231793305233227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00490846074197486,0.00412610120917745,-0.0129956191119627,0.00317869762801294,0.234220270166728
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.00673878532444781,0.00567463264254256,-0.0178610653038312,0.0043834946549356,0.235040266519419
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37039,0.00720034247255994,0.00607243029892484,-0.00470162091333274,0.0191023058584526,0.235745136686224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37388,0.00273268732296705,0.00230822532064823,-0.00179143430550349,0.00725680895143758,0.236476990886278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40012,0.00352816041658454,0.00298326652794517,-0.00231904197818799,0.00937536281135707,0.236965261881237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,-0.0040416204850313,0.00342075091846181,-0.0107462922852165,0.00266305131515386,0.237425065246921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00765044412753599,0.00651856784607947,-0.00512594885077977,0.0204268371058517,0.240560972462222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.00902054455106498,0.00771068131785168,-0.00609239083192431,0.0241334799340543,0.24207192224622
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.0113451224503511,0.00970028721535519,-0.0303576853924473,0.00766744049174506,0.242193233432423
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37039,-0.0071831344242469,0.00614539271323287,-0.0192281041421833,0.00486183529368952,0.242479170361965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00921464872501991,0.00788962296072387,-0.00624901227799888,0.0246783097280387,0.242849924067542
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37056,0.00408651157632092,0.00350895392629066,-0.00279103811920876,0.0109640612718506,0.244203862792828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.00616634537484933,0.00530543153930043,-0.0165649911918782,0.00423230044217952,0.245147763326537
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40052,-0.00315500366946066,0.00273462617292968,-0.00851487096840283,0.0022048636294815,0.248630396814531
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.0100930047504462,0.00879135696909987,-0.00713805490898955,0.0273240644098819,0.250964455346561
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.00595712815571307,0.00519254197750423,-0.0161345104316214,0.00422025412019522,0.251300504498422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.00485020721117399,0.00423279236342669,-0.00344606582114232,0.0131464802434903,0.251871604903507
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00637662331669923,0.00556728100803455,-0.00453524745904848,0.0172884940924469,0.252074708300293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00845524242707011,0.00739843150711732,-0.0229561681810201,0.00604568332687984,0.253124845842092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,36991,0.00623462274349035,0.00545571986564009,-0.00445858819316423,0.0169278336801449,0.253155712924497
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.0133191511538077,0.0116594987988943,-0.0361717687996407,0.00953346649202519,0.253331546909917
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37043,0.00208292601848141,0.0018297184658476,-0.00150332217457988,0.0056691742115427,0.254979994040928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.00555327881715493,0.00488869465778797,-0.0151351203464194,0.00402856271210949,0.256001075738808
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,39889,-0.0034236700496304,0.00301428835391906,-0.00933167522331175,0.00248433512405095,0.256051518314724
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.00692339964079626,0.00609740015799307,-0.0188743039504627,0.00502750466887015,0.256200267016141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.0043031195229897,0.00379987995751536,-0.0031446451937404,0.0117508842397198,0.257472048536574
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00688907969048369,0.00608711084308734,-0.0188198169429349,0.00504165756196749,0.257760774623601
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0122056825759424,0.010807847961396,-0.00897769942839373,0.0333890645802784,0.258776431753307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,36991,-0.00856834453474015,0.00758915540423526,-0.0234430891270413,0.00630640005756097,0.258908004564522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,39985,-0.00345739025207097,0.00306546965901722,-0.00946571078374473,0.00255093027960278,0.259400013199955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.00655257704701644,0.0058188959141696,-0.0179576130387889,0.00485245894475597,0.260146422860436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.00624208649574109,0.00554555289886541,-0.00462719718603511,0.0171113701775173,0.260354237357978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00603302997202519,0.00538016798785547,-0.00451209928417154,0.0165781592282219,0.262160473208233
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00626271065987075,0.00559882864471926,-0.00471099348377901,0.0172364148035205,0.263341932274677
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39415,-0.0034550525521369,0.0030889737678541,-0.00950944113713095,0.00259933603285714,0.263365888666749
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.00624442698116801,0.00558486370784006,-0.0171907598485345,0.00470190588619851,0.263542183492087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37021,-0.00865754256709221,0.007747128632712,-0.0238419146872077,0.00652682955302331,0.263794031007418
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.00430752591472739,0.00385826941725611,-0.0118697339725494,0.00325468214309458,0.264253741896582
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39477,0.00642844862046332,0.00576395996352754,-0.00486891290805065,0.0177258101489773,0.264746176366471
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.00368978876364021,0.00332998896534595,-0.00283698960843784,0.0102165671357183,0.267861152585269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00382743267815625,0.00345588945368884,-0.0106009760073864,0.00294611065107387,0.268093635312487
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.00392959355146768,0.00355733264781036,-0.00304277843824062,0.010901965541176,0.269329391848422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37169,0.00648781274480426,0.00587892721590057,-0.00503488459836085,0.0180105100879694,0.269799291816144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00383418319532312,0.00347534762648281,-0.00297749815258319,0.0106458645432294,0.269938091231436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00534370717216515,0.00484412328059729,-0.00415077445780554,0.0148381888021358,0.269990036929145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00490518761855496,0.00449035432979065,-0.00389590686783472,0.0137062821049446,0.274684187380818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00974589085163917,0.00898622403998782,-0.0273588899700153,0.00786710826673697,0.278143592467215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,0.00270092846182389,0.00249212056306514,-0.00218362784178378,0.00758548476543157,0.27847546992994
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00629750935147802,0.00581515201968637,-0.0176952073100633,0.00510018860710726,0.278850645894707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.0104716637518824,0.00967294263708204,-0.00848730381679843,0.0294306313205631,0.279018003539056
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37311,0.0079797353568783,0.00738369217939063,-0.00649230131472734,0.0224517720284839,0.279839158813381
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00339662105982036,0.0031523621912098,-0.00278200883495084,0.00957525095459157,0.281283616257295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.00922399427630323,0.00858812680609433,-0.0260567228162481,0.00760873426364166,0.2828208908564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.00725248820535741,0.00677176045710558,-0.00602016229056953,0.0205251387012844,0.284193507360765
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.00549178634594693,0.00512814299366912,-0.00455937392164455,0.0155429466135384,0.284229035332955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00548023757716923,0.00512490195600724,-0.0155250454109434,0.00456457025660497,0.284938281890762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00431387367958132,0.00403879370745512,-0.00360216198703071,0.0122299093461934,0.285490827763454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39489,-0.00548314365053977,0.00514165789172638,-0.0155607931183235,0.00459450581724394,0.286252332858281
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37169,0.0180308142832532,0.0169236565880607,-0.0151395526293457,0.0512011811958521,0.286704915015365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00788008735428141,0.00742759638970022,-0.00667800156953102,0.0224381762780938,0.288745401341556
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00537437377350347,0.00507506972501583,-0.00457276288752756,0.0153215104345345,0.289629842252142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.00810526066407347,0.00767191255794235,-0.0231422092776405,0.00693168794949354,0.290766119192491
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00433187756415576,0.00410130957018617,-0.00370668919340914,0.0123704443217207,0.290884384104047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.0034144813278164,0.00324279030810413,-0.00294138767606769,0.0097703503317005,0.29238532095573
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,39775,0.00360186917199208,0.00342478234477138,-0.00311070422375983,0.010314442567744,0.292949751259393
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.00391958558774902,0.00372700256305031,-0.0112245106113276,0.00338533943582958,0.292968708441938
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00548011932490687,0.00522479076544781,-0.00476047057537085,0.0157207092251846,0.29425761424354
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,36962,0.00433691034787092,0.00417342450818685,-0.00384300168817531,0.0125168223839172,0.298743430189631
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0030559721430811,0.00294411980125426,-0.00271450266737725,0.00882644695353946,0.29928937785673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00683688433968436,0.00658993225302992,-0.019753151555623,0.00607938287625428,0.299533972950711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,39587,0.00501973557266344,0.00484117945383095,-0.00446897615684521,0.0145084473021721,0.299806435690391
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.00252242281216244,0.00243583072105704,-0.00225180540110936,0.00729665102543424,0.300430958866724
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.00559637184017134,0.00540586460520955,-0.0161918664663821,0.00499912278603938,0.300575443308779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00486401897384772,0.00472450184064193,-0.00439600463381046,0.0141240425815059,0.303248865731239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.00274907854578329,0.00267597584570324,-0.00799399120336163,0.00249583411179506,0.304286202779572
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00376734639273536,0.00367396908414155,-0.00343363301218208,0.0109683257976528,0.305185799480862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.00677311009535215,0.00661559977665778,-0.00619346546689709,0.0197396856576014,0.305944351465024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37056,0.0109964528990105,0.0107570416051311,-0.0100873486470465,0.0320802544450674,0.306678378803789
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00559666317417988,0.00551167599259228,-0.0163995481196608,0.00520622177130099,0.309921629567505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.00312475024006847,0.00308231715974062,-0.00291659139302315,0.00916609187316009,0.310712806975947
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.00270448018226975,0.00267476939806635,-0.0025380678379403,0.0079470282024798,0.311982838416907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37169,0.00367064068350662,0.00363533441395431,-0.00345461476784383,0.0107958961348571,0.312651660840782
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37411,0.00461731070338102,0.0045894787592919,-0.00437806766483111,0.0136126890715931,0.314402607601141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.00502341599061309,0.00500123966207869,-0.0148258457282873,0.00477901374706113,0.315187380615137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00802019494226915,0.00799617303519528,-0.0076523042067136,0.0236926940912519,0.315877261670503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00816473634626987,0.00815933894545118,-0.0241570406793542,0.00782756798681444,0.317008966676702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,39587,-0.00918053347501422,0.00920917922471904,-0.0272305247554635,0.00886945780543509,0.318833517875146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37411,-0.00387886982484308,0.0039133931295097,-0.0115491203586821,0.00379138070899593,0.321616287836092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00388667121491678,0.00394376803891485,-0.0116164565711899,0.00384311414135633,0.324385225339612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00890405206263079,0.00908475462525817,-0.0267101711281368,0.00890206700287521,0.327050208416503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40011,0.00307336275616232,0.00313976213705751,-0.00308057103247039,0.00922729654479504,0.327667724874438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00830764530534137,0.00849125519750393,-0.00833521488176632,0.0249505054924491,0.327906126511177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00363409992682014,0.00371935389202192,-0.0109240335551831,0.00365583370154283,0.328548325682441
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.00297350715992081,0.00304477168703181,-0.00894125966650315,0.00299424534666153,0.328787865434174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.00764557026308359,0.00785138868354061,-0.00774315155665601,0.0230342920828232,0.330180377052488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00680419548342704,0.00699024713200014,-0.00689668889529325,0.0205050798621473,0.330380298341233
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.00559233491527756,0.0057634709534703,-0.00570406815352422,0.0168887379840794,0.331911432511568
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37235,0.00334435798574311,0.00350403038867993,-0.00352354157606955,0.0102122575475558,0.33988237139264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.00372966763901449,0.00391071840367723,-0.00393534043219288,0.0113946757102219,0.340250982687514
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0024442688140651,0.00257009554575314,-0.00259311845561105,0.00748165608374124,0.341597269005826
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00423759315431029,0.00445778131304649,-0.0129748445278814,0.00449965821926084,0.341821975532421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.00441956739885282,0.00464990917083134,-0.0135333893736822,0.00469425457597661,0.341891566307054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00398612845058768,0.00419729451766721,-0.00424056880404006,0.0122128257052154,0.342287206404747
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,36991,-0.00413474225594846,0.00436992532917068,-0.012699795901123,0.00443031138922606,0.344073459796271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.0057900604482653,0.00612608054475254,-0.0177971783159803,0.00621705741944968,0.344600112486954
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00249977963575323,0.00264901196445701,-0.0026922838145825,0.00769184308608896,0.345355218929836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.00776102855261697,0.00822652092120072,-0.00836295245293645,0.0238850095581704,0.345485738756945
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00261248259515579,0.00279439326294558,-0.00286452820021756,0.00808949339052913,0.349852979721694
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.00815713456377979,0.008734103456681,-0.0252759773388745,0.00896170821131496,0.350351596091456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00400769484843042,0.00429407883369167,-0.00440869966560526,0.0124240893624661,0.350678458372689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.0122438197893207,0.0131633696167076,-0.0135563846594262,0.0380440242380677,0.352310808286434
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.00381963122133001,0.00412236558661176,-0.00426020532842905,0.0118994677710891,0.354170488902543
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.002268611476914,0.00244938647031133,-0.00706940895872421,0.00253218600489621,0.354360725872912
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.00333302367869881,0.00360133787132032,-0.00372559854908903,0.0103916459064866,0.354721931614554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.00762391283122365,0.00825065793177487,-0.0237952023775024,0.0085473767150551,0.35548358130237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.00446790480505449,0.0048574758745263,-0.00505274790901705,0.013988557519126,0.357694404889647
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00483644297013105,0.00526737829945921,-0.0151605044370711,0.005487618496809,0.358537310430547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37043,-0.00276194200764977,0.00301014399428339,-0.00866182423644522,0.00313794022114568,0.35887400715189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00365633197492693,0.00398850234745842,-0.00416113262609157,0.0114737965759454,0.359307216876431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00236979151750219,0.00258834974676043,-0.00270337398614825,0.00744295702115263,0.359914184919428
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0139933610760341,0.015360653787461,-0.0441002424994577,0.0161135203473896,0.362315730945967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,39866,0.00311600037622259,0.00343912853733924,-0.00362469155696232,0.0098566923094075,0.364926418037342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00552731376057059,0.00611135484562219,-0.0175055692579901,0.0064509417368489,0.365782236198998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTN,Titin,37021,-0.00631887264010862,0.00700369381820348,-0.0200461125237874,0.00740836724357019,0.366956523420957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37039,-0.00689965162192512,0.00769407046851064,-0.021980029740206,0.00818072649635573,0.369869134862569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.00528191704746908,0.0058922577625883,-0.0168307422621421,0.00626690816720398,0.370046830790351
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00326217207633735,0.00364337552597723,-0.00387884395457803,0.0104031881072527,0.370604775353806
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0156320363921126,0.0175055312045955,-0.0186788047688946,0.0499428775531198,0.371883118768928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.0077957963668539,0.00875466734459951,-0.00936335162856115,0.0249549443622689,0.373228184243661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.00582761949088509,0.00656054487429185,-0.00703104846272693,0.0186862874444971,0.374401939743851
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.0056038570299773,0.00636101121647453,-0.0180714390142674,0.00686372495431278,0.378350438926413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.00396470731320433,0.00450299490598998,-0.0127905773289447,0.00486116270253603,0.378623332709978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.00641285481128888,0.00728751393851449,-0.0206963821307773,0.00787067250819953,0.378887059801313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00302822098953072,0.00344942659642058,-0.00373265513945361,0.00978909711851506,0.380018810557293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00820551299995984,0.00941113341948475,-0.0102403085022303,0.02665133450215,0.383282018816575
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37056,-0.0043039434167098,0.00494682192996776,-0.0139997143994466,0.00539182756602701,0.384293214638333
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,39892,-0.00394473976068563,0.00456363286762531,-0.0128894601812312,0.00499998065985998,0.387388885641541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,39587,-0.00415405599788704,0.00481692650423917,-0.0135952319461958,0.00528711995042173,0.388487604272777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,36991,-0.00567190258163109,0.00658433966538115,-0.0185772083257781,0.00723340316251595,0.389020762846524
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.00964955484584991,0.0112246874801129,-0.0316499423068711,0.0123508326151713,0.389985229521061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37039,-0.00309479241014707,0.00360011191860242,-0.0101510117706078,0.00396142695031368,0.39000434922932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,39587,0.00678659925443013,0.0079062333583086,-0.00870961812785473,0.022282816636715,0.390692491336886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00800706314265244,0.00934964015015539,-0.0103182315516521,0.026332357836957,0.391790374893544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,39908,0.00267579978568672,0.00312682348818443,-0.00345277425115477,0.0088043738225282,0.392145211237291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00260765110098893,0.00308180234216362,-0.00864798369162962,0.00343268148965177,0.397484613627674
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.00358036082130911,0.00424365417030945,-0.00473720135249741,0.0118979229951156,0.398853704772574
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39524,-0.00401777185601688,0.00478877777740884,-0.0134037762997382,0.00536823258770444,0.401483601167477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,36991,0.00664352473632798,0.00794514807793551,-0.00892896549642562,0.0222160149690816,0.403072345548047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.00446016917307101,0.00534588250333167,-0.0149380988796011,0.00601776053345906,0.404116451292249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37388,0.0025820832743903,0.00309781139763383,-0.00348962706497201,0.0086537936137526,0.404567054861183
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.00337266016351738,0.00404653496930098,-0.0113038687033473,0.00455854837631254,0.404595107526211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37021,0.00548184729452541,0.00659466796118193,-0.00744370190939117,0.018407396498442,0.405844963539189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.00890433902030629,0.0107956377954756,-0.0300637890994385,0.0122551110588259,0.40949502918642
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.00367777842736601,0.00446450099413707,-0.0124282003758747,0.00507264352114264,0.410077833286458
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00646729841824086,0.00801737027805371,-0.0221813441632261,0.0092467473267444,0.41987648383219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39489,-0.00309042079934818,0.0038341069439842,-0.0106052704095572,0.00442442881086085,0.4202354721708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.0050433002276992,0.00628793070963229,-0.0173676444185785,0.00728104396318009,0.422530406308431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00430801405713105,0.00541204697189165,-0.0149156261220387,0.00629959800777658,0.426043807802949
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,36991,-0.0073841659418671,0.00928174286936027,-0.0255763819658132,0.010808050082079,0.426303295269892
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00619583971651628,0.00779836763370371,-0.00908896084554299,0.0214806402785755,0.426916034226579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.00445294385133623,0.00561536519686999,-0.0154590596372014,0.00655317193452894,0.427796378341143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00440076956508376,0.00556661156323524,-0.0153113282290248,0.00650978909885731,0.429212050944263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37437,0.00234105497303687,0.00297675061033608,-0.00349337622322185,0.00817548616929559,0.431619701271059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.00395437826327244,0.0050532259934732,-0.0138587012104799,0.00594994468393504,0.433906028536332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,39587,0.00389709795297426,0.00498118504760613,-0.00586602474033375,0.0136602206462823,0.434012688266017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00240142389622622,0.00307454158726289,-0.00362467761480904,0.00842752540726148,0.4347746699402
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37411,-0.0017083248182765,0.00221577051008856,-0.00605123501805007,0.00263458538149707,0.44072953470837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,36962,0.00560519385533168,0.00730220689397581,-0.00870713165686091,0.0199175193675243,0.442737080205815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.00512216060694659,0.0067107648636428,-0.0182752597396865,0.0080309385257933,0.445310719193418
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,-0.00692280394804382,0.0091447577859476,-0.0248465292085011,0.0110009213124135,0.449046412677462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.00215554224889652,0.00288466952953708,-0.00349841002899615,0.0078094945267892,0.454929602488454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.00555191215306852,0.00745079178285922,-0.0201554640474726,0.00905163974133555,0.456198060655104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00433614210108083,0.00582324996526452,-0.0157497120329993,0.00707742783083763,0.456508897867084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37056,0.00450943014556207,0.00608810910294584,-0.00742326369621177,0.0164421239873359,0.458891752688989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37351,-0.00381118703102852,0.00515846384287505,-0.0139217761630636,0.00629940210100658,0.460027890155551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.00228590192412431,0.0031156424674194,-0.00839256116026635,0.00382075731201772,0.463151332399777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,-0.00267143769151137,0.00365699276343466,-0.00983914350784331,0.00449626812482057,0.465094746429849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39477,0.0122504519308733,0.0167856625479378,-0.0206494466630848,0.0451503505248314,0.465513360531288
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37021,-0.00362290696505864,0.00499320477657629,-0.0134095883271482,0.00616377439703089,0.468116869377438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.00269985684257877,0.00377854373213828,-0.0101058025575698,0.00470608887241226,0.474916422705797
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37056,-0.00295892775082202,0.00417049885317717,-0.0111331055030493,0.00521525000140524,0.478032913067667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-0.00404654870122114,0.00571492567512111,-0.0152478030244585,0.00715470562201624,0.4789164185718
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00435838623845096,0.00615675894411029,-0.00770886129200521,0.0164256337689071,0.479018189788923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.00491919483261067,0.00695764934624332,-0.00871779788602623,0.0185561875512476,0.479566764781748
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.00376053855126862,0.00531943357907567,-0.0141866283662569,0.0066655512637197,0.47961211543416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37368,0.00360566264205563,0.00510942597499773,-0.00640881226893991,0.0136201375530512,0.480394105602688
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00333926510736952,0.00474235730713412,-0.0126342854293524,0.00595575521461335,0.481360461795875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37021,0.00439081695125043,0.00624225192204973,-0.00784399681596703,0.0166256307184679,0.481817257904312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.00212492419153225,0.00302633194827994,-0.00805653481016093,0.00380668642709644,0.482598882597216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00489514421660395,0.00697903464294184,-0.00878376368356206,0.01857405211677,0.483061277089606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00719002352803455,0.0102548346012214,-0.0272894993464285,0.0129094522903594,0.483231161620343
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00533069118305707,0.00761731881400853,-0.00959925369239964,0.0202606360585138,0.484056945327367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.00335680147779089,0.00481180588298602,-0.0060743380528617,0.0127879410084435,0.485428564704841
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,39749,-0.00298374718061438,0.00429015984188696,-0.0113924604707128,0.00542496610948406,0.486760796536353
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,36818,-0.00276049554244294,0.00400828198837488,-0.0106167282396577,0.00509573715477182,0.491025703593777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,-0.00404751100451181,0.00592297316581329,-0.0156565384095059,0.00756151640048224,0.494392719636133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-0.00591488565051182,0.00866358370953313,-0.0228955097211968,0.0110657384201731,0.494787796755501
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37368,-0.00767073422088832,0.0112411192311581,-0.0297033279139581,0.0143618594721815,0.495009315718945
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00461856685260558,0.0068017219105954,-0.00871280809216141,0.0179499417973726,0.497131441977875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,39587,-0.00232245253146963,0.00345645818158646,-0.0090971105673791,0.00445220550443983,0.501646495716361
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00236177902612958,0.00351793915986562,-0.00453338172720703,0.00925693977946619,0.502007327156894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,0.00324444395069696,0.00484373803689836,-0.00624928260162383,0.0127381705030177,0.502982785277085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,-0.0127429222917755,0.0190658768909909,-0.0501120409981176,0.0246261964145667,0.503911731600547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,-0.00167664606782738,0.00251631221510248,-0.00660861800942825,0.00325532587377348,0.505222053623658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.00350936243156792,0.00527986919692036,-0.00683918119439598,0.0138579060575318,0.506274228425859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.0034464128113671,0.00520203490944943,-0.00674957561115378,0.013642401233888,0.507654469861417
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00254491251337275,0.00384846061135766,-0.0100878953116338,0.00499807028488827,0.508442039169194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,39587,-0.00263674761386056,0.00399325423707814,-0.0104635259185337,0.0051900306908126,0.509070704802479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.00231798435317241,0.0035510881652465,-0.00464214845071072,0.00927811715705555,0.513926473226286
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37348,-0.00386821114324457,0.00593732622756371,-0.0155053705492694,0.0077689482627803,0.514730192087594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00254818643609829,0.00393723761504704,-0.0102651721615905,0.0051687992893939,0.517512756241699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,36991,-0.00314495108257804,0.00486560812323799,-0.0126815430041245,0.00639164083896841,0.518055324259399
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.00419981734369774,0.00651695100823165,-0.00857340663243629,0.0169730413198318,0.519298109360055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.00947838994992579,0.0147304928136231,-0.038350155864627,0.0193933759647754,0.519941016999413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00387264726947041,0.00602776817317208,-0.0156870728888877,0.00794177834994687,0.52058064754973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37382,0.0166205027277429,0.0259949353476277,-0.0343295705536073,0.0675705760090932,0.522590066143477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00407942124348515,0.00639300515546251,-0.00845086886122136,0.0166097113481917,0.52341514232242
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00368041687921706,0.00576908602829067,-0.0149878254946668,0.00762699173623265,0.523514167549444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37039,-0.00459620415925714,0.00720731870161055,-0.0187225488144138,0.00953014049589953,0.523671299960145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00169784601221416,0.00267140556711272,-0.00353810889932678,0.00693380092375509,0.525072441016794
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37056,-0.00206796051972883,0.00328627736724669,-0.00850906415953234,0.00437314312007468,0.529182253307485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,39749,0.00226357744910097,0.00359980116155463,-0.0047920328275461,0.00931918772574803,0.529484950722226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,39858,0.0120353772648068,0.0192836840183051,-0.0257606434110713,0.0498313979406848,0.532556167780031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00356787104132268,0.005763055162078,-0.0077277170763502,0.0148634591589956,0.535865385316405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00217476534815752,0.00351444752258756,-0.00906308249242915,0.0047135517961141,0.536052419675816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.00171442374777201,0.0027839472513916,-0.00374211286495552,0.00717096036049954,0.538018816390371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37056,0.00553479426373989,0.0090088829994074,-0.0121226164150986,0.0231922049425784,0.538980947545205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00411923059230137,0.00673597414695745,-0.00908327873573524,0.017321739920338,0.540861142354405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37056,-0.00291093359049766,0.00477679591801294,-0.012273453589803,0.00645158640880771,0.542276188981964
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37368,-0.00232950488230898,0.00385433072989598,-0.00988399311290509,0.00522498334828714,0.54559695944236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00350804031094108,0.00590533938243294,-0.0150825055005096,0.00806642487862748,0.552490282924231
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.0025196824900704,0.00426058651506382,-0.00583106707945468,0.0108704320595955,0.554266945761788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,36962,0.00275886144841837,0.00467258624510923,-0.00639940759199573,0.0119171304888325,0.554908806218212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.0013151885570496,0.00223018863311843,-0.00305598116386252,0.00568635827796172,0.555387965012506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.00459553172183077,0.00792497296367534,-0.0109374152869729,0.0201284787306344,0.562005320817858
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,-0.00461662416340037,0.00798316855495482,-0.0202636345311118,0.0110303862043111,0.563073445188704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00234561231824564,0.00406649314591282,-0.0103159388842348,0.00562471424774349,0.564074620726668
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.0029845719496596,0.00520201886581028,-0.00721138502732855,0.0131805289266478,0.566158029538017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00565571053192033,0.00985915223471779,-0.0249796489119672,0.0136682278481265,0.566213955114158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,36868,-0.00254700992380165,0.00446928578088126,-0.0113068100543289,0.00621279020672562,0.56876083678136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.00447906163383061,0.00786935476341965,-0.0199029969701331,0.0109448737024719,0.569245206476472
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,39587,0.00303336324653035,0.00537756352011724,-0.00750666125289945,0.0135733877459601,0.572709349997249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,-0.00318504849780971,0.00565161287853363,-0.0142622097397356,0.0078921127441162,0.573058433984757
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00277964514701088,0.00495456012853247,-0.0124905829989345,0.00693129270491276,0.574788237232005
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39477,0.00537573726019269,0.00960408409251161,-0.0134482675611301,0.0241997420815155,0.575668570444869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00227115801287043,0.00405961456087551,-0.00568568652644557,0.0102280025521864,0.575863032972879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00254269414758707,0.00454602702216486,-0.00636751881585606,0.0114529071110302,0.575951073323372
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,0.00276219178111336,0.00495907480581718,-0.00695759483828831,0.012481978400515,0.577538663170383
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.00336331644833934,0.00609319927226678,-0.0153059870219822,0.00857935412530354,0.580972051888891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00152620905101244,0.0027671888925117,-0.00694989928033538,0.00389748117831049,0.581272793842968
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.00195710032865112,0.00356769465866957,-0.00894978185964348,0.00503558120234123,0.583315351706037
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,-0.00188358885425423,0.00346673751546874,-0.00867839438457296,0.00491121667606451,0.586908860521311
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37437,0.0024613853803762,0.00455245085863449,-0.00646141830254739,0.0113841890632998,0.588742146379766
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00277594773461301,0.00513550170810792,-0.00728963561327851,0.0128415310825045,0.588833341732218
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.0142894668041801,0.0264875795604,-0.0376261891342039,0.0662051227425641,0.589566175012711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37169,0.00324561428606614,0.00603919189765951,-0.00859120183334649,0.0150824304054788,0.590982882773641
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37021,-0.00206257336166757,0.00384431889237416,-0.00959743839072092,0.00547229166738577,0.591604800958544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.00318225391472538,0.0060140244668472,-0.00860523404029514,0.0149697418697459,0.59671805069331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,39587,0.00151322763785065,0.00286943502979284,-0.00411086502054332,0.00713732029624461,0.597950478379177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00212797343088585,0.00403830506848166,-0.0100430513651099,0.00578710450333821,0.598239057970263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39489,-0.00254165214196575,0.00483135793230452,-0.0120111136892826,0.00692780940535112,0.598844207002658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.00344352717152647,0.00655033979524082,-0.00939513882714553,0.0162821931701985,0.599102685680866
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00180464636142964,0.00343380194945775,-0.00492560545950756,0.00853489818236683,0.599207126432141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.00179142620622979,0.00343467316133499,-0.00852338560244637,0.00494053318998679,0.601977776848838
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.00265378652662328,0.00512533517758446,-0.00739187042144227,0.0126994434746888,0.604621812465709
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.00149632485903397,0.00289297112263647,-0.00716654825940145,0.00417389854133352,0.605004372121866
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.00901317604407054,0.0174429721991786,-0.0251750494663195,0.0432014015544606,0.605358344128125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.00142867502406807,0.00277274479630868,-0.00400590477669695,0.00686325482483308,0.606382372480492
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.0027787294764622,0.00544726685608709,-0.00789791356146849,0.0134553725143929,0.609978448772273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00263352186881975,0.00523917004661096,-0.0129022951601772,0.00763525142253772,0.615211648610308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00259922701897733,0.00520026324101102,-0.00759328893340426,0.0127917429713589,0.6172058528142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.00238648856637113,0.00480115910684257,-0.00702378328304031,0.0117967604157826,0.619150256516365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00202611164422267,0.00408744956349332,-0.0100375127886696,0.00598528950022423,0.62012078828998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37437,-0.00131786775953491,0.00268476297534662,-0.00658000319121429,0.00394426767214446,0.623526815526123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.00134325718235664,0.00274109646354593,-0.00671580625090666,0.00402929188619338,0.624110860878004
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00243932792855424,0.00499315099859598,-0.0122259038858024,0.00734724802869389,0.625177908657414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00283614685538749,0.00582381504790803,-0.0142508243492872,0.00857853063851224,0.626272607562659
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,0.0041664536745894,0.0085721637467671,-0.0126349872690741,0.0209678946182529,0.626943447468477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.00112953117097773,0.00233011655380967,-0.00569655961644468,0.00343749727448923,0.627859488558776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,-0.00132592452010581,0.00274239638190913,-0.0067010214286477,0.00404917238843608,0.628754817973514
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37437,-0.00231987156275825,0.0048028008135127,-0.0117333611572431,0.00709361803172664,0.62908596602256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,-0.00175645764533447,0.0036561317689756,-0.00892247591252665,0.0054095606218577,0.630940662346526
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-0.00171639974851544,0.0036111109752424,-0.00879417725999054,0.00536137776295965,0.634573398413637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.00286773068756276,0.00603538484946704,-0.00896162361739264,0.0146970849925182,0.634685889847011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.00245597212865027,0.00517753378897792,-0.012603938355047,0.00769199409774646,0.635256975668957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,0.00110465536856675,0.00234207891149978,-0.00348581929797282,0.00569513003510633,0.637178797010142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.00313925976183459,0.00665625651286598,-0.00990700300338274,0.0161855225270519,0.637200723031349
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00255762142221473,0.0054277182564688,-0.0131959492048936,0.00808070636046411,0.637495041613996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37169,-0.00412109131724545,0.00899919833135805,-0.0217595200467072,0.0135173374122163,0.647003149528556
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,0.00352313550212305,0.00769705200295269,-0.0115630864236642,0.0186093574279103,0.647157376548253
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37056,-0.0021693674621391,0.00479925421502277,-0.0115759057235837,0.00723717079930553,0.651260717370026
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.00354848472059084,0.00787993499940341,-0.0118961878782398,0.0189931573194215,0.6524878505381
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,39749,-0.00658636128273231,0.0147763007906029,-0.0355479108323141,0.0223751882668494,0.65579246193534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00329019004654648,0.0074108659967226,-0.0178154874001228,0.0112351073070298,0.657072772957032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,-0.00219946949453163,0.00501464218615737,-0.0120281681794001,0.00762922919033681,0.66095174175138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39477,-0.001745061208744,0.00406173572475961,-0.00970606322927283,0.00621594081178482,0.667467569497065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.00365343758756602,0.00851625578198389,-0.0203452989202545,0.0130384237451224,0.667933345052692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,-0.00174745464523313,0.00409013396185076,-0.00976411721046062,0.00626920791999437,0.669214048427147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.00240480698838606,0.00568725246184979,-0.0135518218136116,0.00874220783683952,0.672416447967698
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,39858,0.00217524457573147,0.0051967125990922,-0.00801031211848924,0.0123608012699522,0.675528078456274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00174176620097365,0.00417995397405731,-0.00993447599012598,0.00645094358817868,0.676908258771171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.00441589865103699,0.0106124828332253,-0.0252163650041586,0.0163845677020846,0.677340534307092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.00167345148633845,0.00404375538686296,-0.00959921204458985,0.00625230907191295,0.678999908057154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,36962,0.00335578312026132,0.00814228847578234,-0.0126031022922721,0.0193146685327947,0.680241722833119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.0023949520080046,0.00586812891823878,-0.00910658067174341,0.0138964846877526,0.683185636633873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37039,0.00190374691272524,0.00473481252117996,-0.00737648562878748,0.011183979454238,0.687635791414561
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.00173530558186886,0.00439031190465566,-0.00686970575125624,0.010340316914994,0.692658943413579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00157977513812129,0.00404642876170041,-0.00635122523481151,0.00951077551105409,0.696237907802938
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.00266230846981632,0.00681925652127629,-0.0160280512515178,0.0107034343118852,0.696239430000914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,36991,0.00194440395511289,0.00499084788542664,-0.00783765790032332,0.0117264658105491,0.696843172486494
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.00291326548530402,0.00749830240813344,-0.0176099382052456,0.0117834072346375,0.697635000996127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,39992,0.00167807144068595,0.00431913104207596,-0.00678742540178293,0.0101435682831548,0.697635929923599
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37169,0.00203458646343377,0.00526830742908397,-0.00829129609757081,0.0123604690244384,0.699359487512936
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37388,-0.00281788143778883,0.00742454360004732,-0.0173699868938816,0.0117342240183039,0.704295847942887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,-0.00178044910537655,0.00475039754415322,-0.0110912282919169,0.00753033008116377,0.707815236743613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.0018660711401929,0.00498315499146172,-0.0116330549234579,0.00790091264307206,0.708056376789654
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,0.00208213409913605,0.00557268313256661,-0.00884032484069451,0.0130045930389666,0.708683902237736
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.00292762612368259,0.00787611993337982,-0.0125095689457419,0.018364821193107,0.710115302883143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.00196741871347556,0.00529891514512747,-0.00841845497097429,0.0123532923979254,0.71042969903173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37161,0.00369452267642106,0.0100314436221107,-0.015967106822916,0.0233561521757581,0.712659724978957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.0043657726733109,0.0119604518892382,-0.0278082583762178,0.019076713029596,0.715104320042885
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37056,0.00183307193604808,0.00503751324105374,-0.00804045401641726,0.0117065978885134,0.715950245079609
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40030,-0.000923716534511258,0.00253928222369,-0.00590070969294366,0.00405327662392114,0.716033981320818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0030848015557997,0.00854071814761881,-0.0198246091251326,0.0136550060135332,0.717965029032059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00191187171316607,0.00529738798229496,-0.0122947521584642,0.00847100873213205,0.718173723848012
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.00121386672572053,0.00336737843548618,-0.00781392845927345,0.00538619500783239,0.718495285319155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,39585,-0.00260772229234741,0.0072576423691824,-0.0168327013359449,0.0116172567512501,0.719370202395053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.00232764962433226,0.00649135458034575,-0.0150507046018099,0.0103954053531454,0.719917338257169
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,39585,-0.0011834919678884,0.00330306624156055,-0.00765750180134708,0.00529051786557028,0.720122872553877
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37388,-0.00186240692160678,0.00520200097744174,-0.0120583288373926,0.00833351499417903,0.720335869833236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00154908012476293,0.00434311293095646,-0.00696342121991174,0.0100615814694376,0.721340786059819
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37039,-0.0017621871400806,0.00494644976225836,-0.011457228674107,0.00793285439394579,0.721656871215512
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,0.00234024868970983,0.00661625801162564,-0.0106276170130764,0.0153081143924961,0.723560475929503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00147365486976107,0.00418469281008982,-0.00672834303801499,0.00967565277753712,0.724728660166787
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,-0.00150138851645237,0.00427023048335137,-0.00987104026382107,0.00686826323091632,0.725148226362756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.00128364275870159,0.003728822159156,-0.00602484867324417,0.00859213419064735,0.730664636517488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00238387532018578,0.00697514326171324,-0.0160551561131437,0.0112874054727722,0.732531476541773
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00168872183192068,0.0049898338247637,-0.00809135246461618,0.0114687961284575,0.735042692996064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37249,-0.00108385488468112,0.00320578693640126,-0.00736719728002759,0.00519948751066536,0.735298227223141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00276366099707542,0.00818237603621338,-0.0188011180280536,0.0132737960339028,0.735551123613662
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37388,-0.00299535432078966,0.00891083874122458,-0.0204605982535898,0.0144698896120105,0.736765010100953
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00159675376047956,0.0047593091035577,-0.0109249996034527,0.00773149208249354,0.737252424062798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00266868872917529,0.00805265974794218,-0.0131145243767914,0.018451901835142,0.740343982526431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00187808184000398,0.00568477011074426,-0.0130202312570627,0.00926406757705477,0.741125081589787
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,-0.00134177354069058,0.00408560041776891,-0.00934955035951764,0.00666600327813647,0.742601999967657
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00132720663820733,0.00406838265276729,-0.00664682336121656,0.00930123663763123,0.744259592429442
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,38832,0.00160011207086429,0.00490588987564673,-0.00801543208540331,0.0112156562271319,0.74430677800012
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,39585,-0.00089826559551869,0.00278313311868195,-0.00635320650813532,0.00455667531709794,0.746886320369706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37437,-0.00257626847225031,0.00801922850559995,-0.0182939563432262,0.0131414193987256,0.748017260538428
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,-0.00115152622036701,0.00365863170366772,-0.00832244435955574,0.00601939191882173,0.752962157269064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.0031653499289898,0.0103727406419407,-0.0234959215871936,0.017165221729214,0.760248039794368
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40030,0.000900297682487883,0.00295743117753069,-0.00489626742547227,0.00669686279044803,0.76081275583017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00121696580630353,0.00403103538062484,-0.00668386353972116,0.00911779515232821,0.762733650512671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,39587,-0.00152373176494903,0.00505042856988117,-0.0114225717619161,0.00837510823201805,0.762882120940077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.00179450825526428,0.00598755778743982,-0.0135301215186463,0.00994110500811776,0.764405107891685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.0013928079599934,0.0046792351389339,-0.0105641088323038,0.00777849291231703,0.765969509980655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.00120592275431576,0.00419295549441742,-0.00701227001474238,0.00942411552337389,0.773652217047689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,39587,-0.00140975797729438,0.00497301218688034,-0.0111568618635798,0.00833734590899108,0.776811334889691
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37056,0.00126242714542319,0.00446981891453892,-0.0074984179270731,0.0100232722179195,0.777615466892202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00241344641380542,0.0086135651966243,-0.019296034199189,0.0144691413715782,0.77933510455314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37411,-0.00100077342080968,0.00361054421281235,-0.0080774400779219,0.00607589323630253,0.78164553353862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00166032452826009,0.00599530849909867,-0.0100904801299733,0.0134111291864935,0.781832612690274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,-0.000496985034150232,0.00180269773156665,-0.00403027258802087,0.0030363025197204,0.782790667426523
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,0.00269581030348603,0.00979755347520761,-0.0165073945079209,0.0218990151148929,0.783204251050973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.00108655431079645,0.00406261193753356,-0.00904927370836223,0.00687616508676932,0.789125258556555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.00113081034686553,0.00427431826742016,-0.00950847415100904,0.00724685345727799,0.791353067851821
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.00173937423642116,0.00661371377548849,-0.0112235047635363,0.0147022532363786,0.792558476280129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.000594132624465874,0.0022707490172017,-0.00504480069818122,0.00385653544924947,0.793597670347594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,0.00204704931192167,0.00782674568003541,-0.0132933722209477,0.0173874708447911,0.793675920079351
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,39866,0.00153421448966856,0.00589563776101312,-0.0100212355219171,0.0130896645012543,0.794690670208608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,0.000462201645201541,0.00179393510721094,-0.00305391116493189,0.00397831445533498,0.796682816989046
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.00107844967551137,0.00419941300023706,-0.00930929915597601,0.00715239980495327,0.79732965697759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40052,-0.0010655859802188,0.00417382726529143,-0.00924628742018999,0.00711511545975239,0.798493184629942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37056,-0.000768667526459841,0.00303102432113122,-0.00670947519587704,0.00517214014295736,0.799808608974634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.0016433457343938,0.00649361881724488,-0.0110841471474062,0.0143708386161938,0.800217422541089
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00140895829011624,0.0055801066050877,-0.00952805065585565,0.0123459672360881,0.800660493827736
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.000907245956740001,0.00362362998887168,-0.00800956073492849,0.00619506882144849,0.802304895600257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,-0.000698496767218572,0.00284518033620133,-0.00627505022617317,0.00487805669173603,0.806071766911329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37039,0.00104818396428539,0.00429155439933219,-0.0073632626584057,0.00945963058697648,0.807046095613717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,-0.000464921626267563,0.0019078842885014,-0.00420437483173031,0.00327453157919518,0.807478938467797
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,0.00100611829659585,0.00414072949008931,-0.00710971150397919,0.0091219480971709,0.808023916064341
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37039,-0.000556386594264962,0.00232064775620007,-0.0051048561964171,0.00399208300788718,0.810524026050016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.000769771333048075,0.00325131273117599,-0.00714234428615301,0.00560280162005686,0.812848288861486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00104626552041478,0.0044298787679464,-0.00763629686476016,0.00972882790558972,0.813293641022081
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,39585,0.00255516598786101,0.0110133772675728,-0.0190310534565818,0.0241413854323038,0.816536627817094
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.000692274278377639,0.00298935560401942,-0.00516686270550042,0.0065514112622557,0.816867912787165
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00273610410830276,0.0118621893768195,-0.0259859952868691,0.0205137870702636,0.817584402381031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.000682718364222787,0.00299165460240209,-0.00654636138493089,0.00518092465648532,0.819487722742014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37368,0.000643657064884936,0.00283767446355788,-0.0049181848836885,0.00620549901345837,0.820562829449636
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37445,0.000576838856167939,0.00262855113643562,-0.00457512137124587,0.00572879908358175,0.826301841153572
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.000787893146147284,0.00361403570492303,-0.00787140312779643,0.00629561683550186,0.827425322024294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,-0.000710712049802159,0.00326148776692637,-0.00710322807297784,0.00568180397337352,0.827501764237548
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,36991,-0.00103122532990632,0.00480503261879395,-0.0104490892627425,0.00838663860292983,0.830071925389534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00277934170176479,0.0129650523322802,-0.0226321608695044,0.0281908442730339,0.830259923902854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-0.000486301273639086,0.00230966809484025,-0.00501325073952598,0.0040406481922478,0.833240859416623
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.00133671309097353,0.00637936361992219,-0.011166839604074,0.013840265786021,0.834032251754889
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.000847973166597072,0.00405178558158013,-0.00709352657329999,0.00878947290649413,0.834229920575775
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.000430619154499196,0.00205863963480297,-0.00360431452971462,0.00446555283871301,0.834313062266517
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37056,-0.000558464573738859,0.00267259420588428,-0.00579674921727204,0.00467982006979432,0.834482897810238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39477,-0.00188825794564122,0.00903752028540458,-0.0196017977050342,0.0158252818137518,0.834501391207342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37039,-0.00129132756636332,0.00618122206070392,-0.013406522805343,0.0108238676726164,0.834520657077985
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37169,0.000888058331433453,0.00428439525449621,-0.00750935636737913,0.00928547303024604,0.835796390147401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00075402773687645,0.00369707925663471,-0.00649224760612758,0.00800030307988048,0.838393854181413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,-0.00073183384773428,0.00359721165774435,-0.0077823686969132,0.00631870100144464,0.838790003034835
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37056,-0.00132770270629462,0.00652937655078887,-0.0141252807458408,0.0114698753332516,0.838870120747573
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000665035485114078,0.00329344120461597,-0.00712018024616138,0.00579010927593323,0.839976743012499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.000563168154410818,0.00286062321743508,-0.00616998966058358,0.00504365335176195,0.843932509368217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,0.000512588707540523,0.00261249989692155,-0.00460791109042571,0.00563308850550676,0.844451702915894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37380,0.00091743982367596,0.00478650937496396,-0.0084641185512534,0.0102989981986053,0.848002018654961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,39587,-0.00270678887182673,0.0147197599423083,-0.031557518358751,0.0261439406150975,0.854103601398846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00125005226927156,0.00700208536157298,-0.0149741395779546,0.0124740350394115,0.858312871437704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.000884060474784047,0.00499141996210839,-0.0106672436005165,0.0088991226509484,0.859419990687664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-0.000759400277102491,0.00428942706356207,-0.00916667732168414,0.00764787676747916,0.859479674553119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37437,-0.000766541531953666,0.0043974407637491,-0.00938552542890191,0.00785244236499458,0.861620216424732
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00134881842237302,0.0080420326255837,-0.0171112023685171,0.014413565523771,0.866805257562071
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.000635642451875686,0.003795990242565,-0.00680449842355172,0.00807578332730309,0.867017348948103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39489,-0.000897540141116264,0.00537671110887656,-0.0114358939145143,0.00964081363228179,0.867426445008428
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.000763493114465995,0.00474289194893382,-0.0085325751054443,0.0100595613343763,0.872114094401716
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-0.000913360564245543,0.00580817789670132,-0.0122973892417801,0.010470668113289,0.875046910789869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.000846968572038354,0.00549920729322372,-0.00993147772268014,0.0116254148667568,0.877599036757853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37437,-0.00134721603644415,0.00923007738868567,-0.0194381677182681,0.0167437356453798,0.883955650657204
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37056,0.00112720010534092,0.00782684587116955,-0.0142134178021514,0.0164678180128333,0.885489119236055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,-0.0010008976259259,0.00711869835294174,-0.0149535463976917,0.0129517511458399,0.888186738580262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00056563959393822,0.00406872813186967,-0.00854034673240277,0.00740906754452633,0.889435444403642
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,0.000634713360773208,0.00459816051063708,-0.00837768124007547,0.00964710796162189,0.890213766083348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.00121387070913106,0.00887455517623335,-0.0161802574362863,0.0186079988545484,0.891205988071014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,36962,-0.000833031507226512,0.0062407285663301,-0.0130648594972335,0.0113987964827805,0.893813415466166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,-0.000783555034725545,0.0059925973328345,-0.0125290458070812,0.0109619357376301,0.895972026272593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.000396283802681302,0.00305237403353235,-0.00637893690840471,0.00558636930304211,0.8967043881727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,36962,0.000697428869504875,0.00543390348449562,-0.00995302196010653,0.0113478796991163,0.897875809070275
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,39913,0.00049634204807468,0.00386899139754914,-0.00708688109112164,0.008079565187271,0.897923306479806
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,39903,-0.00069560550793522,0.0055789584516629,-0.0116303640731945,0.0102391530573241,0.900775478096532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,36903,0.000430517826771123,0.00351050926215047,-0.0064500803270438,0.00731111598058604,0.902396555524692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00140836022575551,0.0118252570750212,-0.024585864092797,0.021769143641286,0.90519982529582
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37039,0.000814244132150033,0.00690368021422237,-0.0127169690877258,0.0143454573520259,0.906114231787472
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.000489078778289633,0.00429940403630498,-0.0089159106894474,0.00793775313286813,0.909433714281593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.000816702884413775,0.00764213764877657,-0.0157952926760159,0.0141618869071883,0.914894736317237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.000346737859267093,0.00338586928844062,-0.0069830416646107,0.00628956594607652,0.918434878254933
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.000506468735237786,0.00502821704330558,-0.0103617741401167,0.00934883666964116,0.919770051023766
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37056,0.000651641306092374,0.00647170715322117,-0.0120329047142211,0.0133361873264059,0.919797452395686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.000377019528491546,0.00374573498732285,-0.00696462104666124,0.00771866010364434,0.919827154364185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,-0.000257175876568373,0.00255947351994868,-0.00527374397566778,0.00475939222253103,0.919964750824783
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.000631029383922455,0.00643247286934177,-0.0132386762078323,0.0119766174399874,0.921853910431448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.000310923349395114,0.00327105890939527,-0.00610035211301962,0.00672219881180985,0.924274321674101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37021,-0.000496941882854381,0.00527541976070232,-0.0108367646138309,0.00984288084812216,0.924952119085583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,-0.000641538798605634,0.00700502575850009,-0.0143713892852658,0.0130883116880546,0.927031029612135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.000278927141575863,0.00320397587150345,-0.00600086556657091,0.00655871984972263,0.930627664537179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00052529023575097,0.00611346741102452,-0.012507686361359,0.0114571058898571,0.931528559386239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,39830,0.000681016931529601,0.00805860889159427,-0.0151138564959952,0.0164758903590544,0.93265360067587
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.000385961176235078,0.00504426702221745,-0.00950080218731113,0.0102727245397813,0.939010690690445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,-0.00114184274295778,0.0149268070265087,-0.0303983845149148,0.0281146990289993,0.939025536627651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,0.00100853442074109,0.0137613107274928,-0.0259636346051448,0.027980703446627,0.941578281593944
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.000678967990901775,0.00931759104381829,-0.0189414464367856,0.0175835104549821,0.941911087178868
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.000287121484758994,0.00399352679306003,-0.00811443399915666,0.00754019102963867,0.942685191419342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,39866,0.000277843851447494,0.00394847142173347,-0.0074611601351501,0.00801684783804509,0.943902080039269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.000438757827217274,0.00626774245674341,-0.0127235330424343,0.0118460173879998,0.944192682436473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.000593190595438454,0.00860002454382234,-0.0162628575104533,0.0174492387013302,0.945010194223017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,36991,-0.00025847172129402,0.0038913120969431,-0.0078854434313025,0.00736849998871446,0.947042255077519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-0.000390985584173078,0.00597894850639474,-0.0121097246567068,0.0113277534883606,0.947861356905248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37039,-0.000268133111494945,0.00436116237262715,-0.00881601136184416,0.00827974513885427,0.95097625841144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,-0.000225302413459206,0.00368266159496308,-0.00744331913958684,0.00699271431266843,0.951217232280014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.000163569296427477,0.00268889788155156,-0.00510667055141358,0.00543380914426854,0.951494288095156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,0.000585473858477009,0.0101496718430191,-0.0193078829538404,0.0204788306707944,0.95400119037542
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,-0.000306067442657607,0.00535758917648752,-0.0108069422285731,0.0101948073432579,0.954444097934286
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39405,-0.000366187700884914,0.00687909430660973,-0.01384921254184,0.0131168371400702,0.957547772099896
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,-0.000216148218645653,0.00415992957976205,-0.00836961019497928,0.00793731375768797,0.958561683097657
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.000257846240474367,0.00515696867767478,-0.00984981236776821,0.0103655048487169,0.960123483993802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37124,0.000220945197945327,0.00449276969755418,-0.00858488340926087,0.00902677380515153,0.960778224795375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,39780,-0.000325783504965476,0.00684132547792204,-0.0137347814416927,0.0130832144317617,0.962019738007714
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.000200480680740861,0.00423626167109166,-0.00810259219459879,0.00850355355608051,0.962254995936355
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,36991,0.000296391725472886,0.00659403424520345,-0.0126279153951259,0.0132206988460717,0.964149068893935
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.000168052183714526,0.00423718959265674,-0.00813683941789269,0.00847294378532174,0.96836379128879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.000230974698781353,0.00607725251648669,-0.0121423896310953,0.0116804402335325,0.969683121903077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.000347139372206515,0.00997298952583356,-0.0198941988428403,0.0191999200984273,0.972233405049854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,39585,-0.000187949632368075,0.00546927586197091,-0.0109077303218311,0.0105318310570949,0.972586825453816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,39585,0.000430025407116541,0.012891029389586,-0.024836392196472,0.0256964430107051,0.973389126615948
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,-7.46763598735387e-05,0.00296287346453495,-0.00588190835036205,0.00573255563061497,0.979892551069687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.000290384606778986,0.0122912970377824,-0.0238005575872746,0.0243813268008325,0.981151856291583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,7.0266543948078e-05,0.00349293408563286,-0.00677588426389232,0.00691641735178847,0.983950519689847
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,4.7292648541823e-05,0.0026849190207275,-0.00521514863208407,0.00530973392916772,0.985946912150873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,0.000114611794918256,0.00650950127891663,-0.0126440107117583,0.0128732343015948,0.985952762275162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,36962,0.000151572376485187,0.00943515857305739,-0.0183413384267073,0.0186444831796777,0.987183071841653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-9.35186723918056e-05,0.00672572472963045,-0.0132759391424675,0.0130889017976839,0.988906281215429
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-6.73358822558626e-05,0.0050151312058514,-0.00989699304572461,0.00976232128121289,0.989287698315915
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,39782,-1.3726591965341e-05,0.00420818986775121,-0.00826177873275772,0.00823432554882703,0.997397445277529
